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ABSTRACT 
 
Background: The prevalence of diabetes in the Middle East is amongst the highest worldwide, 
Bahrain ranks amongst the top 10 countries. In particular, increasing number of children are 
being diagnosed with type 1 diabetes mellitus (T1DM) posing a significant public health 
concern.  
Objective: The aim of this thesis was to characterize the population by exploring lifestyle, 
dietary and health risk factors associated with pediatric T1DM and to undertake a local needs 
assessment to inform the development of management strategies.  
Methodology: An observational case-control study of children with T1DM and healthy controls 
(n=59 and 53; mean age 9.66±1.72 and 9.02±1.88 years respectively) was conducted to ascertain 
baseline characteristics of children with T1DM as compared to healthy children with a 
subsequent more detailed prospective investigation (n=20) of the T1DM population, which 
included a focus on vitamin D intake and status. A systematic review of the effectiveness of 
interventions that seek to improve the management of children and adolescents with T1DM and a 
qualitative study using focus groups with service-users and healthcare workers were undertaken 
to inform the development of a specific educational package targeting the needs of Bahraini 
children with diabetes and their families. The findings of all phases were amalgamated to inform 
the design of an education package and associated feasibility study. 
Results: Children with T1DM appeared to be more likely to have suffered from an illness before 
diagnosis of T1DM than their healthy counterparts. Dietary inadequacies were common in 
Bahraini children irrespective of diabetes diagnosis, particularly excessive sodium intakes, whilst 
children with T1DM consumed significantly more calories than controls and more protein 
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relative to their RDA. Serum vitamin D as measured by CLIA assay method (standard practice) 
and by UPLC/MSMS (gold standard) classified 72% and 50% respectively of the children as 
having suboptimal vitamin D levels.  It appears that dietary intake, sunlight exposure and 
physical activity may to some extent impact the vitamin D status of children with T1DM. The 
systematic review identified facilitators of successful interventions aimed at children and 
adolescents with T1DM such as theoretical based interventions. It also highlighted barriers to the 
real-life integration of such interventions. These factors and the themes identified by the focus 
groups such as a need to focus on adolescents prior to transitioning were incorporated into the 
educational package. 
Conclusion: Children with diabetes do appear to differ from age matched controls with respect 
to health factors and socio-demographic characteristics. Larger confirmatory studies are urgently 
needed.  The feasibility and acceptability testing of the proposed educational package is currently 
ongoing with a planned pilot test of the program within the coming year. 
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1.0 INTRODUCTION 
 
1.1 BACKGROUND AND SIGNIFICANCE  
 
The Kingdom of Bahrain is a small island at the heart of the Arabian Gulf and like many 
of its‘ neighboring countries it has not escaped the epidemic of diabetes. Of particular concern is 
the growing number of children being diagnosed with type 1 diabetes mellitus (T1DM) in the 
Kingdom, which has more than doubled in the past ten years alone (1). In Bahrain‘s largest 
serving hospital, the Salmaniya Medical Complex, health statistics have revealed that the 
incidence rate of T1DM in children has increased from 8 per 100,000 in 1995 to 20 per 100,000 
in 2010 (1).  
The prevalence of adults with diabetes (type I and II) in the Middle East and the North 
African region is considered among one of the highest worldwide (2). Bahrain, in fact, ranks 
amongst the top 10 countries for prevalence of diabetes worldwide (3) and is already strained by 
the economic and health-care burden imposed by this disease in the adult population. This 
increase is of major concern as it not only confers significant costs and morbidity, but is also 
taxing healthcare facilities and resources. The World Health Organization (WHO) estimates that 
approximately one in four adult deaths is attributed to diabetes in the Eastern Mediterranean 
region (4), with diabetes-related deaths in Bahrain increasing from 9% in 2002 to 12% in 2010 
(5).  
Nordic countries such as Finland, Sweden and Norway have reported some of the highest 
incidence rate of T1DM in children under 15 years of age according to a published study by 
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Patterson et al (6). This was followed by Saudi Arabia and the United Kingdom with Kuwait 
ranking 10
th
 as shown in Table 1. 
Table 1 Countries with the highest reported incidence rate of pediatric T1DM according to 
published data in 2013 
 
Rank Country Incidence rate (per 100,000 population aged 
under 15 years)  
1 Finland 57.6 
2 Sweden  43.1 
3 Norway 32.8 
4 Saudi Arabia  31.4 
5 United Kingdom  28.2 
6 Canada  25.9 
7 Denmark  25.1 
8 United States of America 23.7 
9 Australia 22.5 
10 Kuwait 22.3 
 
 
In Bahrain, little or no data is currently available on the lifestyle, dietary, or medical factors, 
including the role of infection or childhood illnesses, on the risk of T1DM. After diagnosis it is 
well recognized that a healthy diet that meets the recommendations for children living with 
diabetes and a healthy lifestyle are important in maintaining good blood glucose control and in 
preventing long-term complications (7). No studies, to the best of the author‘s knowledge, have 
looked into the diet or lifestyle factors of children with diabetes in the Kingdom of Bahrain.  
There is an urgent need for more research on this under-researched yet clinically significant 
population. 
 
Source: Patterson, 2014  
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1.2. CURRENT DIETARY HABITS OF BAHRAINI CHILDREN 
 
Musaiger and Gregory (8, 9) were the first to describe the dietary habits of school children in 
the Kingdom. The children were found to skip breakfast more than any other meal of the day and 
compensated with a heavy mid-morning snack. The authors also noted a decrease in the 
consumption of bread as age increased whilst consumption of carbonated beverages increased.  
In a more recent study, Gharib et al (10) further describes the dietary pattern among Bahraini 
school children; snacking was a common occurrence with consequently high daily sugar 
consumption. Sweets and soda drinks were often consumed but milk, fruit and vegetables were 
not consumed regularly (10). The authors found the average energy intake of children to be 
similar to the Estimated Average Requirement (EAR) but dietary fiber fell short of the 
requirements whilst fat intake, particularly saturated fats, exceeded the recommendation.  
1.3. FACTORS AFFECTING DIETARY INTAKE IN BAHRAIN  
 
1.3.1.  GEOGRAPHICAL LOCATION 
 
The Kingdom Of Bahrain is an archipelago of 33 islands, Bahrain being the largest. It lies 
only 24 kilometers from the east coast of Saudi Arabia and approximately 28 kilometers from 
Qatar. In literal translation Bahrain means ―between two seas.‖  
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Figure 1 Geographical location of Bahrain 
Source:  World Map. Available from http://worldmap.org/country.php?ROG3=BA  
          The Arabian Gulf waters are known to host a variety of fish, a typical food staple. Bahrain 
was given the pseudo name of the ―island of a million palm trees‖ due to its abundance of palm 
trees and dates.  However after the discovery of oil, followed by a rapid economic growth spurt 
and the ongoing land reclamation projects that have since paved the way for luxury hotel resorts, 
there has been a decline in fishing and consequently price inflation. Musaiger et al (11) identified 
these changes in food consumption and described a decrease in the intake of fresh fish and dates 
but an increase in processed foods. The authors described these effects as pertaining to 
increasing income and literacy, food price fluctuations, food subsidy policy, and the influence of 
immigrant food habits (11).  
1.3.2. SOCIOECONOMIC AND DEMOGRAPHIC FACTORS 
Along with the increase in wealth, education and standard of living, there has been a 
rapid expansion of infrastructure in Bahrain. In 1952 the Public Health Department was 
established and was responsible for implementing a solid healthcare infrastructure, providing 
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free health care for all citizens and residents (12).  As a result, over the past three decades, 
Bahrain has seen a rapid change in morbidity, with a decline in communicable disease, but an 
increase in chronic diseases such as diabetes (13-16). 
Due to the sweeping effects of globalization and the ―fast food nation‖ trend, new dietary 
habits are quickly replacing older healthier habits in the Kingdom. The impact of media and 
advertisement on dietary choices was also described as a factor contributing to changes in 
Bahraini diet (11). Lifestyle factors such as a skew towards a more sedentary lifestyle, an 
increase in obesity, are all having an impact on the nutritional intake of Bahraini youth (17). 
1.3.3. RELIGION, CULTURE AND TRADITIONAL FACTORS 
 
Bahrain is a liberal Muslim country and religion has an impact on diet. Foods consumed 
in Bahrain are Halal (food prepared according to Islamic dietary law) and although alcohol is 
served it is considered Haram (forbidden). Familial relationship ties are often centered on food.  
1.4. COMMON NUTRITIONAL RELATED DEFICIENCIES 
 
1.4.1 VITAMIN D DEFICIENCY  
 
Although it is perhaps difficult to comprehend how sun-rich countries so close to the 
equator can suffer from vitamin D deficiency, it has, nevertheless, been a major public health 
concern in the Middle East for the past decade (18). In a recent study looking at the vitamin D 
levels of 403 mothers in labor and their newborns in Bahrain, 358 (88.8%) of the mothers and 
364 (90.3%) of the newborns were found to be deficient as defined by a 25(OH)D level below 50 
nmol/l (19). Furthermore, according to the same cut offs, vitamin D levels were found to be 
deficient in 233 (64%) men used as controls in the study (20). A high income, smoking, lack of 
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sun exposure and high body mass index were significantly associated with vitamin D deficiency 
in men (20) whereas for females, living in flats, lower educational attainment, the use of veil, 
gravida ≥4,  and not using multivitamins, vitamin D or calcium supplements, were found to be 
significantly associated with vitamin D deficiency (19). Moreover, a study looking into the 
dietary intake of vitamin D of these couples found a low mean intake of vitamin D (21) and a 
significant association between dietary intake and 25(OH)D levels in both men and women (21). 
1.4.2 RICKETS 
An inadequate intake of calcium, vitamin D or both can result in rickets. Considering the 
prevalence of vitamin D deficiency in the Middle East, the high incidence rate of rickets in the 
region (22, 23) is not surprising. Limited sun exposure and religious/cultural practices which 
include wearing the veil (22, 23) are believed to contribute to vitamin D deficiency.  
1.4.3 IRON DEFICIENCY ANEMIA 
Iron deficiency anemia is a common problem in the Middle Eastern region, being 
described as one of the major public health concerns in Bahrain (24). In a review conducted by 
Musaiger et al in 2002, looking at iron deficiency anemia in children and pregnant women in the 
Arab Gulf countries, the author found the prevalence rate amongst preschool children and 
school-aged children to range from 20% to 67% and 12.6% to 50% respectively; whilst the 
number of pregnant women suffering from iron deficiency anemia ranged from 22.7% to 
54%.(24).  Musaiger identified risk factors associated with iron deficiency anemia in children in 
these Middle Eastern countries which include poor infant feeding habits and in particular 
inappropriate weaning practices using foods with a low iron bioavailability in children. Parasitic 
infection and geographical location with a higher prevalence in rural rather than urban areas was 
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also identified as risk factors for both children and pregnant women.  Parity and early age at 
marriage were identified as factors associated with iron deficiency anemia in pregnant women. 
(24) 
 
1.5 DEFINING DIABETES 
 
Diabetes is a metabolic disorder characterized by either a complete or relative lack of the 
function of insulin producing beta cells in the pancreatic islets resulting in a hyperglycemic state 
(25). Chronic hyperglycemia can lead to long term damage to the kidneys, heart, eyes, nerves 
and blood vessel (25). Hyperglycemia can result from the autoimmune destruction of the beta 
cells in the pancreas resulting in the impairment of insulin secretion or, a defect of insulin action 
which leads to disturbances in carbohydrate, fat, and protein metabolism resulting in insulin 
resistance (26). Though classically two major forms exist (type 1 and type 2 diabetes), they are 
not completely distinctive and may overlap in clinical manifestation. 
Type 1 diabetes mellitus (T1DM), previously known as juvenile diabetes or insulin-
dependent diabetes, results from an autoimmune destruction of the beta cells which consequently 
leads to an increase in blood and urine sugar levels resulting in impaired glucose tolerance as 
described earlier (27). The classical symptoms of T1DM are frequent urination (polyuria), 
excessive thirst (polydipsia), excessive hunger (polyphagia) and weight loss (26).  
The treatment of T1DM involves the lifetime use of exogenous insulin to help maintain 
normal blood sugar levels. Insulin is often injected subcutaneously although some prefer using 
an insulin pump to deliver insulin. Success rates of pancreas transplants have improved (28) 
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although they are not without risk and complications. Pancreatic islet cell transplantations are 
currently in the experimental phase but show promising results (29).  
Type 2 diabetes (T2DM), previously known as non-insulin dependent diabetes mellitus, 
has been increasing in the pediatric population and has become a major public health concern 
(30).  With T2DM the islet cells are able to produce and secrete insulin however there appears to 
be reduced function or potency due to insulin resistance.  Both genetic and environmental factors 
play a role in the development of insulin resistance (31) with contributions from age, lifestyle 
habits, physical activity, dietary intake and obesity. Obesity is one of the markers of T2DM in 
children with approximately 85% of those diagnosed being overweight or obese (32). 
Treatment of T2DM involves making lifestyle changes such as a shift from a sedentary lifestyle 
to a more active one, eating healthier low fat foods with a focus on whole grains, fruits and 
vegetables, and weight loss if overweight to help control and maintain blood sugar levels. When 
dietary and lifestyle factors fail to normalize blood sugar then medications are often used. Oral 
hypoglycemic agents may be given alone or in conjunction with insulin injections.  
Maturity-onset diabetes of the young also known as MODY, was previously believed to 
be a form of type 2 diabetes (33). However with advances in molecular studies, MODY is now 
referred to as a monogenic diabetes, caused by mutations in an autosomal dominant gene (34). It 
typically presents before 25 years of age (34) and frequently in childhood or early adolescence 
(35). It is not uncommon that people with MODY be mistakenly diagnosed with T1DM or 
T2DM (34). The six gene mutations known to cause MODY are glucokinase (MODY2), hepatic 
nuclear factor 1 alpha (HNF1α) (MODY1), hepatic nuclear factor 4 alpha (HNF4α) (MODY3) 
and insulin protein factor 1 (IPF1) (MODY4), hepatocyte nuclear factor-1β (HNF1β) (MODY5), 
and neurogenic differentiation factor (MODY6) (33). Each mutation results in specific clinical 
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and physiological characteristics of the disease making sub-type specific diagnosis important for 
the provision of optimal treatment (36).  
The prevalence of MODY subtypes differs considerably across Europe (37-39) although 
MODY1 (HNF1α), MODY 2 (GCK) and MODY 3 (HNF4α) appear to be the commonest cause 
of defect. In the first U.K survey of type 2 and MODY diabetes in children, the crude minimum 
UK prevalence of MODY was found to be 0.17/100,000 in comparison to the prevalence of type 
2 diabetes which was found to be 0.21/100,000 in children under 16 years of age (40). In a later 
study which aimed to compare the number of confirmed MODY cases across the U.K and to 
estimate the minimum prevalence, molecular genetic testing found the MODY 3 (HNF1α) and 
MODY 2 (GCK)  mutations to be the most common; they estimated the minimal prevalence rate 
to be 10.8/100,000 in the population (34).  
In Saudi Arabia, the prevalence of MODY was found to be approximately 1/2000, 
(50/100,000) (41). El-Haszmi et al found the prevalence rate of MODY diabetes in a sample of  
8762 children under 14 years of age to be 0.148% (n=13).  In Oman, a small sample (n=20) 
looking at patients with diabetes suggestive of MODY were tested for known mutations as well 
as the three most common MODY mutations recognized in Europe; the results of the study 
showed none of the patients to have the tested mutations including the common MODY 
mutations found in Europe suggesting that patients in that region may have a ―novel‖ form of 
MODY (42). 
MODY is a recognized type of DM and in Bahrain genetic testing allows these cases to 
be effectively identified; despite this, there remains a dramatic increase in children being 
diagnosed with T1DM in Bahrain. This rise in children being identified with T1DM has 
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consequently resulted in an increased workload on the pediatric endocrine clinic and an increase 
in hospital admissions incurring greater healthcare costs.   
1.5.1 PATHOGENESIS OF T1DM 
 
Research into the possible pathogenesis and etiology of T1DM has been extensive and 
although the exact mechanism remains unknown there is a general consensus of the combined 
roles of both genetics and the environment (43-45).   
1.5.1.1 GENETICS 
 
The development of T1DM has been linked to several genes; the most studied being 
perhaps the human leukocyte antigen (HLA) gene which is found in the major histocompatability 
complex (MHC) and the insulin gene. The DR genes found in the HLA region, in particular the 
DR3 and DR4 alleles, have been associated with an increased risk of T1DM development (45). 
Certain alleles in the DQ gene also found in the HLA region confer an increased susceptibility. 
Interestingly different DQ and DR allele combinations can also confer a protective effect (43). In 
effect it seems that although genes found in the MHC have a key role in the pathogenesis of 
T1DM this phenotype requires the presence of other genes to appear  (43).  
Most human studies looking into the genetics of disease development come from twin 
studies. In a Finnish study of twin pairs the concordance for T1DM in monozygotic and 
dizygotic twins was found to be 42.9% and 7.4% respectively i.e. a higher disease concordance 
in monozygotic than dizygotic twins (46). Despite the strong evidence of genetics in the 
development of T1DM, the steady but rapid rise worldwide of the disease does not appear to be 
attributed to changes in the gene pool alone (27, 43). Possible explanations are environmental 
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triggers that instigate a cascade of events leading to the development of T1DM by either direct 
means, or indirect means, by interacting with already susceptible genes.  
1.5.1.2. ENVIRONMENTAL FACTORS 
 
Studies have shown that fetal exposure to maternal enterovirus is associated with an 
increased risk of T1DM development (47, 48). Congenital rubella is a virus known to directly 
cause T1DM in the afflicted offspring (49) and will be discussed further under viral and 
microbial infections (see section 1.5.1.3 p. 27). Maternal age, pre-eclampsia and blood group 
incompatibilities are also associated with an increased risk (50) as are caesarean section 
deliveries (51).  It is hypothesized that infants born via C-section are not exposed to the natural 
bacteria found in the passage of the birth canal, which are involved in priming the immune 
system. 
1.5.1.3 VIRAL AND BACTERIAL INFECTIONS  
 
With improvements in sanitation and hygiene, there has been a dramatic decrease in 
communicable diseases but a rise in non-communicable diseases such as diabetes. It is 
hypothesized that viral infections may perhaps play a role in the development of the immune 
system and that, with improvements in hygiene and the use of vaccinations, the absences of 
immune stimuli weakens the body‘s defense and decreases tolerance to beta cell antigens (43). 
Studies looking into the incidence rate of diabetes and child population density or urban/ rural 
status have found a higher incidence rate in areas of low child population density (52). The 
incidence rate was also found to be higher amongst firstborns and those with children with fewer 
siblings, both consistent with the ―hygiene‖ theory (27). 
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It has long been speculated that viruses, in particular enteroviruses, are potential triggers 
of islet cell autoimmunity. Enteroviruses such as the Coxsackie B Virus (CBV) (53, 54), Epstein-
Barr Virus (EBV) (55) and Cytomegalovirus (CMV) (56) have all been hypothesized to play a 
role in the development of diabetes. Islet cell antibodies (ICA) were detected in congenital 
rubella as well as in children with mumps (57). The seasonal variation in diabetes diagnoses, 
with a higher incidence reported in the winter months and a lower incidence in the summer, 
supports the argument that viral infections either trigger or accelerate the destruction of beta cells 
(27). 
Early exposure to cow‘s milk protein has long been postulated to have an etiological role 
in the development of T1DM (27, 43, 45, 50). It is hypothesized that cow‘s milk protein 
exposure results in an immunological response to the protein and in particular to the bovine 
serum albumin (BSA) which in turn triggers autoimmunity. This is indicated by the presence of a 
higher level of BSA antibodies in newly diagnosed children compared to their healthy 
counterparts (43-45).  
Many studies have looked into the association between T1DM and breastfeeding (58-62) 
although the results are inconclusive with some studies finding a protective effect (60) from 
breastfeeding, others have found no significant relationship (62). Rather than a direct effect of 
breastfeeding per se the association may be mediated by a protective effect of breastfeeding 
against enteroviruses (61) or because longer duration of breastfeeding is likely to also be a 
marker for delayed introduction of cow‘s milk protein and/or gluten containing foods (59, 60). 
Some studies looking into the role of vitamin D and the risk of diabetes development have 
hypothesized that low levels of vitamin D in breast milk may be a potential risk factor perhaps 
explaining a negative association between this form of infant feeding and subsequent diabetes 
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development and hence suggesting a potentially protective role for vitamin D supplementation in 
some mother-infant pairs (63). 
The ‗accelerator‘ theory postulates that the development of both type 1 and type 2 
diabetes is a result of metabolic disturbances which leads to insulin resistance and autoimmunity, 
consequently causing beta cell insufficiency (64). The central concept of the accelerator theory is 
that an increased weight gain is associated with a greater risk of developing T1DM (65).  In a 
large cohort study of 9,248 children (65) the BMI of diabetic children in all age groups was 
significantly higher as was the weight and BMI of newly diagnosed children with T1DM as 
compared to their healthy counterparts.   
1.5.2 DIABETES AND VITAMIN D DEFICIENCY 
 
Vitamin D is often described as a fat soluble vitamin but it also exhibits hormonal 
properties in its active form acting via the vitamin D receptors which are found in most tissues in 
the human body (66). It plays an important role in the regulation of calcium and phosphorus for 
bone mineralization in the body (67) but more recently vitamin D has been recognized for its role 
in the immune function and modulation of cell growth as well as its  role in  the inflammatory 
process (68). Vitamin D deficiency has also been linked to cardiovascular diseases, diabetes 
mellitus, autoimmune disorders, and certain cancers (69, 70). There are two forms of vitamin D, 
which are of particular importance; vitamin D2 and vitamin D3. Vitamin D2, also known as 
ergocalciferol, is synthesized by plants whereas vitamin D3, known as cholecalciferol, is 
produced by the skin. Foods may be fortified with either vitamin D2 or D3 (71) although D2 is 
most commonly used in both food fortification and for prescription supplements. It is worthy to 
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note that few foods naturally contain vitamin D. Fatty fish and fish liver oils are a good source 
whereas eggs and cheese contain a small amount.  
Vitamin D can be produced endogenously by the skin via photosynthesis using ultraviolet 
B light (UVb) which converts 7-dehydroxycholesterol (7-DHC) to pre-vitamin D3.It can also be 
obtained from the diet or from a dietary supplement. Regardless of whether it is obtained from an 
endogenous or exogenous source, this form of vitamin D is inert and must undergo a series of 
hydroxylation reactions to convert it to its active form (49). Vitamin D is converted to calcidiol 
also known as 25-hydroxyvitamin D. This reaction occurs in the liver whereas the conversion of 
25-hydroxyvitamin D  to 1, 25-dihydroxyvitamin D occurs primarily in the kidney. Vitamin D in 
the form of 1, 25-dihydroxyvitamin D, also known as calcitriol, is the biologically active form of 
vitamin D. When measuring serum levels of vitamin D, 25(OH)D2 (calcidiol) is measured and is 
considered a good indicator of vitamin D levels (72). 
Studies have reported on the difference in bioavailability between vitamin D2 and D3 
(73-76) with D2 suggested to be a relatively lower potency than D3.  Houghton et al noted that 
vitamin D3 appeared to be more efficient at raising serum vitamin D levels and at maintaining 
these levels (77), whilst Romagnoli noted that vitamin D3 was twice as effective, whether 
administered orally or intramuscularly, at raising serum levels compared to D2 (76). A review 
and meta-analysis of RCT‘s showed that vitamin D3 supplementation has a significantly greater 
effect on raising serum vitamin D levels in comparison to vitamin D2 regardless of the dose 
administration, although the reason for this remains unclear and requires further investigation 
(78); Houghton et al speculate that vitamin D3 metabolites may have a greater affinity to vitamin 
D-binding proteins than vitamin D2.  
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In a large birth cohort study which involved over 12,000 infants born in 1966 and 
followed up until 1996, Hypponen et al found that children who were regularly supplemented 
with vitamin D in the first year of life had a reduced risk of developing T1DM (79). Data on the 
vitamin supplementation of those children within the first year of life was recorded as being 
regular, irregular or without supplementation and where supplementation had occurred, the dose 
was categorized as being either below, within, the recommended intake at the time (2000 IU). 
These results are supported by the EURODIAB sub-study group in which they also found a 
reduction in the risk of development of T1DM in reportedly supplemented children versus non-
supplemented (80). This study involved seven European countries with access to registries of 
patients with T1DM and applied a case-control design to investigate risk factors for T1DM.  In 
all, 820 patients with T1DM and 2334 controls were involved but the questionnaires and 
interviews used to gather data did not collect details on the form or level of supplementation that 
was given.   
1.5.2.1 PROPOSED ROLE FOR VITAMIN D IN DIABETES DEVELOPMENT  
 
As mentioned previously vitamin D is involved in the regulation of calcium metabolism 
along with the parathyroid hormone (PTH) that work both directly and indirectly to maintain 
calcium homeostasis. The presence of vitamin D receptors in the pancreas is believed to be a 
strong indicator of its role in insulin secretion and glucose tolerance (66). It is hypothesized that 
vitamin D influences insulin production by increasing intracellular calcium concentration which 
in turn results in the secretion of insulin from the beta cells (66, 67, 71). Vitamin D is also 
believed to mediate the activation of the calcium endopeptides which play a role in the 
conversion of proinsulin to insulin (66, 71). In addition a role has been hypothesized in the 
expression of insulin receptors which work to enhance insulin action (66). 
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1.5.2.2. IMMUNE MODULATION 
  
Vitamin D receptors (VDR‘s) have been identified on many of the cells of the immune 
system (66). As mentioned earlier, imbalances in inflammatory mediators, pro-/anti cytokines 
such as transforming growth factor beta 1 ( TGF-b1),  interferon gamma (INF-g), interleukin-1 
receptor  antagonist (IL-1ra), interleukin-1 alpha (IL-1a), interleukin -1b (IL-1b), IL-4, IL-6, IL-
12 and tumor necrosis factor (TNF)-a have been implicated in the pathogenesis of T1DM (71).  
These inflammatory mediators and cytokines are produced by the immune system from activated 
T and B lymphocytes, dendric cells (DCs), natural killer cells (NK) and macrophages, all of 
which have VDRs  (66, 71). Physiologically lymphocytes can be divided into two major subsets; 
T helper 1 (TH1) and T helper 2 (TH2).  The function of TH1 is mainly cell-mediated immune 
responses that produce inflammatory mediators, cytokines and produce IL-2, IFN-g, TNF-a and 
TNF-b. TH2, on the other hand, acts as a mediator and activates beta-cells and antibody 
production and produces IL-4, IL-10, IL-13 and TGF-b which promote humoral immunity (71). 
Vitamin D acts to suppress the release of TH1 causing a shift toward the production of TH2. It 
also promotes the production of anti-inflammatory cytokine IL-4 and prevents beta-cell damage 
caused by the pro-inflammatory cytokines by acting as an inhibitor (71).  
Studies on the NOD (non-obese diabetic) mouse models (considered highly relevant to 
models of human disease) have resulted in a wealth of information especially with regards to the 
role of the immune function in the development of T1DM (81). Enteroviruses as mentioned 
earlier, have been of focus for the past decade (82) and there is strong, albeit, circumstantial 
evidence for their role  in the development of T1DM. Several reviews have stated convincing 
evidence that T1DM is linked to infection from enterovirus (83-86) and in particular the 
Coxsackie virus B1 (87, 88). A study conducted by Larrson et al, in which a prototype vaccine 
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against the Coxsackie virus B1 was developed and evaluated for safety resulted in protection 
from the virus without accelerating diabetes development (89). The development of diabetes was 
however, significantly earlier in mice that were not vaccinated and exposed to the virus 
compared to those that had been vaccinated although the vaccine did not prevent or delay 
progression of disease. More recently Yoon et al (90) tested a prototype vaccine with the aim of 
re-educating the immune system to insulin specific autoantigens; the results were promising as 
the vaccine was able to protect 40% of the vaccinated mice from developing diabetes compared 
to the control mice that all went on to develop diabetes (90). 
1.5.2.3 ANTIOXIDANT EFFECT 
 
Reactive oxygen species (ROS) can cause considerable damage at a cellular and nuclear 
level by destroying cell organelles and damaging DNA, leading to cell death by apoptosis (71).  
People with diabetes have been shown to have increased oxidative stress due to overproduction 
of ROS coupled with an impaired ability to neutralize their effects (71).Vitamin D may act as an 
antioxidant by scavenging different ROS and blocking cellular immunity mediated by TH1 (71). 
1.6 MANAGEMENT OF T1DM 
 
The findings of the Diabetes Control and Complication Trial (DCCT) conducted in 1994 
became the cornerstone of diabetes management (91), showing that improved glycemic control 
in T1DM (via three or more daily injections of insulin a day, a minimum of 4 bloods glucose 
reading and dose adjustments for a target of 3.9 to 6.7 mmol per liter  (70 to 120 mg per 
deciliter) pre-prandial and levels less than 10.0 mmol per liter (180 mg per deciliter) postprandial 
was significantly associated with a decrease in complications. The findings of the study 
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ultimately led to a change in policy and practice in the healthcare of people suffering from 
T1DM.  
The DCCT trial examined the effect of intensive insulin treatment with the aim of 
maintaining blood glucose levels in the near normal ranges. The study, which ran over 6.5 years, 
compared a group of participants on intensive treatment and a control group that received 
standard care. In total 1441 patients were recruited from 29 centers between 1983-1989 across 
the United States and Canada. The results of the DCCT trial showed an approximate 60% 
reduction in the risk of developing diabetic retinopathy, nephropathy, and neuropathy (91). The 
benefits of intensive therapy not only delayed onset, but slowed down the progression of 
microvascular complications regardless of gender, age, and onset of diabetes. This prompted the 
American Diabetes Association to review its policy concluding that the primary treatment goal in 
T1DM should be to maintain tight blood glucose control using intensive therapy (IT) which can 
be achieved by using multiple daily injections (MDI‘s) or continuous subcutaneous insulin 
infusion (92). 
The DCCT trial was not without limitations; one of the main adverse events of the trial 
was a significant two-threefold increase in hypoglycemia attacks (93) and weight gain (94). 
Furthermore, the results of the trial failed to show a reduction in cardiovascular morbidity or 
mortality (95) although this was rationalized as being due to the fact that the participants 
recruited were young (13-39 years) hence less likely to demonstrate cardiovascular 
complications in the time-frame of the study.  
In the United Kingdom, the United Kingdom Prospective Diabetes Study (UKPDS) 
found results similar to the DCCT trial but for people with T2DM. The trial was a multicenter 
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trial involving 23 clinics in the United Kingdom, recruiting 5,102 patients with newly diagnosed 
T2DM. The study, which ran for twenty years from 1977 to 1997, showed that intensive blood-
glucose control (achieved by obtaining a fasting plasma glucose of less than 6 mmol/l in 
conjunction with either insulin or an antidiabetic drug) in T2DM could reduce and even slow the 
progression of microvascular complications but not macrovascular disease (96). 
1.7 STRUCTURED AND PSYCHO-SOCIAL EDUCATION IN THE MANAGEMENT OF T1DM 
 
In 1948 the definition of health by the World Health Organization as ―being a complete 
state of physical, mental and social well-being, and not merely the absence of disease or 
infirmity (97)‖  revolutionized the way health care was perceived. Health was no longer to be 
viewed solely from a physical perspective but from a more holistic one that embraced the 
psycho-social wellbeing of individuals. Applying this to chronic conditions such as diabetes can 
be particularly challenging due to the potentially negative psycho-social conditions of managing 
a long term health issue. Diabetes management is particularly challenging for children and 
youths as they try to juggle the use of multiple daily injections, frequent blood glucose 
monitoring, balancing carbohydrates with insulin or managing their blood sugar whilst being 
physically active, travelling or when they fall ill.  It is also challenging for the parents of those 
children whom often must assume the responsibility of such oppressive regiments.  
There is a clear and documented link between diabetes and depression in adults (98, 99) 
which ranges in prevalence from 14.4% to 32.5% (100). Furthermore, depression in adults with 
T1DM also appears to increase the risk of diabetes complications (101) which in turn incurs 
greater health care costs (102). The psycho-social impact of diabetes extends beyond health to 
impact also on quality of life (QoL) and overall functioning (99, 103). The prevalence of 
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depression is believed to be two-folds higher in children and three folds higher in adolescents 
with diabetes compared to their healthy counterparts (104). Specifically, studies have identified a 
depression prevalence in children and adolescent with diabetes between 0.8% and 8.3% (105, 
106) with a marked increase in adolescence due to the added burden associated with this age 
group as a result of attempts to gain autonomy from caregivers, adapting to body changes  
related to puberty and body image issues (107). Some documented consequences of depression 
in children or youth with diabetes include poor adherence to diabetes regimen, including poor 
compliance with insulin injections, dietary management  and monitoring blood glucose (108, 
109),  as well as a poorer quality of life (110), and lower self-esteem (111). It has also been 
linked with an increased incidence of eating disorders (108) and suicide or suicidal thoughts 
(112) in this patient group.  
Management of diabetes from a physical and medical perspective has come a long way 
was since the discovery of insulin by Banting and Best in 1921 (113). However from a psycho-
social perspective, studies determining the effectiveness of psycho-social and educational 
interventions that seek to not only improve glycemic control but also outcomes such as QoL, 
diabetes self-efficacy, and stress in children and youths with T1DM are of great importance,  
especially in light of the real risk from co-morbidities such as suicidal thoughts and eating 
disorders (100). Although it appears that health-related QoL can be improved by such 
interventions, knowing which particular aspect of the intervention brings about the change is not 
always easy to measure. A systematic review of the most recent studies that seek to determine 
the effectiveness of educational and psycho-social interventions are further explored and 
described in Chapter 7.  
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1.8 STUDY RATIONALE 
 
In conclusion, the increasing number of children being diagnosed with T1DM is of great 
concern and requires immediate attention from researchers and clinicians alike. As there are 
currently no studies, to the best of the author‘s knowledge, aimed at identifying modifiable 
factors such as dietary intake, lifestyle or health-risk factors associated with the development of 
T1DM in the Kingdom, there is an urgent need for such research in this clinically significant 
population. By understanding the modifiable correlates of diabetes development alongside the 
user- and health care professional-identified needs in this population and in the region we can 
design a more effective tailored education package to address the current gaps in evidence-based 
practice.  This will aim to optimize the management of those already living with type 1 diabetes 
in the region and inform the development of future preventative research and strategies to 
ultimately reduce the considerable social and economic burden conferred by this condition in the 
Kingdom.  
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2.0 AIMS AND OBJECTIVES 
 
The overall aims of this program of work are: 
 
Aim 1:  
To investigate the lifestyle, dietary intake, and health risk factors associated with the risk of 
T1DM in children in the Kingdom of Bahrain. 
Aim 2: To develop an educational package that specifically targets the needs of Bahraini children with 
diabetes and their families as informed by the needs of the healthcare workers and service-users. . 
The study will be conducted in FOUR phases: 
PHASE I: CHARACTERIZING THE POPULATION – RETROSPECTIVE 
 
This phase will involve the investigation of a cohort of children aged 6-12 newly 
diagnosed with diabetes in the years 2009 and 2010 in the Kingdom. A control group of children 
matched by age, and demographic location will be sought from primary health care centers. The 
specific aims and objectives of this phase will be:  
Specific Aim 1: To describe the food habits/traditions of Bahraini children with and without 
diabetes.  
Specific Aim 2: To determine if the nutritional intake of Bahraini children with diabetes meets 
the current recommended intake. 
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Specific Aim 3:  To investigate the association between lifestyle factors, such as geographical 
location, activity levels, psychosocial issues, infant feeding habits and T1DM occurrence in a 
pediatric cohort. 
Objectives:   
 To extract relevant data from an existing internal registry. 
 To recruit an appropriate control group. 
 To analyze dietary intakes of children in the case and control groups via\ nutrition 
analysis software (Food Processor Software SQL version 10.70, ESHA Research). 
 To assess the adequacy of their dietary intakes as compared to U.S. Recommended 
Dietary Intakes (RDA) as well as recommendations from the International Society for 
Pediatric and Adolescent Diabetes (ISPAD).  
 To compare, using a statistical software package (SPSS version 21, SPSS Inc.) the health 
and dietary factors of children with T1DM with aged matched healthy comparators.  
 
 
Objectives:   
PHASE II: CHARACTERIZING THE POPULATION - PROSPECTIVE 
 
In this phase, dietary intake as well as lifestyle factors will be investigated in more 
details. The serum vitamin D levels of a subgroup of children with diabetes will also be 
measured and compared to data on dietary intakes of vitamin D from a 24hr food recall. Cases 
will also be asked to provide information on diet and lifestyle factors relating to vitamin D status 
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through completion of a food frequency questionnaire and lifestyle questionnaire. The specific 
aims and objectives of this phase are:  
Specific Aim 1: To investigate in detail the dietary, lifestyle behaviors, and physiology of a small 
but representative sub-sample of newly diagnosed children aged 6-12 with diabetes. 
Objectives:   
 To prospectively recruit an appropriate sample of newly diagnosed children with T1DM  
 To obtain and analyze the dietary intakes (three, 24-hr diet recalls) via region-specific 
nutrition analysis software. 
 To administer a vitamin D specific FFQ questionnaire to all participants. 
 To administer the Child Physical Activity Questionnaire (CPAQ) to all participants to 
assess activity level. 
 To analyze all the data via statistical software package to assess any association between 
physiological factors such as body composition/vitamin D levels, or lifestyle factors such 
as activity levels/ frequency of sunlight exposure, and diabetes prevalence. 
PHASE III: DEVELOPMENT AND TESTING OF AN EDUCATION PACKAGE 
 
This phase will involve the development of an educational package that specifically 
targets the needs of Bahraini children with diabetes and their families and care givers. 
Specific Aim 1: To investigate the beliefs and attitudes of a representative sample of children 
with diabetes, their care givers and their families with respect to the etiology and management of 
diabetes in Bahrain. 
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Objectives:   
 To conduct focus groups with the families of a sample of children with diabetes to 
investigate their beliefs/ knowledge about the etiology and the management of T1DM 
including their perception of the admission, education, discharge and follow-up services 
provided as well as exploring recommendations. 
 To conduct focus groups with the pediatric nurse educators and endocrinologist to 
investigate their role in the management of diabetes; perceived barriers to the education 
process as well as behavioral changes and future recommendations. 
 To record and transcribe the focus groups so as to identify common themes. 
 
Specific Aim 2: Undertake a review of the effectiveness of interventions conducted in clinical 
settings that seek to improve the management of children and adolescents with T1DM  
Objectives:   
 To conduct a search of reviews that have already addressed this topic to determine where 
there is a gap in knowledge to be addressed or present an update of new papers since last 
review published. 
 To search electronic databases for new RCT‘S conducted since last published review on 
MEDLINE, Psych INFO, PubMed, Embase, Scopus etc. 
 To identify papers suitable for review, extract relevant data and synthesize to inform the 
development of the Bahraini education resource. 
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Specific Aim 3: To develop an evidence-based education package specifically targeting the needs 
of children with T1DM and their families and care givers. 
Objective:   
 To gather the findings of the qualitative study and the systematic review in order to 
inform the design of an education package for the local population. 
 
Specific Aim 4:  To assess the feasibility of implementing such an intervention. 
Objectives:   
 To present the proposed intervention to the pediatric nurse educators, endocrinologist and 
patients to obtain feedback on the feasibility of implementing the intervention in a real 
clinical setting.  
 To design a pilot test protocol and parallel evaluation strategy for the implementation of 
the education package. 
Phase IV: Dissemination 
This phase involves disseminating the results of the studies to key stakeholders. During 
this phase preparation will be made for the publication of the studies. 
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3.0 CHILDREN WITH TYPE 1 DIABETES & THEIR HEALTHY 
COUNTERPARTS- A CASE-CONTROL STUDY 
 
3.1 INTRODUCTION 
In Bahrain‘s largest serving hospital, the Salmaniya Medical Complex, health statistics 
have revealed an increasingly alarming number of children being diagnosed with type 1 diabetes. 
Although there are no national registries that exist for children with diabetes in the Kingdom of 
Bahrain, an internal registry exits at the Pediatric Endocrine and Diabetes Unit in the Salmaniya 
Medical Complex (SMC). 
The aim of this study was to perform an audit of the Diabetes Registry Form (DRF) 
(Appendix 1) available at the Pediatric and Endocrine Diabetes Unit in the Salmaniya Medical 
Complex and to compare lifestyle factors, psychosocial issues, infant feeding habits, dietary 
habits, childhood illness, and maternal pre and postnatal history of children with T1DM with age 
matched healthy comparators. 
3.2 EXPERIMENTAL DESIGN & METHODOLOGY 
ETHICS APPROVAL 
This study was approved by the Salmaniya Medical Complex Health Research 
Committee and the Primary Health Care Health Ethics Research Committee in Bahrain 
(Appendix 2). Data was collected from the existing DRF for the control groups whereas 
informed and signed consent was obtained from the parents or legal guardians of the control 
group prior to administering the similar questionnaire. 
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3.2.1 EXPERIMENTAL DESIGN & METHODOLOGY-CASE GROUP 
STUDY AREA/SETTING: 
The information was gathered from the Pediatric Diabetes Unit at the SMC complex 
where all completed Diabetes Registry Forms (DRF) for children with confirmed T1DM and 
T2DM are archived. The DRF is an existing data collection tool used to gather information on all 
patients with diabetes and includes information on:  
 Demographic characteristics 
 Current medical regimen (insulin) 
 Infant feeding method 
 Past medical history 
 Family history of - diabetes and/or other diseases or known disorders 
 Psychosocial issues 
 Lifestyle habits which includes usual food intake 
STUDY SUBJECTS:  
The study subjects were children aged 6-12 diagnosed receiving a confirmed diagnosis of 
T1DM informed by either antibody or genetic testing, and attending the Pediatric Endocrine 
Clinic in the years 2009 or 2010.  
STUDY DESIGN:  
The study design was a descriptive study of children aged 6-12 with confirmed case of T1DM. 
INCLUSION CRITERIA  
The inclusion criteria for study subjects were as follows: 
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 The subject was registered as a confirmed case of T1DM at the Pediatric Diabetes Unit 
(PEU) 
 The subject was between 6 and12 years of age at diagnosis 
 The subject was followed up at least once at the Pediatric Diabetes Unit 
 The subject had a completed Diabetes Registry Form (DRF) 
EXCLUSION CRITERIA 
 Children with T2DM 
 Children not having received a confirmed diagnosis of T1DM 
 Children with an incomplete DRF 
  Children not followed up at least once at the SMC 
 Children not within the specified age group 
DATA COLLECTION METHODS: 
The DRF for all subjects was obtained from the Pediatric Diabetes and Endocrine Unit. A 
24 hour food recall gathered by a licensed dietitian or nutritionist at time of admission was also 
available for analysis; the results of which will be discussed in Chapter 4.  All information was 
kept strictly confidential, with subjects allocated a unique identification number.  
3.2.2 EXPERIMENTAL DESIGN & METHODOLOGY-CONTROL GROUP 
 
STUDY AREA/SETTING: 
 A control group of children matched by age, sex, and demographic location were 
prospectively sought from Primary Care Centers, also known as Local Health Centers (LHC) 
from across the Kingdom. Subjects were selected based on whether they met all inclusion criteria 
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and were rejected if they met anyone of the exclusion criteria.  Healthy controls were sought 
from LHC‘s as opposed to children free from diabetes within the Salmaniya Complex so as to 
decrease any confounding effect that a chronic or acute disease may have on dietary and health 
factors.   
STUDY SUBJECTS:  
 
The criteria for the control group: 
 Child between 6-12 years of age visiting LHC  
 Free of any chronic diseases 
 Accompanied by a legal guardian or parent 
DATA COLLECTION METHODS: 
Subjects were approached directly by interviewers. If the subjects met the age criteria, the 
parents were given a brief overview of the study and asked if they were interested in 
participating. If they agreed a letter was given to the parents or legal guardian with details 
regarding the study and informed signed consent was obtained prior to investigation. 
The height and weight of the control group children was measured by a licensed dietitian 
using standardized methods. A 24hr food recall was obtained from the parents in the presence of 
the child by a licensed dietitian or nutritionist. 
The DRF was modified, with any non-relevant information (i.e. type of diabetes, insulin 
regimen etc.…) removed, and administered to the control group once consent was obtained. 
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Demographic, medical and other data was obtained directly from the parent or legal guardian 
(See Appendix 4).  
3.3 ANALYSIS 
All data from the DRF for children with T1DM and data from the questionnaire obtained 
from healthy controls were entered into a spreadsheet and analyzed using SPSS version 21 
(SPSS Inc.). Normality was tested for using the Kolmogorov-Smirnov test. Differences between 
subgroups were analyzed using Chi Square or independent t-test as appropriate. Logistic 
regression analysis was used to evaluate independent predictors of T1DM. A P value < 0.05 was 
considered significant. 
3.4 RESULTS 
In total 59 children with T1DM met the criteria and were included in the study and 
compared to 53 healthy children. The case and control groups were matched for age, BMI, 
gender and geographic location. Demographic information (see Table 2) showed that children 
with T1DM were more likely to be Bahraini nationals (p<0.001) although there was no 
significant difference in self-reported race, with 95% of children being described as of Arab 
origin. A non-uniform distribution of subjects selected from different governorates, although 
non-intentional, reflects the more densely populated areas. 
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Table 2 Baseline characteristics of children recruited to the case-control study at the SMC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         1
SD: Standard Deviation, 
a
Mann Whitney,
 b
 Chi Squared, 
c 
Fisher Exact 
 
 
 
Control Cases  
P Value Mean 
(SD
1
) 
n % Mean 
(SD
1
) 
n % 
Age in years 
9.02 
(1.88) 
53 
 
9.66 
(1.72) 
59 
 
0.063
a
 
BMI percentile 
 
48.80 
(35.76) 
53 
 
 
43.73 
(37.31) 
51 
 
 
0.505
a
 
Nationality 
Bahraini  50 94.3  37 62.7 
< 0.001
b
 Non-
Bahraini 
 3 5.7  22 37.3 
Gender 
Male  24 45.3  29 49.2 
0.682
b
 
Female  29 54.7  30 50.8 
Race 
Arab  53 100  56 51.4 
0.245
c
 
Non-Arab  0 0  3 48.6 
Religion 
Muslim  53 100  56 51.4 
0.245
c
 
Non-Muslim  0 0  3 48.6 
Governorate 
Muharraq  13 24.5  7 12.1 0.088
b
 
Capital  7 13.2  13 22.4 
Northern  18 34  12 20.7 
Central  15 28.3  25 43.1 
Southern  0 0  1 1.7 
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Medical history, as shown in Table 3, revealed that children with T1DM were more likely 
to have suffered from an illness such as tonsillitis than healthy children (54.2% and 5.7% 
respectively; p< 0.001) or to have undergone surgery prior to diagnosis (23.7% and 3.8% 
respectively; p=0.001). Logistic regression analysis showed that children who reported suffering 
from an illness prior to diagnosis were approximately fifteen times more likely to develop 
diabetes [(OR 15.647) 95% CI, 4.075-60.07; P<0.001] than children who did not report an 
illness. However, logistic regression showed no significant relationship (p=0.096) between 
surgeries performed and the risk of developing diabetes. Other common diseases such as 
glucose-6-phosphate deficiency (G6PD), sickle cell disease/trait (SCD/SCT) and thalassemia 
were not found to be significantly associated with diabetes diagnosis. 
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 Table 3 Medical history of children with T1DM and healthy controls 
 
a 
Chi Squared, 
b 
Fisher Exact 
G6PD, Glucose-6-Phosphate deficiency; SCD/SCT, Sickle-cell disease/ Sickle-cell trait 
 
 
Pre and post-natal history shown in Table 4 revealed that mothers of T1DM children 
were more likely to have had gestational diabetes (GDM) (p=0.053) and to have used medication 
during pregnancy than mothers with healthy children. Logistic regression analysis showed a 
significant but weak association (OR 1.7, 95% CI,(1.086-2.637))  between maternal use of 
medication and the risk of offspring‘s developing diabetes; no significant relationship was found 
for mothers with GDM (p=0.065).  Rates of pregnancy complications, gestational hypertension 
or prescribed drug use and exposure to toxins were not found to be significantly associated with 
diabetes diagnosis. 
 Cases      Control 
P-value 
 
OR (95% CI) 
 
Logistic 
Regression 
P-value 
 
n 
 
  %           n   
 
% 
G6PD 
No 51 96.2 53 89.8 
0.277
b
 8.656 (0.342-218.56) 0.190 
Yes 2 3.8 6 10.2 
SCD/SCT 
No 45 84.9 55 93.2 
0.155
a
 0.454 (0.099-2.308) 0.341 
Yes 8 15.1 4 6.8 
Thalassemia/
Trait 
No 51 96.2 58 98.3 
0.602
b
 0.058 (0.002-1.894) 0.109 
Yes 2 3.8 1 1.7 
Surgeries 
No 51 96.2 45 76.3 
0.003
a
 
 
4.687 (0.761-28.86) 
 
0.096 
Yes 2 3.8 14 23.7 
Child Illness 
No 50 94.3 27 45.8 
< 0.001
b
 15.647 (4.075-60.074) < 0.001 
Yes 3 5.7 32 54.2 
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Table 4 Pre and postnatal maternal history 
 
 Cases Control 
P-
Value 
 
OR (95% CI) 
 
Logistic 
Regression 
P-Value 
n % n % 
Pregnancy 
Complications 
Yes 7 13.2 11 18.6 0.434
a
 
0.984 (0.276-
3.504) 
0.981 
Gestational DM Yes 4 7.5 12 20.3 0.053
a
 
3.220 (0.932-
11.127) 
0.065 
Gestational HTN Yes 3 5.7 9 15.5 0.095
a
 
3.685 (0.774-
17.53) 
0.101 
Medication use during 
pregnancy 
Yes 12 22.6 8 13.6 0.034
a
 
1.704 (1.086-
2.637) 
0.020 
Smoking/Drug use 
during pregnancy 
Yes 1 1.9 2 3.4 1.000
b
 
0.868 (0.05-
13.947) 
0.921 
Toxin/Radiation 
Exposure in pregnancy 
Yes 1 1.9 3 5.1 0.620
b
 
2.400 (0.213-
27.081) 
0.479 
a
 Chi Squared, 
b 
Fisher Exact 
 DM, diabetes mellitus; HTN, hypertension 
 
Investigation into the families past medical history identified children with T1DM to be 
more likely to have mothers with T2DM (p=0.053) as shown in Table 5, but a family history of 
T1DM was rarely reported in either group. There was a trend towards a significant relationship 
between maternal hypertension and diabetes (p= 0.095). However, logistic regression analysis 
did not reveal a significant and independent relationship between parental hypertension and 
diabetes. 
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Table 5 Parental history of diabetes and hypertension 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
Mann Whitney, 
b
 Chi Squared 
Hx, history; T1DM, Type 1 Diabetes; T1DM, Type 2 Diabetes 
 
 
No significant difference between children with T1DM and their healthy controls was 
found for infant feeding practices. Approximately 32.8% of the case group and 17% of the 
control children were breastfed beyond 18 months of age (see Table 6). 
 
 
 
 
 Control Cases P-Value  Logistic 
Regression 
P-Value n  % n  % 
Maternal Hx T1DM 
No 53 100 59 100.0 
- - 
Yes 0 0 0 0.0 
Paternal Hx T1DM 
No 52 98.1 58 98.3 
1.000
b
 0.999 
Yes 1 1.9 1 1.7 
Maternal Hx T2DM 
No 53 100 53 91.4 
0.058
b
 0.999 
Yes 0 0 5 8.6 
Paternal Hx T2DM 
No 47 88.7 51 86.4 
0.781
a
 0.619 
Yes 6 11.3 8 13.6 
Maternal Hx 
Hypertension 
No 53 100 54 91.5 
0.059
a
 0.999 
Yes 0 0 5 8.5 
Paternal Hx  
Hypertension 
No 53 100 57 96.6 
0.497
b
 0.999 
Yes 0 0 2 3.4 
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Table 6 Infant feeding history of children with T1DM and their healthy counterparts 
 
 
1
SD: Standard Deviation, 
a
Mann Whitney, 
b
 Chi Squared, 
c 
Fisher Exact 
EBF, exclusive breast feeding 
 
3.5 DISCUSSION  
 
This study is the first of its kind to report on the lifestyle and medical factors associated 
with T1DM in Bahrain. Although this study was unable to fully examine the role of genetics in 
the etiology of diabetes, it appears to supports the role of infection as a potential trigger for 
T1DM, with just over half of the children with T1DM having reported suffering from an illness 
prior to diagnosis. The role of infection in the pathogenesis of T1DM has been studied 
extensively in both animal models (114-117) and in epidemiological studies (118, 119) (refer to 
Chapter 1, Environmental factors). In particular, certain enteroviruses have been found to cause 
 Control 
n=53 
Cases 
n=58 Chi-Square 
P-value 
 
OR (95% 
CI) 
 
Logistic 
Regression 
P-value % % 
Feeding 
History 
Bottle Fed 7.5 5.2 
0.769 
0.918 
(0.755-
1.115) 
0.389 
Mixed breast & 
Bottle Fed 
7.5 15.5 
EBF <6 months 17 20.7 
Breastfed 6-<12 
months 
9.5 8.6 
Breastfed 12-<18 
months 
17 17.2 
Breastfed 18+ months 41.5 32.8 
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beta-cell destruction (120) and can lead to T1DM. However caution is advised when interpreting 
the results of this study due to the relatively small sample size and potential bias introduced in 
the selection method. 
The role of bacterial involvement either as a protective mechanism or an instigator in the 
development of T1DM has also been researched in recent years (121).  The ―hygiene theory‖ 
previously mentioned supports the notation that improper priming of the immune system as a 
result of decreased exposure to infections is correlated with a rise in T1DM, supported by studies 
that have shown a high incidence in first born children who are less exposed to infections than 
their siblings, and in rural,  less crowded areas, as opposed to urban areas (52, 122). The ―trigger 
theory‖ supports the notion that microbes trigger a cascade of autoimmune processes that 
ultimately leads to the destruction of beta-cells (121).  The role of gut microbiota have also been 
investigated as a possible trigger with the proposed mechanism involving  an interplay between 
three risk factors: abnormal intestinal microbiota, a leaky mucosal barrier also known as ―leaky 
gut‖, and alteration in intestinal immune response described by Vaarla and colleagues as being 
the ―perfect storm‖ for T1DM development (123).  Whilst the mechanism is unclear, changes in 
the microbiota appear to affect the development of T1DM as demonstrated in animal models 
(124-126) where the possible protective effect of certain gut microbes has also been shown. In 
particular studies on mice have shown that feeding the probiotic lactobacillus casei to non-obese 
mice prevented the development of diabetes and improved immune response (124). In a study 
conducted by Calcinaro et al, non-obese diabetic female mice were fed an oral dose of the 
probiotic VSL#3 three times a week from 4 weeks of age, which prevented the development of 
diabetes and was associated with an increase in the production of interleukin-10 (IL-10) 
(125).The probiotic induced IL-10 lymphocytes (an anti-inflammatory cytokine) which were 
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found in the spleen and the pancreas of the supplemented mice and appeared to confer a 
protective effect on the beta cells down regulating destructive autoimmune insulitis (125). 
Similar results were seen in rats fed lactobacillus casei and lactobacillus acidophilus with regards 
to the progression of induced T2DM against a background of a high fructose diet (126). In the 
latter study the authors were able to demonstrate a significant delay in the onset of glucose 
intolerance and hyperglycemia amongst other parameters tested (126). 
The aforementioned ‗leaky gut‘ is characterized by abnormalities in the intraepithelial 
junctions in the gastric mucosal barrier which are thought to allow the passage of antigens that 
are normally contained in the gut.  It is hypothesized that these antigens, exposed to the intestinal 
immune system, trigger an autoimmune response that ultimately leads to the destruction of beta 
cells and development of T1DM (123). Interestingly, bovine serum albumin (BSA) found in 
cow‘s milk protein (as mentioned in Chapter 1) is also hypothesized to trigger autoimmunity and 
studies on newly diagnosed children with T1DM have found a higher level of BSA antibodies 
compared to their healthy counterparts (43-45).  The Trial to Reduce IDDM in the Genetically at 
Risk (TRIGR) study is  currently  investigating whether eliminating cow‘s milk protein and 
weaning infants to a highly hydrolyzed formula can reduces the risk of T1DM later in childhood 
(127).  The study is a double-blinded, prospective, placebo controlled intervention trial involving 
over 15 countries and 77 centers that commenced in 2007. It has recruited 2160 newborns with a 
first degree relative with T1DM. The study, which ends in 2017, is based on encouraging pilot 
test results which demonstrated a 50% reduction in cell autoimmunity in children who received 
the hydrolyzed formula as opposed to a cow‘s milk formula (128).  
 Although children with diabetes in the current study were more likely to have undergone 
surgery, no details were given in the DRF as to the type of surgery performed limiting the 
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conclusions which could be drawn. Our findings contrast with those of Cardwell et al (129) who 
reported no increased risk of T1DM in children who had undergone tonsillectomies or 
adenoidectomies. The study gathered information from four hospital databases in Northern 
Ireland and included 25,488 children who had undergone either or both procedures (< 15 years of 
age). Children who had undergone one or both of these surgical procedures, and who had a 
diagnosis of the T1DM, were identified to determine the incidence rate of diabetes. Standardized 
incidence ratios were then calculated which showed no significant association between those that 
have undergone either or both procedures and an increased risk in the development of T1DM. 
The authors acknowledge however, that the incidence rate of T1DM may have been 
underestimated since there is a possibility that not all the cases were correctly identified and not 
all possible confounding variables could be adjusted for via this design, perhaps contributing to 
the lack of association seen.  
The existing relationship between the intrauterine environment and diabetes occurrence 
cannot be ruled out as mothers of children with T1DM in the current study were more likely to 
have T2DM, GDM, or a family history of GDM although it must be noted that far more mothers 
in the sampled cohort did not have gestational diabetes. Penderson (130) was the first to describe 
the association between infant birth weight and length, and maternal diabetes. Subsequent studies 
further examined the in-utero metabolic effects (130-132) suggesting that even minor changes in 
the equilibrium of the intrauterine environment, in particular maternal hyperglycemia, may have 
long-term effects extending beyond the perinatal period (133).  Congenital rubella is the only 
known virus that directly causes T1DM in the offspring (134, 135) but studies have also 
implicated the Coxsackie B virus in the etiology of T1DM (47, 136).  
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There are several studies looking into the association of breastfeeding and development 
of T1DM (58, 59) although the high rates of breastfeeding across both groups (approximately 
80% (n=112) of mothers  breastfed for longer than 6 months) in the current study made it 
impossible to investigate any role for infant feeding in diabetes development in this sample. In 
the most recent study looking at the breastfeeding practices of women in Bahrain (137), they 
found the overall rate of breastfeeding, although not exclusive, in a sample of 408 children less 
than 2 years of age to be  as high as 95 % with a mean duration of 7.6± 5.4 months. A previous 
study found 34% of infants under the age of 4 months to have been exclusively breastfed in 
Bahrain (138). Such a high rate of breastfeeding is thus unlikely to be a discriminating factor in 
the development of T1DM in this specific population.   
  However in other populations where rates of breastfeeding are more variable both 
positive and negative associations have been suggested (58, 60, 62).  Breastfeeding has been 
reported to confer a beneficial effect for T1DM development via mechanisms including 
protection against enteroviruses (60) or delayed introduction of cow‘s milk protein and/or gluten 
containing foods with longer breastfeeding durations (58, 60) but other studies have found no 
significant relationship between breastfeeding and development of T1DM (62). In fact, some 
studies have hypothesized that since breast milk has low levels of vitamin D prolonged exclusive 
breastfeeding may represent a risk factor for diabetes development and that supplementation with 
vitamin D may be required to confer a protective effect (63). The retrospective nature of the 
current study meant that vitamin D levels from the mother and child were not available to allow 
the authors to further investigate the role of vitamin D and the risk of T1DM. However a recent 
study in Bahrain (19) (refer to Chapter 1; Common Nutritional Related Deficiencies) found 
88.8% of the mothers and 90.3% of their newborns to have a vitamin D level below 50 nmol/l 
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(19). In order to fill this gap in knowledge a prospective study of a small but representative 
sample of children was conducted and is described in Chapter 5. 
3.5.1 LIMITATIONS OF THE STUDY 
 
This study was limited in that data on the case group was collected retrospectively and 
therefore restricted to the routinely collected data available within the unit. No follow up of the 
children in the case group occurred and only some of the medical records were examined to 
obtain data that was incomplete in the DRF form. The control children were selected from LHC's 
on the basis that they were free of any chronic disease and essentially healthy. However, a 
control group could have been selected from within the hospital comparing the diets of children 
with T1DM to other children with chronic diseases excluding diabetes.  
The relatively small sample size of the study population and the fact that no official 
sample size calculations were undertaken but instead selection was based on whether or not the 
children met the inclusion criteria does indeed limit any conclusions that may be drawn and can 
introduce bias. Hence, caution is required when generalizing these results due to the non-
probability nature of the small sample size.    
Although mothers of T1DM children appeared to have used more medication during 
pregnancy compared to mothers with healthy children, no detailed information as to the type of 
medication used was given limiting any conclusions that may be drawn. As a result the authors 
were not able to further investigate the role of genetics or environmental triggers in the 
development of diabetes.  Similarly the role of breastfeeding, although previously postulated, 
could not be rigorously investigated due to the general high rates of prolonged breastfeeding in 
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the cohort. The authors were also unable to investigate the possible link between vitamin D and 
risk of T1DM since this was not routinely measured in cases and controls at the time of the 
study.  
3.5.2 AREAS OF FURTHER RESEARCH  
The results of this study have laid the foundations for informing future prospective 
studies that aim to investigate the role that enteroviruses play in the development of T1DM as 
well as the potential protective role microbiota may play in the development of T1DM in 
Bahrain and in the Middle Eastern region. Furthermore, there is a need to investigate the inter-
generational transfer of risk via maternal impaired glucose tolerance.  
3.6 CONCLUSION 
 
Children with T1DM were more likely to have suffered from an illness before diagnosis 
of T1DM than their healthy counterparts.  This self-report analysis could not fully elucidate the 
role of genetics or environmental triggers in the development of diabetes nor were the authors 
able to expand on the role of infant feeding practices due to the high prevalence of breastfeeding 
in both groups. However, the preliminary findings have helped shed light on this under-
researched population and highlighted the need for further work investigating the potential role 
infections and in particular gut microbiota play in the development of T1DM.  
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4.0 DIETARY INTAKE OF CHILDREN WITH T1DM & THEIR HEALTHY 
COMPARATORS 
 
 
4.1 INTRODUCTION 
There are no studies that have looked into the dietary intake of children with diabetes in 
Bahrain and only a few studies have examined the diet of children (139-143) and adolescents 
(141, 142, 144-147) with diabetes elsewhere, most of which are dated. The results of these 
studies, conducted primarily in Europe and the United States, showed that children with T1DM  
exceeded total fat recommendations, in particular saturated fat (139-142) and that children‘s 
intakes of fiber were well below those recommended (140, 142). Some studies also found 
children to be consuming an insufficient amount of vitamin D (140, 141). Studies looking at the 
diet of adults with T1DM have shown similar trends, with these adults consuming a diet high in 
fat and in particular saturated fats coupled with a high intake of protein. Carbohydrate intake  
however was found to be lower than the recommended in one study of 571 adults with T1DM 
and 696 controls, aged between 19 to 56 years (148). According to the second National Health 
and Nutrition Examination Survey, NHANES II, in the United States, fiber intake in adults over 
19 years of age (not specifically those with diabetes) was found to be below the 
recommendations with an average intake of approximately 11g/day (149). The report on the 
achievements of the American Diabetes Association recommendations for adults with diabetes 
for the years 1999-2002 based on the NHANE survey found that only 18.3% of adults with 
diabetes consumed the recommended amount of fiber (150). 
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T1DM is associated with an increased risk for the development of micro- and macro-
vascular complications like retinopathy, neuropathy, and nephropathy (151). People suffering 
from diabetes are also at a higher risk of developing cardiovascular disease than those without 
diabetes (152, 153). As such, compliance to dietary recommendations is especially important in 
children with diabetes as the development of atherosclerosis may begin in childhood and 
adolescence (154-157). The results of the DCCT trial showed a reduction in the risk of 
developing diabetic retinopathy, nephropathy, and neuropathy (91). The benefits of intensive 
therapy delayed and slowed down the progression of microvascular complications. (Refer to 
Chapter 1: Management of T1DM; p.33). 
4.2 METHODS 
 
4.2.1 STUDY DESIGN 
The dietary intake of children from the same case-control study described in Chapter 3 
was analyzed to allow the impact of disease to be investigated independently of other important 
factors like age and weight.  A single 24 hour recall routinely collected for children with T1DM 
by a dietitian or nutritionist at the time of admission was made available for analysis. A 24 hour 
recall was prospectively taken by a dietitian from control children recruited at the LHC‘s 
4.2.2 INCLUSION CRITERIA  
 
Refer to Chapter 3 for inclusion criteria (section 3.3.1 p. 46).  
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4.2.3 ANALYSIS 
 
The 24-hour recalls were analyzed using the Food Processor Software SQL version 10.70 
(ESHA Research). Dietary intake was expressed as absolute nutrient intake and percent 
achievement of the U.S Recommended Dietary Allowance (RDA) (158) by age group. A 
comparison between the percent of cases and controls achieving the recommended dietary 
intakes (Acceptable Micronutrient Distribution Range (AMDR) established based on Dietary 
Reference Intakes (DRI)) and those meeting the International Society for Pediatric and 
Adolescent Diabetes (ISPAD) guidelines are shown in Table 7. The data was statistically 
analyzed using SPSS version 21 (SPSS Inc.). Normality was tested for using Kolmogorov-
Smirnov test and the independent T-tests and Mann-Whitney tests were used as appropriate to 
compare intakes between cases and controls. A P-value of less than 0.05 was considered 
statistically significant. 
 
4.3 RESULTS 
 
In total, 50 children with T1DM (cases) and 55 healthy comparators (controls) were 
included.  The median age was 9.5 (8.0-11.0) years and 9 (7.0-10.0) years respectively. The 
groups were matched for age, gender and BMI. 
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Table 7 Percent of cases and controls achieving the recommended dietary intakes for macro- and micronutrients and meeting 
the ISPAD guidelines  
 
*1 megajoule =239 Kilocalorie 
1 
significance tested using Pearson chi-squared
 Dietary Reference 
Intakes  (RDA) or  
Acceptable 
Micronutrient 
Distribution Range 
(AMDR) where 
applicable (159) 
% (n) of 
Cases 
within 
guidelines 
% (n) of 
Controls 
within 
guidelines 
P
1
 
ISPAD 
Guidelines 
(160) 
% of Cases 
within 
guidelines 
% of 
Controls 
within 
guidelines 
P
1
 
Carbohydrate, % 45-65 88 (44) 78(43) 0.182 50–55 24 (12) 22(12) 0.790 
Fat, % 25-35 60 (30) 55 (30) 0.573 30–35 32 (16) 27 (15) 0.919 
Protein , % 10-30 94 (47) 89 (49) 0.369 10–15 62 (31) 53(29) 0.338 
Saturated fat and 
trans fatty acids, 
%   
7-10 32(16) 30 (16) 0.746 <10 78 (39) 87(48) 0.322 
Polyunsaturated 
fat 
≤ 10 100 (50) 100(55) - <10 100 (50) 100(55) - 
Monounsaturated 
fat,%   10-15 22 (11) 18 (10) 0.625 
>10 (up to 
20 % total) 
22 (11) 22(12) 0.616 
Fiber  25 grams (children 
4-8yrs) 
31 grams (males, 9-
13yrs) 
26 grams 
(females.9-13yrs) 
0 1.8 (1) 0.338 
2.8–3.4 
grams per 
megajoule* 
0 1.8 (1) 0.338 
Sodium  
1.2 g/day of sodium 
(children 4-8yrs) 
1.5 g/day (males & 
females, 9-13 yrs.) 
26 (13) 29 (16) 0.723 
<6  g/day of 
sodium 
chloride 
(2400mg 
sodium) 
68 (34) 82 (45) 0.101 
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ENERGY AND MACRONUTRIENT INTAKE 
The age and gender appropriate estimated average requirement (EAR) for energy was 
met by 96% of the case group and 75% of the control group as shown in Table 8. Children with 
T1DM met their RDA for carbohydrates whereas healthy controls consumed 81% of their 
requirements (p<0.001). Both groups failed to meet the RDA values for dietary fiber intake but 
no significant difference was observed between mean intakes when expressed as a percentage of 
the recommendations (p<0.207). Children with T1DM consumed about 2.5 times their RDA for 
protein whereas their healthy counterparts consumed 2 times the RDA. 
Table 8 Mean energy intakes and macronutrient distribution in children with (n=50) and 
without (n=55) T1DM  
 
 Case Control  
P-Value
‡
 
 
Mean 
(SD) 
Mean 
% RDA
†
 
Mean 
(SD) 
Mean 
% RDA
†
 
Energy (kcals) 
2023.16 
(493.49) 
96 
(28) 
1542.29 
(505.22) 
75 
(24) 
<0.001
a
 
Calories from Fat 
(kcal) 
622.32 
(206.44) 
108 
(45) 
437.58 
(177.97) 
77 
(32) 
<0.001
a
 
Calories from 
Saturated Fat (kcal) 
154.74 
(69.13) 
85 
(49) 
109.22 
(66.54) 
59 
(32) 
0.002
a
 
Protein (g) 
71.75 
(21.37) 
249 
(112) 
54.22 
(23.74) 
196 
(68) 
0.018
a
 
% energy, Protein 
13.80 
(13.65) 
 
13.78 
(3.08) 
 0.962
b
 
Carbohydrates(g) 
300.22 
(78.27) 
103 
(30) 
225.87 
(77.60) 
81 
(29) 
<0.001
a
 
% energy,  
Carbohydrates 
55.84 
(7.10) 
 
57.70 
(7.80) 
 0.190
b
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SD Standard Deviation; 
a
Mann Whitney; 
b
T-test; 
‡
P-value for % mean RDA where available or 
mean absolute intakes; 
†
Mean percent intake relative to Recommended Dietary Allowance 
(RDA); 
 
The percent energy (% E) intake from protein, carbohydrate and fat for the two groups is 
also shown in Table 8. No significant difference was observed for intake of macronutrients 
(expressed as percentage of total energy intake) between the groups. Children with and without 
T1DM were within the AMDR range for macronutrients. The mean percent energy intake from 
 Case Control  
P-Value
‡
 
 
Mean 
(SD) 
Mean 
% RDA
†
 
Mean 
(SD) 
Mean 
% RDA
†
 
Dietary fiber (g) 
12.88 
(5.26) 
42 
(18) 
10.16 
(5.71) 
36 
(20) 
0.064
a
 
Fat (g) 
69.15 
(22.94) 
108 
(44) 
48.93 
(19.82) 
77 
(32) 
<0.001
a
 
% energy,  Fat 
29.64 
(20.68) 
 
28.44 
(7.64) 
 0.376
b
 
Saturated Fat (g) 
17.19 
(7.68) 
85 
(45) 
12.14 
(7.39) 
59 
(32) 
0.002
a
 
% energy,  Saturated 
Fat 
7.68 
(7.17) 
 
7.09 
(3.78) 
 0.280
b
 
Monounsaturated 
Fats (g) 
19.75 
(8.08) 
84 
(39) 
13.72 
(8.21) 
61 
(37) 
0.001
 a
 
% energy,   Mono Fat 
10.60 
(8.09) 
 
8.17 
(4.24) 
 0.128
b
 
Polyunsaturated Fats 
(g) 
9.94 
(4.23) 
47 
(22) 
7.12 
(4.24) 
35 
(21) 
0.007
 a
 
% energy,  Poly Fat 
5.10 
(4.10) 
 
4.15 
(2.05) 
 0.169
b
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polyunsaturated fats was below the recommendation in both groups and the mean percent energy 
intake of monounsaturated fats was slightly higher than the recommendation in children with 
T1DM compared with healthy children.  However when compared to the ISPAD guidelines 
specific to children and adolescents with T1DM, both children with T1DM and their healthy 
counterparts were found to consume more than the recommended percent energy intake from 
carbohydrates (50-55%) although they were within the recommendations for % E of fat and 
protein (158). The % E from saturated and polyunsaturated fats was also within the ISPAD 
guidelines. Children with T1DM achieved the recommended % E from monounsaturated fatty 
acids although the control group was found to consume less than the recommended proportion.   
Under reporting of energy intake was assessed using Torun cutoffs (161). Table 9 shows 
the number and percent of children that were found to have under-reported energy intake. When 
under-reporters were excluded and data re-analyzed the results revealed similar trends in energy 
and macronutrient intakes (data not shown). Both children with T1DM and their healthy 
counterparts consumed an excess amount of sodium and protein but failed to meet vitamin D and 
calcium requirements. Furthermore, children with T1DM also consumed a significantly higher 
amount of energy and fat, including saturated, polyunsaturated, and monounsaturated fats than 
the control group. Both adequately reporting children with T1DM and adequately reporting 
healthy controls were within the % E of fat, carbohydrates and proteins when compared to the 
AMDR and were within recommendations for saturated, and polyunsaturated fatty acids. Similar 
to the results, for the whole sample children with T1DM slightly exceeded % E 
recommendations for monounsaturated fats as compared to the controls (10.63% vs. 8.10%). 
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Table 9 Number and percentage of cases and controls that under reported energy intake as 
assessed by the Torun Cutoffs (161)  
 
 
Cases Control Pearson Chi-
Square n % n % 
Adequate under-reporting 30 75.0 28 50.9 
0.017 
Under-reported  10 25.0 27 49.1 
 
4.3.1 VITAMIN INTAKES 
Vitamin intakes between the groups, shown in Table 10, revealed that children with 
T1DM consumed a significantly higher amount of vitamin B1 (p=0.034), vitamin B3 (p=0.016), 
vitamin B6 (p= 0.006) and vitamin A (RAE) (p=0.007) as compared to healthy children but these 
differences were no longer significant when adjusted for energy intake. The vitamin A intakes, 
although highly variable, were a true reflection of the diversity of diets within this group and 
specifically the high intakes of vitamin A achieved by those children consuming liver; a common 
food for some families in the region. After adjusting for energy, vitamin K intake was found to 
be higher amongst healthy children as compared to those with T1DM (p=0.016). The foods 
contributing most to vitamin K intake appeared to be oils used in fried foods (e.g.  French fries, 
potato wedges) and dairy products (milk. yogurt, cream cheese) as well as other miscellaneous 
foods like biscuits, chocolate spread etc… No significant difference was observed between 
children with T1DM and healthy control groups for vitamin D intake (unadjusted; p=0.061; 
energy adjusted p = 0.456, respectively) and both groups failed to meet the RDA requirements. 
Similarly no significant difference was observed between the groups for folate consumption 
(p=0.095) and again both groups failed to meet the recommended folate intake regardless of diabetes 
status requirements for vitamin C were met or exceeded (non-significant between groups with or without 
energy adjustment). 
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Table 10 Distribution of vitamin intakes* between children with and without T1DM (n=50 
and n=55 respectively). 
                                                                  
*Vitamin intakes analysis did not include dietary supplements. SD Standard Deviation; 
a
Mann 
Whitney; 
b
T-test 
‡
P-value for % mean RDA where available or mean absolute intakes;
 †
Mean 
percent intake relative to Recommended Dietary Allowance (RDA). 
 
 Case Control 
 
P-Value‡ 
 
Mean 
(SD) 
Mean 
% 
RDA† 
Mean 
(SD) 
Mean 
% 
RDA† 
Vitamin A (RAE) 
385.88 
(768.88) 
72 
(129) 
194.32 
(238.47) 
41 
(57) 
0.007
 a
 
Vitamin D (mcg) 
0.74 
(0.86) 
15 
(17) 
0.55 
(0.70) 
11 
(14) 
0.061 a 
 Vitamin E - Alpha Tocopherol 
(mg) 
2.02 
(1.08) 
21 
(11) 
1.68 
(1.48) 
19 
(17) 
0.122a 
Vitamin K (mcg) 
11.97 
(13.06) 
20 
(22) 
8.86 
(19.15) 
16 
(34) 
0.001
a
 
Vitamin C (mg) 
133.66 
(119.7) 
352 
(357) 
88.84 
(92.18) 
277 
(285) 
0.127a 
Vitamin B1 (mg) 
0.94 
(0.46) 
120 
(60) 
0.70 
(0.42) 
93 
(48) 
0.034
a
 
Vitamin B2 (mg) 
1.11 
(0.70) 
146 
(95) 
0.92 
(0.85) 
128 
(134) 
0.0877a 
Vitamin B3 (mg) 
13.43 
(7.36) 
127 
(70) 
9.20 
(6.81) 
95 
(62) 
0.016
a
 
Vitamin B6 (mg) 
1.35 
0.60) 
163 
(83) 
0.94 
(0.62) 
121 
(74) 
0.006
a
 
Vitamin B12 (mcg) 
2.64 
(3.57) 
173 
(211) 
1.58 
(1.86) 
107 
(116) 
0.102a 
Folate (mcg) 
186.59 
(107.63) 
71 
(42) 
136.77 
(95.73) 
56 
(36) 
0.095a 
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Table 11 Distribution of Vitamin Intakes expressed per 1000 kcals in children with and 
without T1DM (n=50 & n= 55 respectively). 
 
 
†
SD Standard Deviation; 
a
Mann Whitney 
 Case Control 
 
P-Value 
 
 
Mean 
 
(SD)
†
 
 
Mean 
 
(SD)
†
 
Vitamin A (RAE) 
 
191.96 368.33 141.05 219.29 0.087
 a
 
Vitamin D (mcg) 
 
0.37 0.42 0.38 0.45 0.456
 a
 
 Vitamin E - Alpha Toco 
(mg) 
 
1.03 .59 1.09 1.01 0.362
a
 
Vitamin K (mcg) 
 
5.63 5.80 5.91 14.85 0.016
a
 
Vitamin C (mg) 
 
65.02 55.45 55.78 51.03 0.223
a
 
Vitamin B1 (mg) 
 
0.47 0.19 0.47 0.23 0.827
a
 
Vitamin B2 (mg) 
 
0.56 0.34 .64 0.66 0.893
a
 
Vitamin B3 (mg) 
 
6.72 3.61 6.00 3.40 0.326
a
 
Vitamin B6 (mg) 
 
0.68 0.27 0.63 0.37 0.097
a
 
Vitamin B12 (mcg) 
 
1.32 1.68 1.08 1.22 0.464
a
 
Folate (mcg) 
 
91.63 46.98 93.30 60.64 0.985
a
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4.3.2 MINERAL INTAKES 
The mineral intakes of children with and without T1DM are shown in Table 12.  It was 
observed that children with T1DM consumed significantly higher amounts of iron (p<0.001) and 
potassium (p<0.001) as compared to their healthy counterparts. The control group met the RDA 
for iron but children with T1DM consumed on average 1.5 times their requirement and 
potassium intakes were well below the requirements in both groups. After adjustment for energy 
intakes, the differences in potassium but not iron intakes remained significant (p=0.005 and 
p=0.773 respectively). A significant difference was observed between the groups for calcium 
intake (p=0.008) with children with T1DM consuming more compared with healthy children, 
however this difference disappeared after adjusting for energy (p=0.218). Children with T1DM 
and healthy controls exceeded recommendations for sodium by approximately 1.4 times and 1.1 
times the RDA requirements respectively although no significant difference was noted between 
the groups (p=0.402) and this remained non-significant after adjusting for energy. 
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Table 12 Distribution of mineral intakes between children with (n=50) and without T1DM 
(n=55) 
 
SD Standard Deviation; 
a 
Mann Whitney 
‡
P-value for % mean RDA where available or mean absolute intakes;
 †
Mean percent intake 
relative to Recommended Dietary Allowance (RDA) 
 
 
 
 
 
 
 
 
 
 Case Control  
P-Value
‡
 
 
Mean 
(SD) 
Mean 
% RDA
†
 
Mean 
(SD) 
Mean 
% RDA
†
 
Calcium (mg) 
609.34 
(266.33) 
56 
(27) 
411.44 
(237.31) 
42 
(23) 
0.008
a
 
Iron (mg) 
12.57 
(5.57) 
151 
(65) 
9.12 
(4.97) 
106 
(63) 
<0.001
a
 
Magnesium (mg) 
143.50 
(76.70) 
71 
(44) 
93.99 
(53.08) 
55 
(28) 
0.028
a
 
Phosphorus (mg) 
903.15 
(272.26) 
97 
(45) 
598.52 
(261.31) 
81 
(39) 
0.072
a
 
Potassium (mg) 
1751.03 
(859.98) 
40 
(20) 
1025.22 
(573.85) 
25 
(13) 
<0.001
a
 
Sodium (mg) 
2390.15 
(1394.55) 
138 
(97) 
1851.60 
(1261.0
8) 
114 
(65) 
0.402
a
 
Zinc (mg) 
6.14 
(4.07) 
90 
(69) 
4.12 
(2.21) 
65 
(30) 
0.045
a
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Table 13  Distribution of mineral intakes expressed per 1000 kcals between children with 
(n=50) and without T1DM (n=55) 
 
          †
SD Standard Deviation; 
a
Mann Whitney; 
b
 T-test. 
 
 
4.4 DISCUSSION 
 
This study is the first of its kind to evaluate the dietary intakes of Bahraini children with 
diabetes and compare them to those of matched children without the disease. The results of this 
study show some similarities with other work reporting the dietary intake of healthy school 
children in Bahrain (8-10). Of particular note children with T1DM consumed a significantly 
higher intake of energy and total fat including saturated, polyunsaturated and monounsaturated 
fatty acids, than children without T1DM. Excess intake of fat can lead to an acceleration of blood 
vessels damage, leading to the rapid progression of atherosclerosis and cardiovascular disease 
(162) and  is of particular concern in children with diabetes since people with T1DM are thought 
to be 10 times more likely to develop cardiovascular disease as compared to an age matched 
healthy population (163, 164).   
 Case Control 
 
P-Value 
 
 
Mean 
 
(SD)
†
 
 
Mean 
 
(SD)
†
 
Calcium (mg) 308.61 
 
132.96 281.33 157.99 0.218
a
 
Iron (mg) 6.19 
 
2.30 6.18 2.67 0.773
 a
 
Magnesium (mg) 69.93 
 
28.57 64.15 31.35 0.100
a
 
Phosphorus (mg) 458.02 
 
122.92 408.66 147.52 0.048
b
 
Potassium (mg) 861.53 
 
339.48 690.83 313.36 0.005
a
 
Sodium (mg) 2390.15 
 
1394.55 1851.60 1261.08 0.783
a
 
Zinc (mg) 2.99 
 
1.57 2.72 1.12 0.468
a
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Both children with T1DM and healthy controls failed to meet fiber requirements, 
achievement of which is essential for maintenance of proper bowel health.  An increased intake 
of fiber can help improve glycemic control and insulin sensitivity in individuals with diabetes 
(165). Studies have shown that an optimal fiber intake can also decrease the risk of heart disease, 
certain cancers and type 2 diabetes mellitus, with suboptimal intakes of fruits and vegetables, 
whole-grains, legumes and nuts in the U.S. population cited as impeding health promotion and 
chronic disease prevention (165, 166).  The low fiber intakes in the Bahraini cohorts may be a 
result of their low intakes of fruits and vegetables as well as whole grains and their choices of 
foods rich in fats and refined sugars, common dietary patterns previously reported in this age 
group (8, 10, 17). 
High protein intakes in children with T1DM and their healthy counterparts is not 
surprising and substantiated by several other studies looking into dietary intake of children with 
diabetes (139). Similarly in a cross-sectional study looking at the dietary intake of school 
children aged 7-10 years in Bahrain, protein intake was found to be 2.5 times more than the 
recommended (10). Approximately 75% of the male and 66% of the female children in that study 
reported consuming fish, meat or poultry on a near daily basis (5-7 times a week), as compared 
to only 9% of males and females reporting daily consumption of eggs and a mere 2.5 and 2.8% 
of males and females respectively contributing to their protein intake via daily (or near daily) 
consumption of legumes (10). 
Kidney disease is a major risk factor for people suffering from diabetes (167) and 
therefore maintaining protein consumption within the recommendations is important because  
excessive intakes have been associated with worsening glomerular filtration rates (GFR) in 
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people suffering from chronic kidney disease (168). Furthermore, excessive intakes of protein 
may be converted to fat which could increase the risk of obesity later in life (169).  
Vitamin D intakes were well below those recommended in both groups with no 
significant difference between the groups. Failure to find an association between vitamin D 
intakes and diabetes, as have been postulated previously, could be due to variations in study 
design and methodologies, differences in sample size or the sample population studied. 
Specifically the current study only assessed current intakes of vitamin D in children newly 
diagnosed with T1DM and their non-diabetic counterparts rather than attempting to quantify 
early-life exposure to vitamin D via diet or supplements or actual vitamin D status which may be 
influenced by factors other than diet alone. Vitamin D status of a sample of children with T1DM 
will be described in Chapter 5. The ISPAD does not recommend the routine supplementation of 
vitamins and minerals unless there is a confirmed deficiency, and supplementation of vitamin D 
for young children is left to the discretion of a country‘s national guidelines (164). However in 
Bahrain there are currently no national guidelines or protocols that guide physicians on how to 
manage vitamin D deficiency and management is left either to the individual physician or is 
carried out in accordance with hospital policy if one is made available.  
Both children with T1DM and their healthy counterparts consumed an excess amount of 
sodium and had potassium intakes well below recommended levels. High sodium, low potassium 
diets in early childhood have been linked to hypertension later in adulthood (170). Excessive 
intake of sodium coupled with low intake of potassium is of particular concern in children with 
T1DM as it increases the risk of vascular damage and diabetes related complications.  
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4.4.1 LIMITATIONS OF THE STUDY  
 
The current study was limited by the use of a single 24-hour dietary recall to assess 
dietary intake. The possibility of under reporting of food consumption in 24-hour dietary recalls 
due to recall bias and the inability to reflect day-to-day variations in intakes may be a potential 
confounder (191). It is recognized that food intake at the time of diagnosis in children with 
T1DM could have been impacted by the symptoms of the disease itself which, asides from 
excessive urination, includes excessive thirst and appetite (26). The use of dietary 
supplementation was not included in the dietary analysis due to inconsistencies in the naming 
and dosage of supplements used. Furthermore, as children were selected based on 
inclusion/exclusion criteria, bias must be acknowledged. Also, the relative small purposive non-
probability based sample size limits conclusions that may be drawn. Nonetheless, this study 
provides support for endorsing existing dietary guidelines (164) which promote increased intakes 
of dietary fiber, fruit and vegetables and limited intakes of fats and salt for children with T1DM 
and investigating the barriers to adherence with this existing advice.  
4.4.2 AREAS OF FURTHER RESEARCH  
 
Future work should focus on designing prospective and intervention trials to improve the 
diet and lifestyle behaviors of Bahraini children with and without T1DM since there appears to 
be widespread deviation from the recommendations in this age group.  
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4.5 CONCLUSION 
 
Children with T1DM and their healthy counterparts in Bahrain consumed protein and 
sodium above the recommendation but fiber intakes fell short of requirements. Calcium and 
vitamin D intakes were also below the RDA recommendations in both groups. The diet of 
children with T1DM differed from healthy controls in that they consumed a significantly higher 
amount of dietary fat. The results of this study highlight the need to continue to recommend and 
promote adherence with the existing ISPAD nutritional guidelines for children and adolescents 
with T1DM (164). 
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5.0 PROSPECTIVE STUDY ON CHILDREN WITH T1DM 
 
5.1 INTRODUCTION  
The purpose of this study was to investigate in more details the dietary and lifestyle 
behaviors of a small sample of newly diagnosed children with T1DM in the SMC hospital. This 
sub-study aims to provide greater quality of data rather than quantity data to add to that already 
gathered and described previously in Chapters 3 and 4.  
5.2 EXPERIMENTAL DESIGN & METHODOLOGY 
 
Children admitted at the SMC with a confirmed diagnosis of T1DM meeting the selection 
criteria from January to March 2014 were invited to participate in this prospective study. In total 
a convenience sample of 20 children were recruited during this period. No differences were seen 
in terms of gender, race, age, or BMI between the prospectively recruited children with T1DM 
and those in the previous case-control study. 
5.2.1 STUDY AREA/SETTING 
 
Information was gathered from the Pediatric Diabetes Unit which holds the completed 
Diabetes Registry Forms of newly diagnosed children. A vitamin D specific food frequency 
questionnaire and lifestyle questionnaire (Appendix 5 and 6) were administered face-to-face by a 
licensed dietitian in either the Pediatric Diabetes Unit or at the patient‘s bed side.  
5.2.2 STUDY SUBJECTS:  
The study subjects were children aged 6-12 years receiving a confirmed diagnosis of 
T1DM and attending the Pediatric Endocrine Clinic from January to March 2014. All newly 
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diagnosed children with T1DM diabetes during this time period that met the inclusion criteria 
were invited to participate. Subjects were recruited directly onto the study at the time of 
admission or once they were taken to the wards where written consent was obtained (see 
Appendix 7). 
The inclusion criteria for study subjects were as follows: 
 Newly diagnosed children aged 6-12 years with a confirmed case of T1DM 
 Informed, written consent from parents or legal guardian 
 Attended at least one follow up appointment at the Pediatric Endocrine Unit 
Children were excluded if they had T2DM, did not give consent or were not planning on 
following up in the SMC.  
5.3 DATA COLLECTION METHODS: 
Information on the newly diagnosed children was gathered from the existing Pediatric 
Diabetes Registry Form (refer to Chapter 3 and Appendix 1).  
5.3.1 ANTHROPOMETRIC DATA 
Measurements were taken using standard techniques by a trained health professional 
which included: 
 Weight 
 Height 
 Waist circumference 
 Triceps skin-fold thickness 
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  Height and weight were measured using standardized techniques (171). BMI was 
calculated by taking the weight of the subject in kilograms and dividing it by the square of their 
height in meters. Triceps skinfold thickness and BMI are often used in clinical and 
epidemiological studied to measure adiposity (172, 173). Triceps skinfold thickness and waist 
circumference, were also measured by the diabetes nurse educators using standardized 
techniques (174). The measurements were taken on the subject standing in a relaxed manner, 
usually on the right hand side, although no statistical difference between measurements on either 
side of the arm have been found (175). The posterior midline of the upper arm, halfway between 
the shoulder and the elbow was identified; a vertical skin fold was then pinched and a caliper 
used to measure the fat fold.  
5.3.2 DIETARY DATA 
 
The vitamin D specific food frequency questionnaire (see Appendix 5) was administered 
before the patient was discharged. A 24-hour recall was obtained from parents or legal guardians 
at the time of admission with the child present and two other 24-hour recalls (including one 
weekend) were taken by phone one week after the patient was discharged. The subjects were 
interviewed using a reverse chronological order interview method with the interviewer 
prompting the subject to describe the previous night‘s evening snack, dinner, working back to 
what the subject consumed at breakfast. The interview was directed at the parents in conjunction 
with the child. As food in Bahrain is traditionally eaten as a family from one common dish, the 
individuals were asked to describe portion sizes and preparation methods for the foods eaten 
using commonly available household food items such as a 180 gram yogurt cup container which 
is equivalent to a measuring cup (240ml). For example, when the subject described eating rice, 
the interviewer prompted the individuals to explain approximately how many yogurt cups‘ full of 
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rice was eaten. Teaspoons and tablespoons, also common household items, were also used to 
estimate portion size. In the absence of these measuring spoons, qahwa cups (traditional Arabic 
coffee cups) which hold approximately 50ml were used to approximate quantity. For example 
when chai karak (tea with milk) was identified as a beverage consumed, the interviewer asked 
how many qahwa cups of milk or sugar was added to the water. 
The dietary information obtained was analyzed using the Food Processor Software SQL 
version 10.70 (ESHA Research) to provide an estimation of usual intake of key micro- and 
macronutrients. Dietary intake for vitamins and minerals were expressed in absolute mean intake 
and in energy-adjusted mean intakes expressed per 1000kcals.  
Vitamin D intakes were assessed by administering an existing food frequency 
questionnaire
 
(Appendix 5)
  
which was  used determine calcium and vitamin D intake (21). The 
original questionnaire was previously validated however modified to reflect local food items 
known to contain vitamin D including locally eaten fish.  Vitamin D values were based on 
information from the Food Composition Tables for Arab Gulf Countries (176) and the Food 
Composition Tables for the Kingdom of Bahrain (177). Values for non-local foods (e.g. tuna and 
salmon) were obtained from the US Department of Agriculture (159).  
The initial questionnaire asked how often the respondents had consumed a specified 
serving size based on the exchange list for diabetes (e.g. 1 cup of milk or yogurt, ½ cup of ice 
cream or pudding, 1oz of cheese etc.…) or unit of food on daily, weekly and monthly basis. The 
intake of vitamin D was then calculated by multiplying the frequency of consumption of each 
unit of food by vitamin D content of the specified portions; hence the average daily intake was 
calculated. 
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5.3.3 SERUM VITAMIN D LEVELS  
Serum levels of vitamin D were measured using an aliquot of blood taken from routine 
blood collection before the patient was discharged. The blood sample was sent to Al-Jawhara 
Center in Bahrain to be analyzed by Ultra-Pressure Liquid Chromatography/ Mass Spectrometry 
(UPLC/MSMS method) and compared to the Salmaniya Medical Complex laboratory via 
chemiluminescence.  
5.3.4 LIFESTYLE AND SUNLIGHT EXPOSURE DATA 
Environmental factors affecting vitamin D status were assessed by a lifestyle and sunlight 
questionnaire (see Appendix 6) which was administered by a licensed dietitian at the patient‘s 
bedside or at the Pediatric Diabetes Unit. The questionnaire was specifically developed for this 
study with the purpose of addressing any gaps in the data regarding factors that can impact 
vitamin D intake from sunlight. It specifically explored: 
i) Living conditions and whether or not the patients lived in a flat or house and if the 
children played in a garden or patio. 
ii) Personal practices such as the use of a veil in females and the degree of body exposure 
to sunlight.  
iii) Other factors such as the use of sunscreen, multivitamin use and if the patient had had 
a suntan in the past year.  
Outdoor sunlight exposure was also investigated and an average daily and yearly sunlight 
exposure was calculated.  
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5.3.5 PHYSICAL ACTIVITY 
Physical activity levels were assessed using the Child Physical Activity Questionnaire 
(CPAQ) (see Appendix 8). The questionnaire was administered to the parents or legal guardian 
and asked about the physical activities their child had undertaken in the past 7 days. The number 
of minutes spent in sedentary, moderate and vigorous activity was then calculated for a 24hr 
period. Metabolic Equivalents (METs) were used to express the intensity of physical activities.  
One MET is defined as the energy cost of sitting which is equivalent to an energy consumption 
of 1kcal/kg/hour. A person's caloric consumption is three to six times higher when being 
moderately active (3-6 METs) and greater than six times higher when being vigorously active 
(>6 METs) compared to if they were sitting (178). Moderate intensity physical activity requires a 
moderate amount effort which results in a noticeable increase in heart rate. Examples of 
moderate physical activity include brisk walking, housework and domestic chores. Vigorous 
physical activity requires a large amount of effort that results in a significant increase in heart 
rate and rapid breathing which includes running, fast cycling, playing football or other 
competitive sports games.  
5.4 RESULTS 
 
5.4.1 BASELINE CHARACTERISTIC  
 
A total of 20 children were recruited for the purpose of this study with no subjects 
dropping out after consent. Table 14 shows the mean age of the children was 9.15 [SD2.16] 
years. There were no significant differences in terms of gender, race, age, or BMI between the 
recruited children with T1DM and those in the previous case control study (see Chapter 3). 
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Table 14 Baseline characteristic of children with T1DM in prospective study (n=20) compared to 
children with T1DM in case-control study (n=55) 
 
T1DM Children in 
Prospective Study 
T1DM Children in Case 
Control Study 
P-value 
n (%) 
Mean 
[SD]
1
 
n (%) 
Mean 
[SD]
1
 
Gender 
Male 
10 (50)  29 (49)  
0.941
a
 
Female 
 
10 (50)  30 (51)  
Race Arab 19 (95)  56 (95)  
1.00
b
 
Non-Arab 1(5)  3 (5)  
Age, years  
20(100) 
9.15 
[2.16] 
59(100) 
9.47 
[1.58] 
0.492
c
 
BMI
2
, percentile  
20(100) 
53.08 
[37.65] 
59(100) 
41.67 
[39.67] 
0.312
c
 
Waist Circumference, cm 20 (100) 
67.7 
[12.3] 
   
TSF
3
, mm 20 (100) 
17.4 
[6.8] 
   
1
SD: Standard Deviation
 a 
Chi –Squared, b Fisher Exact, c T-test 
2
BMI:  Body Mass Index, 
3 
Triceps Skin Fold Thickness 
 
There was a significant, positive correlation between BMI and TSF and between BMI 
and waist circumference as shown in Table 15. However, a negative, weak, and non-significant 
correlation was found between BMI and serum vitamin D status as assessed by UPLC/MSMS 
method.  
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Table 15 Pearson’s correlation coefficients (r) for the relationship between BMI and serum 
vitamin D (nmol/L), waist circumference and TSF in children with T1DM (n=20)  
 
 
 
 
 
 
 
                    2
BMI:  Body Mass Index; 
3 
Triceps Skin Fold Thickness; *Sample n= 18 
 
 
 
The mean total 25(OH) D levels for males was 58.0±14.2 and for females was 41.3±19.7; 
a difference approaching significance (p=0.056) although no statistically significant difference 
was found between males and females in the likelihood of being deficient (data not shown).  
5.4.2 DIETARY INTAKE 
5.4.2.1 ENERGY AND MACRONUTRIENT INTAKE 
 
Age and gender appropriate estimated energy requirement (EER) (179) were used to 
calculate energy requirement. In total, 55% (n=11) of the children met 75% or more of their 
requirements, 30% (n=6) exceeded their requirements and 15% (n=3) of the children‘s energy 
intake was less than 75% of EER. They met their RDA for carbohydrates but fell short in fiber 
intake consuming only half of the requirements (see Table 16).  Protein intake was about 2.5 
times the RDA values. The children in this study were within the AMDR range for 
macronutrients with a mean percent energy intake from polyunsaturated fats below the 
recommended. 
 Correlation Coefficient r 
(r
2
) with BMI 
P-Value 
TSF (mm) 
 
0.721(0.52) <0.001 
Waist circumference (cm) 
 
0.897(0.80) <0.001 
*Serum vitamin D levels 
(nmol/L) 
-0.298 (0.21) 
 
0.229 
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Table 16 Mean absolute (n=20) and adjusted (n=13) energy intakes and macronutrient 
distribution in children with T1DM (n=20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
SD: Standard Deviation;
 †
DRI: Dietary Reference Intake; *Adjusted mean intakes to account for 
over and under reporting using Torun Cut Offs (161). 
 
 
 
 
Absolute Mean 
(SD)
1
 
Absolute Mean 
% DRI
†
 
*Adjusted 
Mean 
(SD)
1
 
*Adjusted 
Mean 
% DRI
†
 
Calories (kcals) 
1766.52 
(303.16) 
90.64 
(16.85) 
1896.65 
(291.13) 
98.57 
(14.70) 
Protein (g) 
76.77 
(20.01) 
250.08 
(87.26) 
83.77 
(19.03) 
287.16 
(79.52) 
%Kcal, Protein 
16.01 
(1.76) 
 
16.5 
(1.38) 
 
Carbohydrates(g) 
258.43 
(68.42) 
102.81 
(21.21) 
284.18 
(52.87) 
106.82 
(15.07) 
%Kcal,  
Carbohydrates 
55.91 
(4.47) 
 
56.45 
(3.58) 
 
Dietary fiber (g) 
14.20 
(5.40) 
51.81 
(19.83) 
15.60 
(6.09) 
57.36 
(21.71) 
Fat (g) 
58.93 
(12.77) 
97.70 
(24.25) 
60.61 
(13.14) 
101.51 
(23.48) 
Fat (% of energy) 
28.09 
(4.58) 
 
27.06 
(3.49) 
 
Saturated Fat (g) 
16.32 
(3.52) 
85.28 
(26.47) 
16.76 
(3.93) 
89.01 
(28.87) 
Saturated Fat (% of 
energy) 
7.97 
(1.67) 
 
7.61 
(1.88) 
 
Monounsaturated Fats 
(g) 
13.24 
(3.82) 
62.63 
(23.90) 
13.54 
(3.45) 
64.99 
(23.85) 
Mono Fat (% of 
energy) 
6.43 
(2.10) 
 
6.19 
(1.81) 
 
Polyunsaturated Fats 
(g) 
8.73 
(12.27) 
30.87 
(13.55) 
10.34 
(15.03) 
31.64 
(11.92) 
Poly Fat (% of energy) 
2.86 
(1.22) 
 
2.71 
(0.86) 
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5.4.2.2 VITAMIN INTAKES 
 
Vitamin intakes are shown in Table 17. Intakes of vitamin E, D and K did not meet the 
recommended levels whereas the children met and exceeded levels for all B vitamins. 
Recommended intakes of folate were met by approximately 90% of the children. Micronutrients 
were expressed per 1000 kcal in order to adjust for the greater volume of food consumed by 
some children that may skew the results.  
Table 17 Distribution of vitamin intakes in children with T1DM (n=20) 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
Absolute Mean 
(SD)
1
 
*Adjusted Mean 
(SD)
1
 
 
Absolute Mean % 
DRI
†
 
(SD)
 1
 
 
Vitamin A (RAE) 
285.88 
(668.88) 
208.40 
(335.25) 
78.91 
(56.19) 
Vitamin D (IU) 
43.07 
(48.50) 
24.38 
(27.46) 
16.21 
(10.94) 
 Vitamin E - Alpha 
Tocopherol (mg) 
1.38 
(0.40) 
0.78 
(0.23) 
 
15.28 
(4.58) 
Vitamin K (mcg) 
6.62 
(3.06) 
3.75 
(1.73) 
11.49 
(5.29) 
Vitamin B1 (mg) 
1.01 
(0.27) 
0.57 
(0.15) 
136.40 
(39.36) 
Vitamin B2 (mg) 
1.37 
(0.64) 
0.76 
(0.36) 
178.24 
(68.34) 
Vitamin B3 (mg) 
11.95 
(3.91) 
6.76 
(2.21) 
120.30 
(43.60) 
Vitamin B6 (mg) 
1.12 
(0.40) 
0.63 
(0.23) 
143.24 
(59.15) 
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1SD: Standard Deviation; †DRI: Dietary Reference Intake; *Adjusted mean expressed per 
1000kcals. 
 
 
5.4.2.3 MINERAL INTAKE 
 
The iron intake of the children in this prospective study was approximately 1.6 times 
their requirement (see Table 18). Potassium and calcium levels were below the RDA values 
whereas sodium levels were in excess by approximately 1.5 times the RDA values.  
Table 18 Distribution of mineral intakes in children with T1DM (n=20) 
 
 
 
 
Absolute Mean 
(SD)
1
 
*Adjusted Mean 
(SD)
1
 
 
Absolute Mean % 
DRI
†
 
(SD)
 1
 
 
Vitamin B12 
(mcg) 
2.98 
(1.88) 
1.69 
(1.06) 
207.29 
(113.55) 
Folate (mcg) 
219.67 
(67.29) 
124.35 
(38.09) 
89.98 
(29.73) 
 
Absolute Mean 
(SD)
1
 
*Adjusted Mean 
(SD)
1
 
 
Absolute Mean % 
DRI
†
 
(SD)
 1
 
 
Calcium (mg) 
691.83 
(215.97) 
391.63 
(122.26) 
68.7 
(26.78) 
Iron (mg) 
13.80 
(4.89) 
7.81 
(2.77) 
159.06 
(65.60) 
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1
SD: Standard Deviation;
 †
DRI: Dietary Reference Intake; *Adjusted mean expressed per 
1000kcals. 
 
5.4.3 VITAMIN D INTAKES & STATUS (FOOD FREQUENCY QUESTIONNAIRE & SERUM LEVELS) 
 
Tables 19 and 20 show the top five foods that contributed to the highest and lowest 
dietary vitamin D intakes as assessed by the average of three food recalls and the vitamin D 
specific food frequency questionnaire. 
 According to the food records, the children that had the highest intakes of vitamin D 
commonly consumed milk and dairy products (cornflakes with milk, ice cream, yogurt, and 
flavored milks), eggs, fish, liver, rice and bread. Children with the lowest vitamin D intakes 
commonly consumed fried foods such as nuggets, fries, chips, hamburgers and pizza. They had a 
tendency to drink juices and sugary drinks several times a day. As with the children with the 
highest vitamin D intake, rice and bread were consumed on a daily basis in children with the 
lowest intake levels.    
 
Absolute Mean 
(SD)
1
 
*Adjusted Mean 
(SD)
1
 
 
Absolute Mean % 
DRI
†
 
(SD)
 1
 
 
Potassium (mg) 
1562.20 
(625.06) 
884.34 
(353.84) 
37.58 
(14.86) 
Sodium (mg) 
2520.51 
(984.51) 
1426.82 
(557.32) 
153.73 
(68.61) 
Zinc (mg) 
6.44 
(2.87) 
3.65 
(1.62) 
101.20 
(47.82) 
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Table 19 Top 5 foods which contributed to vitamin D intake in children with highest 
vitamin D intake 
Food Recall Food Frequency Questionnaire 
Cornflakes with milk Milk  
Cream cheese or cream cheese 
sandwich 
Cornflakes with milk 
Milk Pasta with cheese 
Egg Ice cream  
Buttermilk Cream cheese 
 
Table 20 Top 5 foods which contributed to vitamin D intake in children with lowest vitamin 
D intake 
Food Recall Food Frequency Questionnaire 
Cream cheese Milk 
Tea with milk  Cornflakes with milk  
Milk Pasta with cheese 
Egg Beans  
Liver  Pizza 
 
Food intake of vitamin D was not normally distributed and hence non-parametric 
methods were used to compare the results from the FFQ and the FR. Spearman's rank correlation 
coefficient was also calculated. Table 21 shows the baseline dietary intakes calculated from the 
food frequency questionnaire (FFQ) (taken before the patient was discharged) and the average of 
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three 24hr food recalls (FR) (one taken at the time of admission and two by telephone one week 
after discharge).  
 
Table 21 Baseline dietary intakes and serum vitamin D levels in children with T1DM 
(n=20)  
 
 
 
 
 
 
 
 
 
 
 
FFQ, food frequency questionnaire; FR, 24hr Food Recalls; SD, standard deviation 
 
 
 
A Bland Altman plot (Figure 2) comparing the two methods shows poor agreement with 
the FFQ estimating higher intakes of mean vitamin D (131.50 [95.86]) compared to the FR 
(43.07 IU [48.50]). Dietary vitamin D as assessed by FFQ was moderately but significantly 
correlated with serum vitamin D levels (Spearman's rho = 0.547). However no association was 
found between serum vitamin D status and dietary intakes as assessed by the three FR‘s.  
 
 
 Dietary Vitamin D Intake 
(IU/day) 
FFQ 
(Mean, SD) 
FR 
(Mean, SD) 
Vitamin D Intake 
 
131.50 (95.86) 
 
 
43.07 (48.50) 
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Figure 2 Bland Altman plot showing the level of agreement between vitamin D intake 
(n=20) from the FFQ and the 24hr-FR. A statistically significant difference was shown 
between the two measurements (P=0.008) with the FFQ method estimating higher intakes 
than FR method. 
 
A Bland Altman plot (Figure 2) comparing the two methods showed poor agreement 
with the FFQ estimating higher intakes of mean vitamin D (131.50 [95.86]) compared to the FR 
(43.07 IU [48.50]). The correlations between dietary vitamin D levels (as derived from the from 
the two different assessment methods) and serum vitamin D are shown in Table 22. Dietary 
vitamin D as assessed by FFQ was moderately but significantly correlated with serum vitamin D 
levels (Spearman's rho = 0.547). However no association was found between serum vitamin D 
status and dietary intakes as assessed by the three FR‘s.  
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Table 22 Spearman’s Correlation r (r
2
) for the relationship between dietary Vitamin D (IU) 
intake levels and serum vitamin D (nmol/L) as measured by the UPLC-MSMS method in 
Children with T1DM (n=20)  
 
 
 
 
 
 
 
       FFQ, food frequency questionnaire; FR, 24hr food recall 
 
5.4.4 SERUM VITAMIN D LEVELS 
 
The mean 25-hydroxyvitamin D (25(OH) D of the children was 49.65 [18.75] when 
analyzed using the ultra-pressure liquid chromatography mass spectrometry method 
(UPLC/MSMS) and 44.60 [13.20] when analyzed in the hospital laboratory using 
chemiluminescence immunoassays (CLIA) (see Table 23) 
 
 
 
 
 
 
 Correlation (r
2
) with serum 
Vitamin D levels (nmol/L) 
P-Value 
FFQ  
 
0.547(0.299) 0.013 
FR 
 
0.353(0.125) 0.126 
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Table 23 Mean 25-hydroxyvitamin D (25(OH) D) values as assessed by two methods for 
Children diagnosed with Type 1 Diabetes Mellitus (T1DM) (n=18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 Ultra-pressure liquid chromatography mass spectrometry (UP) LC MS/MS; 
2
Chemiluminescence immunoassays (CLIA) 
 
 
 
There was a statistically significant difference between the two assay methods (p= 0.048.)  
The Bland and Altman plot (Figure 3) which shows the discrepancies between results for 
individual samples was used to reveal the differences between the two methods and clearly 
indicates that the CMIA method is biased compared to the UPLC/MSMS method. The CMIA 
overestimated insufficient values and underestimated deficiency as compared to UPLC/MSM. 
 
 Mean (SD) Range P-value 
VitaminD3+D2  
UPLC-MSMS
1
 
 
49.65 (18.75) 
 
18.10-78.30 
 
 
0.048 
Vitamin D CMIA
2
 
 
44.60 (13.20) 
 
22.70-67.30 
VitaminD3 UPLC-MSMS 
 
49.10 (19.00) 
 
16.80-78.3 
 
VitaminD2 UPLC-MSMS 
 
2.00 (2.00) 
 
0.00-5.00 
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Figure 3 Bland Altman plot showing a concentration dependent difference between the 
UPLC-MS/MS and the CLIA method. Linear regression analysis and 95% confidence 
intervals are graphed. Coefficient of determination R
2
=0.332 (P=0.01) 
 
 
As shown in Figure 4 below, 22% of the children analyzed using the UPLC/MSMS 
method, were classified as being deficient with a serum vitamin D level below 30nmol/L, 28% 
had insufficient vitamin D levels between 30-50nmol/L and 50% of the children had optimal 
levels of vitamin D above 50nmol/L. Analysis using CMIA on the other hand classified 11% of 
the children as being deficient, 61% as being insufficient and only 28% as having optimal levels 
of vitamin D. 
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Figure 4 Percentage of children with T1DM classified as being deficient, insufficient or 
having optimal serum levels of vitamin D using UP(LC)-MSMS (n=18) and using CLIA 
(n=18) assay methods.  The difference in classification between the two methods was 
significant p=0.004 (Chi-squared). 
 
 
5.4.5 LIFESTYLE AND SUNLIGHT EXPOSURE QUESTIONNAIRE  
 
Table 24 shows the association of lifestyle factors with 25(OH) D levels (as measured by 
UPLC-MSMS). There was a trend towards an association between reported sunlight exposure 
and vitamin D with those exposed to more than 30 minutes per day having higher 25(OH) D 
levels (p=0.057) whereas no significant associations were shown between vitamin D levels and 
living conditions, veil use, playing outdoors, use of sunscreen or having had a suntan in the 
previous year.  
22% 
28% 
50% 
11% 
61% 
28% 
< 30nmol/L
(deficient)
30- <50nmol/L
(insufficient)
>50nmol/L
(optimal)
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Table 24  Association of lifestyle factors with 25(OH) D level measured by HPLC in children with T1DM (n=20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
SD: Standard Deviation
 
 
 
n 
Vitamin D (nmol/L) 
Mean (SD
1
) 
P-Value 
T-test 
Living  Flat 10 44.88 (15.87) 
0.261 
House 9 53.99 (20.94) 
Outdoor Patio/Garden None 6 55.27 (19.85) 
0.288 
Patio or Garden 14 45.63 (17.27) 
Play outdoor No 8 48.56 (18.59) 
0.994 
Yes 10 48.49 (18.63) 
Veil use No 11 52.89 (16.14) 0.244 
 Yes 7 43.19 (19.89) 
Suntan No 16 49.78 (18.53) 
0.623 
Yes 4 43.50 (17.90) 
Use of Sunscreen on 
Face 
No 18 48.91 (18.87) 
0.784 
Yes 2 45.05 (12.66) 
Use of Sunscreen on 
Body 
No 19 49.18 (18.37) 
0.497 
Yes 1 36.10 
Average Daily Sunlight 
Exposure 
Less than 30 mins/ 
day 
14 43.53 (19.07) 
0.057 
More than 30 mins/ 
day 
6 60.17 (8.35) 
97 
 
Table 25 shows the association between annual sunlight exposure and vitamin D levels as 
assessed by a questionnaire with scores ranging from 4 to 24 and where 4 reflected a higher 
exposure and 24 a low exposure.  
 
Table 25 Association between annual sunlight exposure score with 25(OH) D level (n=20) 
which approached significance at p=0.062. 
 
1
Assessed via questionnaire with a possible score ranging from 4 to 24 where 4 = high exposure 
and 24 = low exposure 
 
5.4.6 PHYSICAL ACTIVITY (C-PAQ QUESTIONNAIRE) 
 
Table 26 shows the association between physical activity levels (expressed in mean 
number of minutes spent doing moderate or vigorous activity per day) as assessed by the 
Children‘s Physical Activity Questionnaire (C-PAQ) with 25(OH) D levels. This shows that 
there was no significant association between activity levels (as expressed by mean time spent in 
moderate and vigorous activity) and adequacy of vitamin D status. In fact the time spent in 
moderate or vigorous activity was lower for those with adequate vitamin D status although there 
was substantial variation within the group. 
 
 
 
  
Pearson‘s Correlation  
(r2) 
 
P-Value 
Annual Sunlight Exposure score
1 
& 
25(OH) D Level -0.424 (0.180) 0.062 
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Table 26 Association between mean time spent in moderate and vigorous activity and 
25(OH) D Level (n=20) 
 
 
Less than 50nmol/L 
serum Vitamin D 
 
More than 50 nmol/L 
serum Vitamin D 
 
 
P-Value 
Median [IQR] Mean [IQR] 
Time spent in moderate 
and vigorous activity, 
minutes  
25.71 [26.43] 17.14 [42.50] 0.759
a
 
a 
Mann-Whitney test; IQR, Interquartile Range 
 
Table 27 shows the correlation between the physical activity level in percentage as 
assessed by the CPAQ questionnaire and serum vitamin D levels. It shows a negative, non-
significant and weak association (Pearson‘s rho=-0.133; p=0.577) between the percent of 
physical activity levels and 25(OH) D level as assessed by HPLC assay method.  
 
Table 27 Pearson’s correlation between percentage of time spent doing moderate and 
vigorous physical activity and 25(OH) D level (n=20) 
1Assessed by the Children‘s Physical Activity Questionnaire (C-PAQ) 
 
 
Figure 5 shows the time children with T1DM (n=20) reported spending in moderate and 
vigorous activity in a 24 hour period.  The current physical activity guidelines recommend that 
children and adolescents spend at least 60 minutes (1 hour) of moderate to vigorous activity daily 
  
 
Pearson‘s Correlation (r2) 
 
 
P-Value 
Physical Activity Level as expressed 
in %
1 
& 25(OH) D Level 
-0.133 (0.018) 0.577 
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(180). Only twenty percent of the children in the sample met the minimum requirements for 
physical activity. 
  
Figure 5 Time children with T1DM (n=20) spent in moderate to vigorous physical activity 
 
 
Figure 6 shows the percent of time that children with T1DM (n=20) spent doing 
moderate and vigorous activity from total reported time. A mere 4 children (20%) spent 50% or 
more of the reported total time doing moderate and vigorous activity.  
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Figure 6 Percent of time the children with T1DM (n=20) spent doing moderate and 
vigorous activity from total reported time. 
 
 
5.5 DISCUSSION 
 
The aim of this study was to provide more in depth data on a smaller group of children 
seen within the unit to add to that previously gathered and to assess in detail the dietary and 
lifestyle behaviors of a small sample of newly diagnosed children with T1DM in the SMC 
hospital.  
  The results of this prospective study showed a significant correlation between BMI and 
TSF as well as waist circumference.  Measurement of waist circumference is a simple tool for 
screening body fat and in particular is a good indicator of abdominal fat, especially intra-
abdominal fat in children (181, 182). Furthermore, waist circumference appears to be a better 
predictor of the risk of cardiovascular disease than BMI and waist to hip ratio (183).  Most of the 
studies looking at adiposity as measured by BMI, waist circumference and/or skinfold thickness 
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measurements were limited to children with type 2 diabetes (184, 185). No significant 
correlation was found between BMI and serum vitamin D levels although some studies have 
found a relationship between insufficient vitamin D status and increasing BMI in otherwise 
healthy children (186-189). Perhaps one of the reasons we were unable to find a relationship 
between increasing BMI and vitamin D insufficiency is due to the relatively small sample size.  
5.5.1 DIETARY INTAKE  
 
No significant differences were seen in terms of gender, race, age, or BMI between the 
recruited children in this small prospective study and those recruited in the larger study described 
in Chapter 3, suggesting that the in depth cohort were representative of the wider T1DM 
population seen in the unit and therefore that the results of the current study are generalizable 
within the SMC.  
The dietary intake of the children with T1DM in this prospective study showed similar 
trends to the intake of children with T1DM in the case-control study described in Chapter 4, 
confirming the issues highlighted with respect to the quality of the diets consumed. 
Protein intake was similar to the protein intake of T1DM children in the larger group 
study with both groups consuming approximately 2.5 times the RDA. The mean percent energy 
intake from polyunsaturated fats was below the recommendation, although iron intake was in 
excess by approximately 1.6 times; again following the same dietary trend as the children with 
T1DM in the case-control study (see section Chapter 4: Mineral Intakes; p. 72 ) 
Averages of three 24-hour diet recalls were used to assess the nutritional intake of the 
children. A diet recall is a quantitative method used in nutritional assessment which asks the 
subject to recall foods and beverages consumed the previous day or the previous 24 hours. A 
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single 24 hour recall is not considered representative of an individual‘s habitual diet; however, it 
is considered representative when surveying a large group or mean intakes. Studies looking at 
the effectiveness of a 3 day multiple-pass recall in young children found them to be sufficient for 
group estimates but not at an individual level for energy intake (190, 191). 
 Dietary intake in this study was assessed using the traditional 24-hr recall method with a 
reverse chronological order to obtain information on what was consumed the previous day. In  
recent years, the USDA‘s five-step multiple-pass method for dietary recall has become a popular 
and accurate method of performing food recalls (190, 192) and  it may be that given greater time 
during clinical consultations this could be adopted to provide more accurate representation of the 
children‘s intakes.  
 Dietary intake was taken from the parent or legal guardian in the presence of the child as 
this has been found to produce more accurate recalls (193). Children‘s ability to recall food 
varies widely as demonstrated in a study of 203 children aged 5 to7 years to determine the 
accuracy of lunch time meal recall during school (194). However, their ability to recall food 
increases after the age of 8 years (195). The preferred chronological order of recall in children 
remains unclear (196).  
 Children with T1DM in this study were found to consume a greater amount of protein 
than RDA requirements (although comparable  to results of healthy Bahraini children (10)) and 
to consume an excess amount of sodium. Furthermore, potassium and calcium levels were well 
below the recommended RDA values along with fiber intake. The results of this study reinforce 
the need to find ways to implement and encourage compliance with the available general 
population dietary guidelines. 
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5.5.2 VALIDATION OF VITAMIN D SPECIFIC FFQ 
 
In this study a vitamin D specific FFQ and the three 24hr food recalls were used to assess 
dietary vitamin D intake alongside measurement of serum vitamin D levels. Sub-analysis of the 
children that consumed a higher amount of vitamin D rich foods as reported by the FFQ 
identified dairy products and in particular daily milk consumption as a key contributor to overall 
higher intakes. This was verified by scrutinizing the FFQ‘s of children with the lowest levels of 
vitamin D intake who were found not to consume milk on a daily basis. Despite some children 
eating fish four times a week, it did not appear to be as large a contributor as milk to total 
vitamin D, suggesting that strategies to promote milk and work to identify barriers to milk 
consumption may be most effective in increasing vitamin D intakes in this population.   
Dietary intakes vary from day to day for many individuals. Variations in meal patterns 
may be due to food availability, whether an individual is eating at home or outside the home, and 
working/ education patterns to name just a few examples. Capturing an individual‘s habitual 
food habits can be assessed by a food diary or repeated 24 hour recalls only if sufficient days of 
intake are assessed. In order to obtain a representative reflection of an individual‘s usual intake, 
the more days that can be recorded the better although in practice this is cumbersome and can 
affect recruitment and compliance. The review by Bingham in 1987 is still used for guidance on 
the number of days that are sufficient to assess intake depending on nutrient. Although vitamin D 
was not one of the nutrients analyzed, Bingham  recommends 12 days of repeated recalls or the 
equivalent amount of information from a food diary to capture iron intake ± 10% of the average; 
she recommends 19 days for riboflavin and 36 days for vitamin C (197). Macronutrients tend to 
require fewer recording days than micronutrients especially those that are found in a limited 
number of foods such as vitamin A and the wider the within individual nutrient variation the 
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greater the number of days that will be required to study a particular nutrient (197). The 
advantage of a FFQ is its‘ ability to capture these specific food items which are good dietary 
sources but may not be consumed on a daily basis (198). Furthermore, the FFQ being specific to 
vitamin D containing foods would be expected to be a better indicator of intake than the average 
of three day FR. In the UK, the National Diet and Nutrition Survey was reduced from 7 days to 4 
days so as to improve recruitment. No difference was found in nutrient intake when a four food 
diary versus a 4 day 24hr food recall was used (199).  
Bahrain‘s market is saturated with imported milk from Saudi Arabia which claims to be 
fortified with 400 IU of vitamin D per liter of milk. Despite this claim, a study conducted by 
Sedrani and colleagues, looking into the fortification of milk in Saudi Arabia (200) found that as 
much as 57% of the sampled fortified milk in Saudi contained undetectable levels of vitamin D, 
28.5% contained vitamin D exceeding the 400 IU and the remaining 14.5% contained 
approximately 250 IU of vitamin D per liter. In light of this study the results of our FFQ analysis, 
which assumes the fortification of foods, must be interpreted with caution since they may have 
consistently overestimated true vitamin D intakes. Furthermore, given the prevalence of Saudi 
dairy products within the Bahrain market, assuming poor or erratic fortification suggests that the 
results of the FFQ are not representative of true intake as levels may not be constant across the 
population.  
In the United States fortification of milk began in the early 1930‘s with the aim of 
preventing rickets (201). Today, fortification of foods with vitamin D is voluntary in the United 
States with the exception of foods that claim to be fortified with vitamin D (202). Foods 
voluntarily fortified are strictly regulated in order to avoid over-fortification (203). Most of the 
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milk in the U.S is fortified although not all dairy products such as cheese are fortified; it is not 
uncommon to see vitamin D fortified breakfast cereals, soy milk and even orange juice in the 
U.S (203).  
Canada on the other hand mandates the fortification of milk to provide 180 IU/250mL as 
well as milk alternatives and margarine with 530 IU/100gm (203). Fortification of other foods is 
permitted although strictly regulated, with the exception of the fortification of ready-to-eat 
cereals with vitamin D which is considered illegal in Canada, unlike in the U.S (203). Australia 
mandates the fortification of edible oils spreads such as margarine although fortification of other 
foods is voluntary (204). Fortification of vitamin D in Europe varies significantly; the United 
Kingdom fortify edible spreads and cereals (205) and Norway fortifies spreads such as margarine 
and dairy products (206).  
As there are no mandates for the fortification of foods in Bahrain, the results of our study 
highlights the need to consistently fortify dairy and milk products as they were the main foods 
that contributed to vitamin D intake (if fortification at reported levels is achieved). This has been 
suggested previously in a study looking at the vitamin D intake of women in labor and their 
partners (21) in Bahrain. Furthermore, in light of the study conducted by Sedrani et al, there 
needs to be strict quality control implemented to assure that content of vitamin D in fortified 
foods is homogenous.  
 Assuming that a stronger correlation of dietary vitamin D with serum levels can be 
interpreted as an indication of greater validity, it would appear that the vitamin D specific FFQ 
produces more valid estimates compared to the three 24hr food if we are to assume that food 
fortification is indeed consistent as a significant positive moderate correlation (r=0.547; p=0.013) 
was found between the FFQ and serum vitamin D levels. However, as mentioned earlier, 
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interpretation of the results of the FFQ should be made with caution and may indicate a ‗best 
case‘ scenario given the tendency to overestimate intakes via FFQs (207, 208) and the known 
inconsistencies in fortification of products.   
It is worthy to note that the food composition of specific Bahraini dishes included all 
major macronutrients but data on micronutrient, and in particular on vitamin D was limited to the 
typical fish consumed in Bahrain (177), possibly underestimating vitamin D intake from other 
locally eaten dishes. The two assessment measures also have common error sources such as their 
reliance on memory (209) and estimation of portion sizes (210). Although both methods were 
interviewer based, the FFQ relies on long-term memory whereas the FR relies more on short-
term memory.   
When assessing vitamin D, it is important to note that body status is not affected by diet 
sources alone and more than 90% of the vitamin D requirement for most people is believed to 
come from casual exposure to sunlight (70, 211, 212). This may provide some basis for the 
generally low correlation between intake and status.  It is important to recognize and 
acknowledge that relatively few foods naturally contain vitamin D and therefore diet contributes 
only minimally to overall vitamin D requirements in many people.  It is the author‘s opinion that 
safe sun-exposure in children with T1DM, as well as healthy children, should be recommended 
especially since sunlight is plentiful all year around in Bahrain. Holick recommends sun 
exposure 2 or 3 times per week for approximately 5–10 minutes and specifically exposing the 
arms and legs or hands, arms, and face between 10:00 to 15:00hrs (69). A suggestion would be to 
integrate this recommendation into the physical activity lessons of school children.  As children 
are required to have two 45min sessions a week of physical activity, the last 5-10 minutes of 
class could focus on ―getting our vitamin D‖ allowing children to expose arms and legs or hands, 
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arms and face. Furthermore, as schools in the Kingdom segregate males and females, the cultural 
issues of body exposure would not be an issue for the females.  
5.5.3 LIFESTYLE AND SUNLIGHT EXPOSURE 
Vitamin D can be produced endogenously by the skin via photosynthesis using ultraviolet 
B light (UVb) which converts 7-dehydroxycholesterol (7-DHC) to pre-vitamin D3.  It can also be 
obtained from the diet or from a dietary supplement. As previously mentioned few foods 
naturally contain vitamin D with the exception of fatty fish and fish liver oils which are a good 
source; eggs and cheese and meats contain a small amount (213). However, the results of this 
study have shown that milk (if presumed fortification levels are achieved) contributed most to 
dietary vitamin D intake in the sampled children. 
Whilst likely to represent the greatest contributor to vitamin D status, cutaneous synthesis 
itself is subject to a range of  factors affecting extent and efficacy namely latitude, altitude, time 
of day and season (214, 215). Environmental factors also need to be considered such as air 
pollution, cloud cover and ozone levels which affect U.V ray absorption (216). Cutaneous 
vitamin D synthesis is impacted by clothing (217), sunscreen (218), and skin pigmentation (219) 
with darker skin colored people synthesizing less vitamin D.  
Although there was a trend towards an association between sunlight exposure and 
vitamin D in the current study, with the children exposed to more than 30 minutes per day having 
higher 25(OH) D levels (p=0.057), no significant associations were shown between vitamin D 
levels and lifestyle and living conditions as described previously. In the study conducted by 
Mahroos et al, looking into the role of lifestyle and sunlight exposure in serum vitamin D levels 
in pregnant women and their partners, the results showed veil use and living conditions  to be 
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significantly associated with 25 (OH) D deficiency (19). Of the females in the current sample 8 
(80%) were veiled but no association was found between veil use nor living conditions in this 
study perhaps due to the small sample size of the study population or because veil use in young 
female girls is not as strict as it is in older women and therefore is unlikely to exert such a great 
or consistent effect on sun exposure and therefore vitamin D status.  
5.5.4 SERUM VITAMIN D LEVELS  
An increased interest in the role vitamin D plays in health and in particular recognition of 
the non-bone effects has led to an increase in the frequency of vitamin D status testing in recent 
years (220). Variations in measured circulating 25(OH) D levels between assay methods and 
inter-laboratory measurements can however confound the diagnosis of hypovitaminosis D (221). 
The results of the current study, put into clinical context, suggest that (if we assume any newly 
diagnosed child with T1DM with a 25(OH)D of less than 50 nmol/l were indicated for 
supplementation) 50% of the children would require supplementation according to UPLC/MSM 
measurements as compared to 72% of children according to CMIA measurements. Previous 
work (222) has cited an approximate 20% misclassification rate between samples assessed using 
chemiluminescence immunoassay and LC-MS/MS with 57% and 41%  respectively being 
classified as deficient using a cut-point of 50nmol/l. 
There is currently no consensus amongst clinicians as to the optimal reference to classify 
moderate to severe insufficiency in children and adults and this may be in part due to inter-
method bias (223). Furthermore, there is no consensus on the amount of vitamin D intake 
required for optimal health despite a substantial number of published literature and studies 
conducted trying to determine what constitutes an adequate intake. The U.S Institute of 
Medicine‘s (IOM) recommend an intake of 600 IU of vitamin D in children one year of age and 
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older in order to achieve a 25(OH)D level of 50nmol/l to meet the requirements of 97.5% of the 
healthy population (224). There has been however, recent controversy regarding the accuracy of 
this estimation (225, 226) with authors Veuglers and colleagues claiming that over 8000 IU of 
vitamin D is a more accurate estimation of  the needs of 97.5%  of a healthy population (225). 
Furthermore, the study by Heaney and colleagues supported these findings and put forth the 
argument that a total intake of close to 7000 IU per day is a more accurate recommendation. 
  Studies comparing commercially available assays using CLIA or RIA assay methods to 
HPLC have found low inter-assay agreement (223, 227, 228). Farrell and colleagues (228) 
describe the variability in results of vitamin D in automated immuno-assays including the Abbott 
(Architect) that is currently used in our facility. The Abbott Architect automated immunoassay in 
Farrell‘s study showed the greatest deviation of all assays when compared to the LC-MS/MS. 
Detection of 25(OH)D appears to be method-dependent (228, 229), although the precision of 
immunoassays as well as HPLC, LC-MS/MS are comparable in detecting severe vitamin D 
deficiency (230). 
Deciding on which assay method to use depends on balancing out many factors. Firstly, 
laboratories that test on a frequent basis and that require a higher output may benefit more from a 
commercially available kit (231), similar to the one used at the SMC hospital laboratory. 
However, inexperienced users of such commercial kits may introduce more assay variability 
(221). Secondly, one must take into consideration the commercial assays that discriminate 
between D2 and D3 which may result in an underestimation of vitamin D. Thirdly, cost is another 
factor to consider as the cost of running vitamin D assay using HPLC method is currently three 
times the cost of the CMIA assay method used in the hospital laboratory.  
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In light of the multifactorial issues surrounding diagnosis and treatment of 
hypovitaminosis D, we should exercise prudence when assessing a single 25 OH D value (221) 
especially when the "gold standard" assay method is not feasible. Since vitamin D is believed to 
be implicated in a number of disorders, the wider implication of inaccurate readings in the 
management of hypovitaminosis D is not limited to children with T1DM. 
5.5.5 PHYSICAL ACTIVITY  
 
Physical activity is related to many important health benefits; in fact studies looking at 
the health benefits of physical activity of school-aged children found a dose-response 
relationship between physical activity and health with increasing physical activity providing 
greater health as assessed by biochemical markers and anthropometric measurements (232). 
There are several studies that have examined the impact of physical activity in children with 
T1DM and its impact on cardiovascular function (233-235). In a Swiss studying examining 
specific markers of atherosclerosis in children and adolescents aged 6-17 years with T1DM, 
those patients who practiced more than 60 min/day of moderate-to-vigorous physical activity 
were found to have improved vascular function (233). Other studies found similar results 
whereby the children and adolescents who engaged in moderate to vigorous physical activity for 
more than five days in the week had lower triglyceride levels and better metabolic control than 
inactive patients (234). Better glycemic control with increasing physical activity was also 
reported (235) in another multicenter European study.  
In this study only 20% of the sampled children that completed the CPAQ questionnaire 
met the current recommendation. It is important note that the CPAQ questionnaire is self-
reported and tends to overestimate activity level and so this evaluation is likely to be the ‗best 
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case‘ scenario for the assessed sample. Other studies found a generally low adherence to 
recommendation of physical activity with only 38.5% of T1DM children meeting the 
recommendations (236).  
Whilst investigating the impact of physical activity and serum vitamin D levels, no 
significant association between mean time spent in moderate and vigorous activity and adequacy 
of vitamin D status was found. Surprisingly, the more time the children spent in moderate and 
vigorous activity, the lower their vitamin D levels were. The investigators rationalized that the 
climate in Bahrain being hot and humid for a majority of the year, could possibly impact outdoor 
physical activity.  Hence, the more physical activity the children are engaged in, the more likely 
it would be done indoors to avoid the hot climate. This highlights the need to be cognizant of 
environmental factors and the need for novel approaches to the communication of 
recommendations where these may otherwise be inadvertently counterproductive. 
5.5.6 LIMITATIONS OF STUDY 
 
One of the limitations of this study is the small number of children sampled and therefore 
interpretation of the results and estimation of the true effects of the variables must be done with 
caution. Furthermore as participants were selected as a convenience sample, selection bias 
cannot be ruled out. 
  Diet recalls were obtained using the traditional method instead of the five-step multiple 
pass recall which is thought to be more accurate and reflective of habitual dietary intake.  The 
use of household items is not a reliable method of estimating portion sizes and thus could have 
introduced bias. Another limitation was that the FFQ were based on the assumption that foods 
such as milk were fortified although in reality, the consistency of fortification in Bahrain is 
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questionable. Furthermore, accuracy of vitamin D intake from the FFQ cannot be generalized 
with such a small sample size thus limiting any conclusions that may be drawn. 
  Establishing vitamin D status in the SMC is based on the hospital immunoassay results 
and existing cut-offs and although experienced users are employed to run the immunoassays the 
level of accuracy cannot be confirmed.  
5.5.7 AREA OF FURTHER RESEARCH 
 
Larger more adequately powered confirmatory studies need to be designed to investigate 
the relationship between dietary intakes of vitamin D, sunlight exposure, and exercise on 
children with T1DM as compared to healthy children.  The development of public health 
campaigns which encourage sensible sun exposure as a health recommendation should be 
explored especially in light of the abundance of sunlight that Bahrain enjoys.  Finally, studies 
looking at the feasibility of fortifying flour with vitamin D as has been previously done for iron 
in Bahrain to prevent anemia in the National Flour Fortification Program, should be explored.  
5.6 CONCLUSION  
 
In conclusion, the results of this prospective study has shown that dietary intake, sunlight 
exposure and physical activity may to some extent impact the vitamin D status of children with 
T1DM but that the relationships do not always follow previously reported patterns perhaps in 
part to environmental influences. Children with T1DM were found to consume a greater amount 
of protein than the RDA requirements and an excess amount of sodium. Furthermore, potassium 
and calcium levels were well below the recommended RDA values as was fiber intake; similar to 
the results of the previous case-control study. There was a trend towards an association between 
reported sunlight exposure and vitamin D with those exposed to more than 30 minutes per day 
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having higher 25(OH) D levels. Greater time spent doing moderate and vigorous activity 
appeared to be associated with lower vitamin D levels. This study has highlighted the wider 
implication of inaccurate readings of serum vitamin D as assessed by different techniques in the 
management of hypovitaminosis D.  
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6.0 QUALITATIVE PEDIATRIC DIABETES STUDY (QualPDS) 
 
6.1 INTRODUCTION 
 
In order to further investigate the beliefs and attitude of a sample of children with 
diabetes and their care givers in relation to the etiology and the management of their diabetes, 
focus groups were set up. In qualitative research the quality rather than the quantity of the 
sample is paramount. Qualitative research aims to generate data for analysis from direct 
observations that involve open-ended and documented interviews (237). The aim in doing so is 
to generate in depth narrative descriptions that will yield themes (237). Qualitative data is 
becoming increasingly recognized as a valuable research method and using both qualitative and 
quantitative data has the potential to generate a wealth of information that neither could produce 
alone (238). 
The systematic review undertaken by the Health Technology Assessment (HTA) of the 
most effective educational or psycho-social intervention for improving metabolic control of 
children and adolescents with T1DM, identified the need for more rigorously designed studies 
and demonstrated a  lack of clear evidence by the studies reviewed (239). Since then, the HTA as 
well as the National Institute for Health Research (NIHR) have adopted evidence-based 
approaches to allow the participation of key and lay stakeholder including service users in the 
development of interventions (240). More and more funding bodies now require the involvement 
of stakeholders which reflects the growing focus on service users and public involvement in the 
research process stages (240, 241). Involving such participants in the research process is a  
means by which the researchers can address the validity of the research intervention (242, 243). 
The DEPICTED (Development and Evaluation of A Psycho-social Intervention in Children and 
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Teenagers Experiencing Diabetes) Study was developed with the active participation of children 
and  teenagers with diabetes as well as their parents or caregivers (244) (Refer to Chapter 7 for 
more details of the DEPICTED study). The lay participants, as described, played a crucial role in 
helping the research team to design the intervention tool and inform guideline development. 
Interesting to note is that none of these stakeholders, parents and children with T1DM, withdrew 
from the DEPICTED study‘s development phase which the authors rationalized as being due to 
the value placed on being able to influence improvements in services (244).  
6.2 EXPERIMENTAL DESIGN & METHODOLOGY 
STUDY AREA/SETTING: 
The study recruited from within the patient, relative and staff populations at the 
Salmaniya Medical Complex. 
STUDY SUBJECTS:  
i) Parents of children who are newly diagnosed with T1DM and admitted to the 
Salmaniya Medical Complex.   
ii) Health professionals working with children with diabetes and their families (doctors 
and nurses). 
SAMPLE SIZE: 
In total, the families of 5 children out of 20 approached agreed to participate in the focus 
group. All three of the diabetes nurse educators and two of the three endocrinologists at SMC 
also participated in the staff focus groups.  The focus groups for parents, nurses and physicians 
were conducted separately. No difference was observed in terms of the nationality, religion, race, 
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geographic location or gender of the child whose caregivers‘ participated  in the focus groups 
versus those that did not (see Appendix 9).  
DATA COLLECTION METHODS: 
The focus groups were recorded and transcribed verbatim before undergoing systematic 
qualitative analysis. Focus groups lasted between 30 and 45 minutes and were facilitated by the 
principal investigator who used a prepared set of open-ended questions to facilitate the 
discussions (see Appendix 10). Although the children themselves were invited to participate only 
one child accompanied his parents to the focus group session.  
The focus groups for the parents aimed to explore the following areas of discussion: 
 Perceptions of the disease prior to and after admission 
 Evaluation of the hospital stay and whether it was considered a good or bad experience 
 Evaluation of the education received during the hospital admission period  
 Evaluation of the follow-up system at the pediatric diabetes clinic 
 Exploring recommendations for future support programs 
 
The focus groups of the pediatric nurse educators aimed to explore the following areas of 
discussion: 
 Barriers to the education process and behavioral changes 
 Evaluating the role of the health care workers in educating the family post diagnosis. 
 Exploring recommendations for future educational programs   
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The focus group of the pediatric endocrinologist aimed to explore the following areas of 
discussion: 
 Evaluating the role of the health care workers in educating the family post diagnosis 
 Evaluating barriers to education process and behavioral changes 
 Recommendations for future educational programs  
6.3 RESULTS  
Figure 7 shows the process of admission, education, discharge and follow-up of children 
with T1DM at the Salmaniya Medical Complex (SMC). 
6.4 PARENTS OF CHILDREN WITH DIABETES AND THEIR FAMILIES FOCUS GROUP 
 
6.4.1 FAMILY FOCUS GROUPS 
6.4.1.1 PERCEPTIONS OF THE DISEASE PRIOR TO AND AFTER ADMISSION 
Knowledge of the disease prior to diagnosis Most focus group members had a pre-conceived 
notion about diabetes prior to their child being diagnosed.  Their knowledge of the disease 
seemed largely dependent on whether or not they had a family member or relative with diabetes. 
One group member stated ―I just knew what it was because my mother had it‖ whilst another 
parent stated ―I had no clue what it was because no one in our family has it.‖  When probed 
further about the type of diabetes one parent replied:  ―The type that requires taking injections.‖  
Other group member‘s replied simply ―It was high‖  
118 
 
Breaking news and diagnosis of the diabetes Some group members explained that the news of 
the disease was broken to them by the attending physician at their local health center whilst 
others had the news broken to them at the emergency department in the hospital by the 
consultant endocrinologist. However, all group members expressed their sense of shock when 
they discovered their child had diabetes.  One group member explained, ―Diabetes to me was a 
shock…it was a shock when I found out it was diabetes ―another member stated ―I was surprised 
he was diagnosed with diabetes‖ and ―it took me a month to come to terms with the disease…‖ 
One mother reported that she did not know about the disease before her child was diagnosed and 
―that it had not even passed [her] mind that she could have this illness.‖ 
Social and future concerns All group members expressed either social or future concerns in 
regards to their child‘s diabetes.  Many of the members had concerns about the side effects of the 
disease as expressed by one mother ―I am worried their blood sugar will be very high and that it 
will affect part of their body negatively‖ or as another mother explains who already has a child 
with kidney failure ―I fear the side effects of diabetes like kidneys and kidney problems because I 
hear a lot of people talk about this. People say for example that they got kidney failure from 
diabetes…‖ 
When asked about other concerns asides from physical side effects, one mother explains: 
Well I am worried it will impact his studies, and I think about when he is older and starts to 
work, will he be able to lead a normal life?! I am thinking even about when he marries. That’s 
what I think about. 
Particularly interesting in the above statement is this mother‘s concern about the far-reaching 
impact of her child‘s diabetes on their ability to get married or any marriage itself. This concern 
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was shared by other parents regardless of whether the child diagnosed was male or female. For 
example another parent explains 
 “Me too, I have many concerns…in terms of people’s perception….because she is still young. I 
am worried about when she gets older when she marries… 
Many of the parents also expressed concerns about their child‘s schooling and the social stigma 
of diabetes. For example one mother states:  
Yes and many families they hide the fact that their children have diabetes one child in my son’s 
school they found out he had diabetes and the father wouldn’t give him his insulin injection at 
school because he felt ashamed to give it to him for people to know and the school discovered 
only after my son was also diagnosed. 
The reaction of their child‘s school to the diagnosis was also discussed by parents with one 
mother reporting that her daughter‘s school were ―very concerned and they offered to switch her 
class so she would be closer to the nurse.”  However their experiences were not always so 
positive with one member believing that ―…the schools should understand when my son asks to 
go to the washroom, you know because of his condition.”  
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6.4.1.2 EVALUATION OF THE INITIAL HOSPITAL STAY 
Admission process Most group members explained that they were diagnosed at their local health 
center (LHC) before being transferred to the hospital for admission and education. One family 
member explains the process:  
“We were taken by ambulance from the local health center…everything went smoothly a couple 
of hours later we were in the wards.”   
Other members describe their experience at the LHC: 
M was first diagnosed at the local health center where they referred us to the Salmaniya Medical 
Complex Accident and Emergency and a week later his sister exhibited same symptoms so I also 
took her to the local health center and we were again referred to the Accident and Emergency. 
But M didn’t need to be admitted as her brother was diagnosed a week before and I knew what 
to do.  
Hospital experience and length of stay Several members explained that they felt more 
comfortable when they were in the wards; ―it was more relaxed upstairs.‖   All of the group 
members were given a private room with the exception of one who was initially admitted in the 
pediatric intensive care unit after which she was moved to a private room in the general pediatric 
wards. One group member explained that the nurses in the wards were ―better than the nurses in 
the Accident and Emergency”, they were ―more caring‖ and “…in the wards there was no 
shortage.” Linked to this, another parent reported that staff in the Accident and Emergency 
―…were under a lot of pressure‖   suggesting that requiring newly diagnosed children with 
diabetes to be admitted via A&E may not be the most practical or acceptable approach. 
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All of the group members felt that the length of stay was adequate and they expressed their 
comfort in the private room as one member expressed ―it was a nice room.‖  
6.4.1.3 EVALUATION OF THE EDUCATION RECEIVED DURING THE HOSPITAL ADMISSION PERIOD  
Role of nurse educators’ One common element in many of the focus groups was the emphasis 
on the importance of the role of the nurse educators at the time of admission.  They described 
them as having done ―their job well‖ and ―…no one can fault them… they were excellent.‖  
One group member described her experience with the nurse educators:  
―…after we left the ICU and were admitted in a private room in a general ward, the nurse 
educators were there for us immediately and the nurse educator sat with me and H‘s father for a 
long time and explained to us to give insulin and injection site rotations.‖ 
Length of education All group members expressed satisfaction at the length of the education as 
one member describes:  
“…I feel that she went at the pace that I wanted and you know my son didn’t want to stay long so 
as long as I understood the essentials and was able to give the injections that was enough to be 
discharged.” 
As highlighted in the above statement and reinforced by other parents is the fact that the nurse 
educators were able to match their pace to the needs of the families in terms of education, 
spending a longer or shorter time according to their receptiveness: “She sat with us several hours 
a day and devoted her entire attention to us.‖ This was further highlighted by comments from 
group members acknowledging that ― …the time was enough and they were very clear‖ and ―It 
was a good time‖  or ―Yes, I agree she moved at our pace…‖ 
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 Education materials When asked about the educational materials used one group member 
responded ―Oh it was excellent, very complete.‖ This was the general response across all focus 
groups. One parent explains further: 
“ I liked the drawings [the nurse educator]  used to explain my child’s condition. I mean even at 
home when I was trying to become more knowledgeable about my son’s condition I would go 
back to the drawings.” 
Dietician role All group members learnt how to carbohydrate count and although many of the 
members knew about healthier food options, this was not always applied prior to diagnosis. One 
focus group members explains that prior to her child‘s diagnosis she ―…didn‘t know about 
portions and now I have to give meals at specific time and quantity and it should be healthy.‖  
One group member describes what she learnt from the dietitian:  
“I learnt that I could give my son everything but within the portions allowed. He wasn’t deprived 
of anything…but he could eat at specific times. I also learnt that if his sugar is high I shouldn’t 
give him foods that will make it even higher and you know I knew about healthy eating and 
portions before but I didn’t apply it, now I am…” 
Another member describes similar experience:  
“I learnt about the healthy and unhealthy foods. I have applied this with all my children not just 
M. We stopped the sugar and the sweets. His brothers are the same.” 
One group member explains that although she ―found it difficult to plan meals to calculate 
carbohydrates” she now feels ―… it’s not so bad, he isn’t being denied from anything I just 
make sure that his food is healthy and within the amount of carbohydrates.‖  
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It is evident from the statements above that after sitting with the dietician the families made an 
effort to make healthier food choices for the entire family and not simply for their child with 
diabetes.  
Endocrinologist role A majority of the focus group members describe their encounter with the 
consultant endocrinologist as being "once‖ and ―briefly.‖  When asked about if the 
endocrinologist had answered any questions or concerns the members may have had, one parent 
explained: 
No but to be frank I didn’t really ask him…. The nurses had answered all my questions.  
Others describe a similar experience with regards to the endocrinologist‘s role: 
“ …[The endocrinologist]  didn’t sit down with us, he just passed by. I would have liked it if he 
stayed longer to answer some of our questions.  
In contrast one mother whose child was admitted to the Pediatric Intensive Care Unit describes 
much more input from the endocrinologist and explains that  ― I saw him three times in H’s 
admission period” and ― He explained everything to us….” suggesting that their input is largely 
driven by the child‘s condition on admission and therefore the care setting in which they are 
initially seen.  
6.4.1.4 EVALUATION OF THE FOLLOW-UP SYSTEM AT THE PEDIATRIC DIABETES CLINIC 
Voicemail Approximately two thirds of the members of the focus group explained that their 
preferred method of following up is with the voicemail. One member states ―Ohhhh I always use 
the voicemail” and ―If I need anything I leave a message for the nurses.‖ They explained that the 
nurse educators will respond ―within the same day or next day.‖ However one parent described a 
negative aspect of using the voicemail: 
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―They are good but at times when I call they won’t respond till next day maybe it’s because they 
are very busy.  So it’s late. That’s the only negative point.” 
Another focus group member describes the same experience: 
“….but if I call at 1:30 or 2pm they won’t respond till next day.” 
Hotline use All of the group members describe depending on the hotline mostly ―Just in the 
beginning...” When asked what reason would prompt them to use the hotline, one member 
explains that she would use it ―when she gets hypoglycemia…‖  Another explains: 
―Well his sugar was always high and he would be lethargic and I would get worried and call.”  
In terms of promptness of response, one mother explains that ―…they pick up immediately.‖  
Some group members explained that they try to deal with events of hyper or hypoglycemia and 
that they ― …try to deal with this myself first before calling the nurses.‖  
Supply issue Half of the group members complained about insufficient supply of blood glucose 
strips, needles, and other supplies. One member explains: 
“Yes we don’t get enough strips…sometimes I need to check his blood sugar more than 
the times given but maybe because he complains of a headache or stomachache so I 
check his sugar again but they give us a limited supply.” 
Another focus group member describes a similar complaint: 
“The only issue I personally have with is the supplies and obtaining enough supplies.” 
[Note: Upon discharge from the hospital, patients are given a 6 months prescription for insulin 
and supplies such as needles, glucometer strips, alcohol swabs etc.… These can be obtained 
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either from the SMC pharmacy or from the pharmacy at the local health center.  The prescription 
is renewed at their next follow up visit. 
 Improvements A common comment from group members was that that the clinic area itself “It 
needs to be bigger!”  
6.4.1.5 EXPLORING RECOMMENDATIONS FOR FUTURE SUPPORT PROGRAMS 
Future program When parents in the focus groups were asked what types of programs they 
would like to see for their children, the majority exclaimed that they wished their child could 
meet other children with diabetes ―…so that they don’t feel like they are in this alone‖ and  ―so 
that psychologically they feel better.‖ Others voiced similar concerns stating: 
“Yes especially if they could mix with children with the same condition they will feel that they 
are not all alone.” 
Psychological support was requested by approximately half the members with one parent stating: 
“I would like to address their attitudes; you know everything changes when they start insulin. So 
yes yes…psychologically.  
One parent explained that they wished that the initiative be taken by the diabetes clinic in order 
to avoid parent-child clashes stating: ―but I want it to be through the clinic through you guys, 
they listen to you.” 
The rest of the members requested more trips and social gatherings for the children.  
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6.4.2 PEDIATRIC NURSE EDUCATORS FOCUS GROUP 
6.4.2.1 BARRIERS TO EDUCATION  
Social barriers When exploring some of the main barriers to education from the point of view of 
the pediatric diabetes nurse educators (PDN), familial social problems was one of the main 
themes which resonated throughout the focus group as an obstacle to education.  One nurse 
described it in the following way: 
―Sometimes social problems, it will be the main our main uh problem with the patient. Uh like if 
the patients uh uh parents are divorced sometimes or uh if they are non-educated ah well so it 
will be very difficult for us for education.‖ 
Another diabetes nurse educator agreed that ―social problems some psychiatric issue‖ are 
barriers to education and follow-up.  
Logistical barriers Another barrier to education as identified by the PDN‘s are logistical issues 
such as ―shortage of staff‖  They reported finding it difficult to juggle the influx of outpatients 
coming for follow-ups post discharge or for review of blood logs resulting in long waiting times 
due to limited working space as highlighted in the following passage:  
“Sometimes for example for walk in patients on Wednesday we are taking patients without any 
appointments. If there are so many patients and want to review for them umm some educational 
material and there is standing outside patients and we are only three and the place for education 
only here for outpatient. This suggests that the issues were a combination of inadequate space 
and staff combined with unpredictable nature of the caseload. 
It would appear that one of the impacts of this shortage is the loss of patients to follow up 
appointments as explained in by one educator:   
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― …because of the shortage the shortage of the staff and in between the patient will be missing 
even if they are new patients because of the shortage of the staff. So imagine that we are three of 
us ah doing all this job…” 
When asked about the length of education time, the nurses explained that although the average 
inpatient education time was two days, they moved at the pace the patient was most comfortable 
with as described:  
“Some families they need one or two days according to their education, according to their 
response to the pathways.” 
Facilities The lack of adequate facilities such as space is a theme that was echoed throughout the 
focus group. One nurse explains:  
“Sometimes we are also arranging for re-education here for outpatient department and we don’t 
have rooms.” 
Another nurse explains how the limited space available impacts education: 
―The limitation of the place it is one effect and the ahhh the time the time that we are spending 
for the outpatient re-education, whatever we will give in three days maximum staying at home 
need to be reviewed.” 
The nurses all agreed that if logistical problem were to be resolved that the time spent educating 
would be reduced and education could be completed within a 24hr period. One nurse explains it 
in this way:  
―If we are crossing these problems yeah, it will be in one day the patient will be discharged.” 
Relationship with patients Clearly the nurses develop a close relationship with the patients and 
this relationship has an impact on education and the willingness of families to undergo 
129 
 
behavioral changes.  One of the main concerns of the nurses is what they describe as the abuse of 
the 24hr hotline. One nurse gives more details:  
“Any time they are calling for silly things, silly silly things for nothing. We are with our children 
ahh praying or our special work we have it is not their business in between also they are 
shouting to us even and even emergency they don’t want from us anything and they are going on 
calling us so…” 
The above passage highlights the frustration the nurses feel in relation to the 24hr hotline and its 
infringement on their personal time with their families. It also highlights the fact that some 
patients are using the emergency line for non-urgent matters and at times these patients can be, 
as put by the nurses, impolite.  
The 24hr hotline was described as being an additional work pressure as described by this one 
educator: 
“…the call that is 24 hours call the hotline this is too much pressure for us.” 
6.4.2.2 BARRIERS TO BEHAVIORAL CHANGE 
Treatment The treatment of diabetes was described as one of the main barriers to behavioral 
changes and in particular ―the injection itself.‖  One nurse explains it in the following way: 
“The injection and accepting that their son or their daughter has diabetes and this disease will 
be long life. It is very difficult to tell you that your son or your daughter is diabetes and this is his 
life and he should give this injection in all of his life. That’s the complication.” 
Factors affecting acceptance Accepting the disease itself either by the child or their family, 
appeared to be a significant determinant of willingness to undergo the necessary behavioral 
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changes.  Several themes were highlighted that relate to acceptance. One such factor is the 
family‘s personal beliefs. One nurse described it in the following way:  
“Also the belief, the belief of the family aahh that this ahh disease will go. Always they are 
thinking that for type 1, temporary.”  
From the statement above it is evident that there are overt misunderstandings amongst parents as 
to the pathophysiology of the disease and that this then impedes behavioral changes and even 
education process.  
Whereas the impact of education level had appeared more clear cut earlier in relation to disease 
acceptance this did not seem to be the case as one nurse replied:  
“It’s random… so you will have very highly educated families unable to accept….” 
Effect of Religion on acceptance Religion was described by the nurses as having a ―positive‖ 
impact on accepting the disease. One nurse states: 
―The religion also itself it is affecting in the accepting.”  
Another nurse further explains: 
“Uhh, like what we are getting….uhh what are getting most of our patients what we are getting 
is something from the God and we will get some benefit in in…” 
The above statement highlights how some families believe that this illness is a test from God and 
hence a challenge to their faith that should not be viewed negatively.  This belief gives them 
―strength to cope.‖ 
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Social factors Some social factors, according to the nurses, also have an impact on the 
acceptance of the disease such as “…the social also life of the family‘ or “the surrounding.‖  
However these were not expanded on and so did not appear to be major influences  
Knowledge/family history Having a family history of the disease or prior knowledge appears to 
have an impact on accepting the disease. One nurse explains:  
―Especially if they are having family history; so that’s means they will accept their daughter or 
son to be diabetes.”  
However the social stigma of the disease remains a concern of the families according to the 
nurses negatively impacting on their acceptance of their child‘s condition. This was highlighted 
in the following statement:  
“But here the society is having bad uhhh..you know anybody is knows that you, that your son is 
having diabetes that means that is very big big problem, its huge problem, it’s the main problem 
in your life…you cannot live with this problem. This is what they are thinking.”  
6.4.2.3 ROLE OF PEDIATRIC DIABETES NURSE EDUCATORS  
Treatment One of the main roles of the PDN‘s is in the active treatment of the disease which as 
described by the nurses involves ―adjusting the blood sugar‖ and ―increase and decrease insulin 
with doctors…”  The nurses explained that during the admission period the physician will adjust 
the dose but that post-discharge if necessary they will make adjustments without referring back 
to the primary consultant. They did acknowledge however the need to refer back to the physician 
when a difficult case presents stating that ―Sometimes yes, sometimes we need our doctors.‖ 
Their role is also to ―review the information‖ and as one nurse explains:  
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“...will review whatever they have problems at home even diet sometimes we are giving advice 
and we are adjusting the glucose also and we are repeating education for some patients.” 
Support The PDNs also felt that they had a significant support role for families “ because at first 
they will be in shock.”  And when asked if emotional support takes up a major part of their time 
one nurse replied: 
“Yes yes… it will take a big big part of our management.” 
Besides emotional support, the nurses are also there to guide the patients on how to manage 
diabetes post-diagnosis advising them on the support options available as explained by one nurse 
in this statement:  
“…to serve the patients ahh at home how to manage diabetes ahhh and the follow up system by 
either telephone, fax or walk in patients ummm” 
Education Another major role is to ―To start education,‖  ―Educate, re-education‖ and 
―Modeling…‖ One nurse explains: 
“We are following the patients uhh uhhh during three days after diagnose.. after discharge in 
24hours hotline so any problem they are calling us ahhh anytime we are covering ,and the 
readings should be followed every day for three days…” 
The above statement shows the close follow up the nurses provide post-discharge and in 
particular in the days after diagnosis in providing support by being available if needed 24hrs a 
day to adjusting blood sugar readings. Besides educating the patients and their families, the 
nurses are also involved in training other nurses or educating medical students with regards to 
the treatment and management of diabetes. One nurse explains:  
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“… the medical students also sometimes in between they are coming for us for teaching them 
and some of the staff also coming in between for us to take our service from us or ahh any  
information and they are coming for us students to train them in between.”  
Management The nurses also have a managerial role in the department which involve reporting 
on statistics, administrative issues, and are involved in liaising with the Diabetes Society and 
their activities such as the annual diabetes camp, and other activities organized by the society:  
―…management job we are doing and we have to uhh cover the society also the activities of the 
society”  
6.4.2.4 FUTURE RECOMMENDATIONS TO STRENGTHEN THE EDUCATION PROGRAM 
Several ideas were identified by the nurse educators that they felt would help improve and 
strengthen the education program they are currently delivering. 
Logistics There is a basic need for more educational materials as one nurse states:  
“we need educational materials to develop educational materials” 
Equipment There is a need for equipment “like colored printer‖ and as one nurse states: 
“We need telephone we don’t have telephone, telephone hotline we don’t have it, we need 
camera we need laptop we need educational materials to develop educational materials.”  
Facilities As mentioned earlier, there is a need for more space to accommodate the patients. 
Age-specific support The nurses highlighted the need to focus on “adolescents” with diabetes as 
they described them as being in a ―crisis age‖ and ―lost.” They highlight that this population in 
particular requires more of their attention as they will be moved from the pediatric clinic to the 
adult clinic. One nurse explains more:   
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“Ahh this period is very crisis period for the children. That they are newly diagnosed in this 
period they are teenagers they are not accepting sometimes. They are doing so many many 
things false from the disease. So they need support they need very strong support so the patients 
when they are transferred to adult they are coming back to us because nobody is there for them.” 
Another nurse expands further:  
―Because they are in between pediatric and adult and pediatric and adult some they will go into 
pediatric and some year they want to go into adult and this area they need a transitional clinic. 
This clinic is supposed to be for adolescents and there will be pediatric nurse and adult nurse 
and even the consultant they can match in this idea.” 
Social Support All of the nurses agreed and recognized that there should be more of an initiative 
to provide social support for families. One nurse explains 
―We need support for so many things to give the patients to encourage the patients in so many 
things.” 
They focus on the need to provide a strong social support group for parents of very young 
children: 
         “They need to see be socials relationship especially for small, small, kids the parents will 
be very effective.‖  
Finally the nurses underline the need to engage key stakeholders along with the Diabetes Society 
to provide activities and support groups for the families and the children:  
“For the society what they are doing, only the camping and now they are starting summer 
activities only that things but the children themselves they need more. For the whole of the year 
they need somebody to support continuous support continuous activities.” 
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Finance Financial constraints are identified as being a major barrier to providing better 
education. One nurse explains:  
“We have also the proposal for the diabetes center it is still not done because of the economy…” 
So although a proposal has been in place for a diabetes center the ―financial problem‖ according 
to the nurses is hindering the development of the center which they hoped would resolve all 
logistical problems.  
 Staffing The nurse educators recognized many of their weaknesses and wanted to implement 
changes but due to the shortage of staff and limited work space they felt they were unable to do 
this as explained by one diabetes nurse educator: 
"…and we don’t have the place to meet them together or the people to work on them we are only 
three of us we cannot do all of this. We have the ideas but we cannot do it because of the 
shortage. 
Education for PDN Finally, the nurses stress the importance of educational courses and updates 
on diabetes in order for them to be able to provide the most up to date materials and education. 
They stress that ―updates in diabetes should be yearly.‖ The nurses voiced the need for taking 
courses in dietary management in order to better understand the impact of nutrition and insulin as 
well as courses in psychology and counseling as this takes up a major part of their management.  
To sum up one nurse states: 
―We should go for further study… for the diabetic educator course that we went it is not enough 
with our practice…. It is OK but we need more life is changing day by day.” 
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6.4.3 PHYSICIAN FOCUS GROUPS  
6.4.3.1 ROLE OF HEALTH CARE WORKERS IN EDUCATION POST-DIAGNOSIS  
Whilst evaluating the role of the health care workers in educating families post diagnosis 
from the perspective of the physicians several themes were highlighted.  
Reliance on teamwork The physicians voiced strongly the importance of teamwork and their 
reliance on the nurse educators and dietician. When asked who they rely most on one replied 
“All of them!  
And another physician exclaimed:  
―Well yes I cannot do my job without the diabetes nurse educators or the dietitians. They are all 
equally important.” 
Role of physician at time of diagnosis The role of the physician at the time of the diagnosis is to 
break the news if this was not done so previously and explain to the parents about diabetes, its 
treatment and management. As one physician recounts:  
“Well I go to see the patient whether they are admitted in the ward or if they are in the 
emergency and I explain to them about the disease and about the management and I address any 
concerns they may have”. 
Another physician explains:  
First of all I think I have to sit with the parent and explain what is diabetes so they understand 
what is the problem exactly and then after introducing after discussing what is diabetes is, I try 
to calm them down and tell them that there is a team that is going to take care of you so you are 
not alone. The team consists of the following and they will come and sit with you they will 
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discuss with you what is diabetes in details with you. Whatever you need from diabetes they will 
help you to understand to learn how to manage and we will be there for you. 
Breaking news The physicians recount that most of the families they see have already been told 
about the diagnosis either ―From the local health center‖ or when at the pediatric emergency 
department.  When it comes to breaking the news one physician states:  
“It is our job but most of the time when we see the patient they already know as the news was 
broken to them from the health center or in emergency or even some parents when they see blood 
sugar is high they know immediately that is diabetes.” 
Patient visit during admission period It would seem that that although the physicians do daily 
rounds on their patients, as noted earlier their presence is more prominent in the severe cases that 
present with diabetic ketoacidosis and those that require pediatric intensive care. One physician 
explains:  
“It depends on the condition if they are admitted with DKA usually I go frequently and make 
sure the acid-base balance in correcting. Once the acute management is done then daily I need 
to see them once or twice.”  
Patient knowledge of disease prior to diagnosis The physicians explained that ―almost all of 
them they know what is diabetes before” but most will have only a superficial knowledge of the 
disease. The physician explained in more details:  
“Well…let’s put it this way, they have all heard of diabetes but we explain to them in more detail 
and we explain the management.”  
Often, the knowledge they have of the disease comes from their family members with the disease 
or from their community:   
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“Ya, so they relate it to the people they know and one more thing is the beliefs in the 
community”.  
Parental concerns at time of diagnosis The physicians had varying views about what most 
concerned the parents at the time of diagnosis. One physician states:  
“…from what I hear, parents are always concerned about the diabetes complications. So once 
they hear about the diagnosis they are afraid of the complications.”  
The physician explains further:  
“In the beginning yes maybe the injection but once we sit with them and start the uh treatment 
they find that that the blood glucose is coming down. I feel most of them… number one is the 
complication cause they are afraid from what happened to their grandma or grandpa because 
they have confusion they don’t know what is type 1 and type 2, so they are always confused with 
the types of diabetes.”  
One physician explains that initially they will start to worry about the treatment about the 
injection and that they many have queries regarding ―the food.‖ The physician elaborates:  
“Yes they are so worried about what their child can and cannot eat and how they will be able to 
handle this…I tell them don’t worry our dietician will sit with you and explain about the diet. I 
reassure them that they can eat everything but in quantities prescribed by the dietician.” 
Physician role in post-discharge follow-ups The role of the physicians as explained by one 
doctor ―is to follow up with patient, to adjust insulin to check rotation site…‖ The physician 
explains in more details:  
―What happens uh during their hospital stay, uh, I trust my team so I don’t interfere in uhh, the 
knowledge that they give to them but post discharge I ask my patients a few questions just to 
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make sure that they grasped the information, they understood the information, they are 
comfortable with the information they got.”  
Role of the nurse educators The physician‘s explained from their point of view the role of the 
nurse educators:  
“The nurses in my team they explain again what is diabetes in their way, their own way, then 
they sit with the parent and try to calm them down try to make them feel better and then they go 
into the diabetes education…” 
And,  
“So, usually they go into the details of acute complications, chronic complications, how to 
manage sick days, how to manage school days, how to manage parties, how to manage 
picnics…”   
Another physician acknowledged that families tend to have a closer relationship with the nurses 
and explains further:  
“Well the nurses they have closer contact with the patients. Whereas they will see us once every 
4 months, they have access to the nurse daily…and if there are any serious concerns about the 
patient the nurse educators will come and discuss with us.” 
Role of the dietician The role of dietician is ―very important‖ as exclaimed by one physician as 
―many times the first things the parents ask us is what can our child eat.‖ Another physician 
explains the role of the dietician further:  
―My dietician, my dietician also sits with the patient and will go into the details of the diet and 
uh try also to clear the things for them and try to give them clear information and tell them that 
type 1 diabetes is different in children than type 2 and she goes into the details of the dietary 
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management what is allowed and what is not allowed and how to balance the diet and the insulin 
requirements in relation to activity and in relation to sick days. So almost she is covering 
everything in relation to diabetes and the diet.”  
One physician explains the need to have one dietician to focus on just the children with diabetes 
and states:   
“Because she is the one dietician to cover all of pediatrics so she does not have enough time…” 
And  
―We need our own dietitian….”  
Referral to other consultant The physicians explained that they do not often refer to other 
consultants as one states:  
Sometimes yes, most of the times it is with the nephrologist but it is very rare.  
Another physician reiterates:   
“..it does but rarely like to a nephrologist if we suspect that there is kidney damage….but not 
often.” 
They do acknowledge the need to refer to the psychiatrist although as one physician states:  
“…we need a psychologist. But the doctor working with us is a psychiatrist”  
And another physician states:  
―…we refer to a psychiatrist a lot also….for families or children themselves having difficulty 
psychologically dealing with illness.”  
141 
 
6.4.3.2 BARRIERS TO EDUCATION PROCESS  
Limited resources/ Limited Facilities One of the main barriers to educating as described by the 
physicians were limited facilities such as workspace and shortage of staff. One physician states:   
“We are short staffed….. the diabetes nurse educators…we don’t have enough and no proper 
room or space.” 
Another physician expands further:  
“Yah I think there is uh, I mean what we have now, we are trying to cope with because usually 
we are trying to do our best even with the minimal as a team I mean. With the minimal available 
resources… but I think if we have a well-organized diabetic unit a place where we can either me 
or the dietician or the educators somewhere where we can sit in a calm quiet place with the 
parents and try to give them the information in a clear way in a suitable situation quiet…” 
From the statement above, it is interesting to see that the physician recognizes the difficulty 
faced by the team and acknowledges that they do their best with the limited resources they find 
themselves confronted with.  
Lack of awareness/knowledge Another barrier to education perceived by the physicians is the 
lack of knowledge of the disease and the family‘s reliance on word of mouth with regards to the 
management and even complications of the disease. As one physician states 
“They don’t have awareness; they don’t read other than their uhhh fields… So when you come to 
them they really know nothing. The knowledge they have is just the knowledge that is spread in 
the community. What everyone else knows they know. Whether they are educated or not educated 
it is the same for everyone…” 
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It would appear from the above statement that the physicians feel that dealing with educated 
families is not necessarily synonymously with the successful management of diabetes.  
Another physician states in agreement:  
“No I don’t think it is making a difference…. Sometimes I get illiterate people and umm they 
want to put more effort and do good for their kids and they do very well…” 
6.4.3.3 BARRIERS TO BEHAVIORAL HEALTH RELATED CHANGES  
Misinformation/ lack of Awareness Again, the theme of misinformation and lack of awareness 
of the disease were highlighted by the physicians as being a barrier to behavioral health changes.  
They reported that families sourced information from their surroundings and from their 
community which were not necessarily reliable sources. 
One physician states:  
“Ya, so they relate it to the people they know and one more thing is the beliefs in the 
community.” 
Difficult age group The physicians' state that specific age groups are also a barrier to behavioral 
changes:  
“Adolescents and infants so those are the two groups you feel there needs to be more focus on 
them…” 
Another physician states:  
“I face the greatest difficulty with the adolescents. The young children they are easy to control. 
The older ones we have difficulty. They don’t want to take injection sometimes or sometimes they 
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don’t want to check blood sugar. They also want to eat at any time like their friends…. They are 
very difficult. You know it is the age”.  
The physician went on to say:  
“They need for us to spend more time with them, to try and deal with all these issues….you know 
especially when they transition to adult clinic they will feel lost  because there they have no time 
to do this.”  
6.4.3.4 RECOMMENDATIONS FOR FUTURE EDUCATIONAL PROGRAMS  
When asked about future recommendation and suggestions for improvement, one 
physician states:  
“I think we are providing an excellent job and service educating the families especially when 
they have been admitted. We admit for an average of 2 days only…” 
And another confirms: 
“We have an excellent team but most of the things we are doing it’s on a personal effort basis…” 
It is interesting to see from the above statements that before elaborating on the needs for 
improvement, both physicians began by commending their team‘s effort and achievements.  
Facilities/limited resources The physicians explained the need to provide more adequate 
facilities and resources as explained by one:  
“So if it done in an organized way and the people get what they deserve and the Ministry of 
Health try to help us in having a really well organized unit with all the facilities that we need I 
think that we can give more.” 
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Finance The doctors agreed strongly with the need to provide more financial support in order to 
update everyone on the current management and practices regarding diabetes. As they state:  
―We especially need to send the nurses, the dietitians and even ourselves to conferences and we 
do not have the financial support.” 
Training or educational courses The physician also stressed the need to train the entire team 
and ―even after finishing the training we need updates‖ Another physician explains:  
“All of us including the doctors, I think we need updates. Like the things that we saw 10 years 
back it was amazing and I don’t think that things are the same. We are reading we are attending 
conferences, but working with the right people also makes a difference.”   
Shortage of staff  The shortage of staff is a theme that consistently arises throughout the focus 
groups and the physicians were equally concerned:  
“We need more staff more diabetes nurse educators and we need more dieticians one is not 
enough to cover the whole hospital. We need time more for the patient. They should come for 2 
or more sessions as outpatient.” 
6.5 DISCUSSION  
 
This study aimed to gain a better understanding and insight into the relationship between 
healthcare providers and caregivers of children newly diagnosed with diabetes. In particular we 
aimed to explore the process of admission and education and the characteristics of the exchanges 
between various health care providers (HCP‘s) and caregivers. Furthermore we wished to 
investigate processes which caregivers felt were conducive to successfully managing diabetes 
and those that imposed barriers. Finally we aimed to get an overview of the perceived roles of 
HCP‘s in relation to each other and in relation to the caregivers of children with diabetes.  
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The themes highlighted from the focus groups have given invaluable insight and 
information with regards to the views of the families of children with diabetes and health care 
workers in this field. Perhaps one of the most beneficial insights gained from the focus groups is 
the way in which a lack of proper awareness and knowledge of diabetes prior to diagnosis can 
impact on treatment of the disease. As highlighted by the physicians and nurses alike, and 
confirmed by the families themselves, most of the awareness and information regarding the 
disease is obtained from their immediate community or from family members. Furthermore, this 
problem was identified as being non-discriminating of the social and educational strata but was 
―random.‖ This is contrary to some studies which have shown that lower socioeconomic status 
and  educational level are contributing factors to health knowledge regarding diabetes care (245). 
Studies have shown that greater diabetes knowledge is associated with better adherence 
outcomes (245, 246), lower hemoglobin A1c (247) and fewer family conflicts (246). 
Furthermore, some studies  suggest that better glycemic control can be achieved by improving 
health literacy, in particular the numerical skills of the caregivers of children with T1DM (248, 
249), and can result in better adherence to insulin regimen (250). The authors of these studies 
suggest developing educational programs that address the issue of diabetes health care literacy 
(245) and intensive diabetes education for parents with low health literacy (250) and, although 
health literacy per say was not directly assessed in the current study, this approach would be 
expected to also help tackle the general misinformation identified amongst our population.  
 Another interesting insight from the focus group was the identification of future concerns 
of the families and the perceived concerns reported by the nurses and the physicians. Although 
the physicians felt that complications of the disease were the most dominant concern for parents 
of children with diabetes, the group members themselves also voiced concerns such as the fear of 
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social stigma of the disease and fear of their child being treated differently or concerns about 
when and if their child marries. Although these concerns are not medical, it is important that they 
be recognized and addressed by the healthcare workers as a means to influence change. The 
reports of concern regarding future complications and overall control of diabetes are consistent 
with the findings of Faulkner et al (251). The parents of children with diabetes in their study 
―reminisced‖(251) about the events that led up to the hospitalization and voiced their sense of 
shock and denial, as did the parents in our study.  Also consistent with the findings of Faulkner et 
al are the reports of changes in diet subsequent to the diagnosis of diabetes. The admission 
process and hospital stay was deemed by group members in the current study as being a positive 
experience. Most focus group members‘ children were diagnosed at local health centers and then 
referred to the Salmaniya Medical Complex center physician or at the emergency department in 
the hospital (see flowchart in Figure 7).   
In the most recent publication by the American Diabetes Association on the standards of 
medical care in diabetes (252), they state that diabetes education should be a collaborative 
partnership between the multidisciplinary healthcare team and the patients themselves. 
Treatment of patients should be tailored to the their individual needs and should adopt  diabetes 
self-management education (DSME) which is aimed at empowering patients to self-manage their 
illness (252). Application of this systematic educational program, DSME, in the United States  
has resulted in improvement in A1C levels (253, 254).  In the United Kingdom, the Dose 
Adjustment For Normal Eating curriculum (DAFNE) is recommended for all adults with T1DM 
(255) and is a validated reproducible education program used to empower patients to take control 
of their disease (256) and which has shown to improve glycemic control and quality of life (257). 
The Kids in Control OF Food (Kick-Off)  program adapted from the DAFNE curriculum targets 
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children aged 11-16 years (258). Pilot studies of the program are on-going but show promising 
results especially in improving quality of life (259). In Bahrain the current care models for 
diabetes management are based on acute care management and the reactive management of 
individual problems as they arise, instead of using a more proactive form of management. Such 
health care management is not sustainable in the long-term and can be taxing on health care 
systems and facilities (260). According to the American Diabetes Association, diabetes care 
should follow the chronic care model (CCM) (252) which has been shown to be effective in 
improving quality of care (261). The CCM has six main evidence based components which are 
(262) 1) delivery system design 2) self-management 3) decision support, 4) clinical information 
5) community resources and 6) health systems. Hence, diabetes health care services in Bahrain 
may benefit from a shift which results in the  increased use of primary and preventive care and a 
decrease in the use of acute tertiary hospital care (252). 
In recent years several studies (263-267) have looked into the management of non-
acutely ill newly diagnosed children with diabetes at home versus hospital care setting and have 
found a lower healthcare cost (265, 267) and increased overall satisfaction (264, 266) associated 
with home care. Home care is started by a pediatric diabetes nurse (PDN) who visits the home to 
educate the parents on the management of diabetes in practical terms (268). Depending on the 
pediatric diabetes center the patient is affiliated with, home care could mean the complete 
avoidance of hospital care (269, 270)  or a short hospital stay (271) followed by home care 
management. The application and feasibility of a home-based healthcare approach in the 
Bahraini context could be further investigated as a means to decrease work load in hospital 
settings, and healthcare costs, whilst continuing to provide satisfactory education.  
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In the current study the roles of the health care workers as described by the families and 
the healthcare workers themselves generated some interesting themes. The role of the pediatric 
nurse educators was expressed as being central to the educational process both during and after 
admission. Their role was felt by many of the group members as being significant and they 
appreciated the time spent on education and the individualized pace at which the nurses took this.  
This is consistent with the study conducted by Howe et al (272) examining parental expectations 
of diabetes health care providers, in which group members also expressed their appreciation of 
health care provides that were ―present for them‖ and ―mindful in their interactions‖ despite 
having a busy clinic and suggests it may be the interactions of the HCP rather than their specific 
job title which is most important in effecting a satisfactory relationship. Furthermore, Howe et al 
found that  parents in their study expressed their desire for the provision of practical 
individualized solutions to diabetes care, and they also voiced their desire for visits to be 
―efficient, convenient, and comfortable (272).‖ Despite the satisfaction of the parents or legal 
guardians, the current model of educating does not conform to the best practice as described by 
the literature stated above.  The focus group members in our study expressed their appreciation 
of the health care providers but voiced their concerns about the difficulty in obtaining medical 
supplies from the hospital pharmacy due to issues with shortage of supply.   
The physician‘s role became more dominant during acute management such as when the 
patient was admitted with ketoacidosis. The physicians acknowledged the closer relationship and 
contact between the nurse educators and the patients. The dietician‘s role was described as being 
very important and central to meal planning and carbohydrate counting. It was evident from the 
focus group that there was a strong reliance and sense of teamwork. The physicians had trust and 
confidence in the management of their healthcare team.  
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 In terms of the follow-up and post discharge education, the majority of the focus group 
members expressed overall satisfaction at the services available. Most used the voicemail system 
to review blood sugar levels. They appeared satisfied with this although some parents 
acknowledged that if the readings were sent at the end of the day the response would not be 
received until the following day. It was interesting to note the high levels of dissatisfaction the 
nurses felt with regards to the 24hr hotline and what they believed was its infringement on their 
personal lives. They felt this system was abused, although most of the focus group members 
interviewed described their limited use of the hotline and its use only in times of real urgency. In 
a study conducted by Chiari et al (273), that looked at the effectiveness of an emergency hotline 
for children and adolescents  with T1DM in Italy, they found that only 24% of the phone calls 
received were considered real emergencies. Furthermore, they also found in that 5 year 
retrospective analysis, that the real emergency phone calls came from parents of younger 
children with a shorter duration of diabetes and that the phone calls were often during the 
weekends or holidays (273). Perhaps in the future, an audit of the voicemail and hotline usage in 
the pediatric diabetes clinic in the SMC could help in defining where there is an issue and how 
these issues can be resolved.   
In a recent review by Balkhi et al (274), on the impact of  telehealth interventions to 
reduce management complications in T1DM,  they state that one of the main challenges to 
telehealth is the provision of  financial compensation and reimbursement to  skilled staff 
delivering this service (274). Although the nurse educators did not highlight financial 
reimbursement as an issue in our focus group, it is worthy to note that the provision of the 
hotline is in effect only possible due to what one physician describes as a ―personal effort basis;‖ 
of these nurses who in fact are not paid for the provision of this service.  This could explain the 
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frustration that was exemplified in the focus group session by the nurses and should be an area of 
further exploration. 
 Several issues were identified by healthcare workers and focus group members as being 
barriers to education and behavioral changes. One of the main barriers from the point of view of 
the healthcare workers is dealing with the misconceptions and preconceived notions of the 
disease followed by social and psychological issues related to the acceptance of the disease. 
Several reviews have been published in the past decade looking at the impact of interventions on 
children with T1DM (275-281). These studies have shown that psychosocial interventions 
demonstrate greater efficacy than educational interventions alone in improving glycemic control 
as well as secondary outcomes such as quality of life, reduction in stress and family conflict.  
Furthermore it has been established that theory-based interventions appear to be more effective 
in achieving positive outcomes than interventions that are not built on the basis of a theoretical 
model (277, 281).  Hence, family and child education should be supported by systematic, theory-
based  psychosocial interventions (281).  
The focus group interviews allowed us to gain more insight into what the families and 
healthcare workers would like to improve and their future recommendations. Families stated that 
they would like to see the problem of lack of adequate supply of medication and strips resolved. 
They would also appreciate the nurse educators having a larger room to work in. Beside 
improvements in facilities and services, parents wanted to see more socialization and in 
particular social gatherings used as a platform for children with diabetes to meet and interact. 
The physicians and nurse educators also agreed that there is a need for more social support 
services for the families and in particular for very young children and the adolescents who are in 
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need of a transitional clinic. They expressed the need for psychological support especially at time 
of diagnosis when the family is in shock.  
Adolescents with diabetes were highlighted as a significant yet under treated group which 
require more focus and attention. This is in agreement with previous research which has deemed 
adolescents with diabetes to be a high risk group with these emerging adults being prone to 
deteriorating diabetes control (282). Worsening of metabolic control in this vulnerable age group 
is due to multiple factors which include insulin resistance due to hormonal changes (282, 283) 
and growth (283) and psychosocial issues (282) coupled with poor decision making and 
impulsivity (284). It has been well established that parenteral involvement in collaboration with 
health care professionals during this critical period is associated with improved glycemic control 
(285-287). 
The healthcare providers in our study underlined the need for continuous updates and 
education on the diabetes management. Furthermore, there is a need to engage key stakeholders 
in order to provide awareness campaigns that aim to differentiate between the various forms of 
diabetes and disseminate fact from fiction in the community. The healthcare workers recognize 
the weaknesses in their service but state limited resources and facilities as the main barrier to 
making improvements. The healthcare workers also describe the need to improve facilities and 
update their knowledge on a continuous basis by being provided with the opportunity to undergo 
more training and update courses and conferences. 
6.5.1 LIMITATIONS OF STUDY 
 
A limitation of this study is the very small number of subjects who voluntarily 
participated in the focus groups introducing a potential bias. Because there was only one 
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parent/child focus group, one nurse/educator focus group and one physician focus group making 
it difficult to make generalizations in regards to the results. Another limitation of this study is 
that we only assessed opinions, which can be subjective as opposed to outcomes, which are more 
objective and measurable. Furthermore, although families seemed to be overall happy with the 
educational process, which focuses on acute care management, there is now a general trend 
towards more of a preventative and primary care focused health care management as a more 
sustainable means of healthcare.  This approach was not discussed with the current sample nor 
was a sample of families exposed to such an approach available for comparison meaning that the 
strengths and benefits of such an alternative approach in this population can only be 
hypothesized at the current time. 
6.5.2 AREAS OF FURTHER RESEARCH  
 
Further work needs to be undertaken investigating the usage of the voicemail and hotline, 
the feasibility of putting into place a structured psychoeducational program for adolescents, and 
the delivery of partial home care as opposed to complete hospital care at diagnosis. Finally, 
parental concerns besides the evident complications of the disease should be explored and used 
as a means to help bring about positive behavioral changes.   
6.6 CONCLUSION 
 
These focus groups were unique in providing an all-around and in depth insight into the 
beliefs and attitudes of children with diabetes and healthcare workers on topics ranging from the 
admission and educational process, to barriers to change and future recommendations.  Overall 
the educational process and services were described positively although these did not conform to 
current best practice as described in the international literature. All stakeholders agreed with the 
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need to make improvements to facilities and to solve logistical issues in order to provide better 
services. Finally, the focus group highlighted the need to provide specialized care to adolescents 
in order to tackle the particular issues of this challenging group.  
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7.0 SYSTEMATIC REVIEW OF RANDOMIZED CONTROL INTERVENTIONS 
IN CHILDREN & ADOLESCENTS WITH T1DM  
 
7.1 INTRODUCTION  
 
Diabetes has been on the rise worldwide (281, 288). In the United States, the incidence 
rate of diabetes in youth was expected to increase by 23%  between 2010 and 2050 and in the 
United Kingdom the incidence rate in children and adolescents under 16 is also on the rise (289). 
Bahrain has not escaped this increase with a reported incident rate of T1DM in children of 8 per 
100,000 in 1995 increasing to nearly 30 per 100,000 in 2014 (290). 
Maintaining good glycemic control is critical in preventing complications of the disease; 
nonetheless this can be a difficult task especially for children and adolescents as it requires the 
careful balancing between the daily insulin regimen, frequent blood glucose monitoring, diet and 
exercise (291, 292) all set against a background of usually reducing parental control and 
increasing patient autonomy as the child gets older. The current target for glycemic control in 
children is a HbA1c of < 7.5% (58 mmol/mol) without frequent hypoglycemia (293).  Despite 
the importance placed on obtaining good glycemic control, studies have shown that children and 
adolescents are having difficulty achieving this in practice (294). However, according to the 
National Pediatric Diabetes Audit report in 2013-14, in the United Kingdom 18.4% of children 
and youths were achieving an HbA1c of less than 7.5%, a significant increase from the 2012/13 
statistics in which only 15.8% of youths were achieving this target. Furthermore, the percentage 
of  children and youth with an unacceptable level above  9.5% (80 mmol/mol) also decreased 
from 25.8% in 2012/13 to 23.9% in the most recent report (295). The audit also reports on 
variables affecting diabetes control which include ethnicity, with white ethnic groups achieving 
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better control than non-white ethnic groups, and socioeconomic status, with those living in 
deprived areas having poorer outcomes (295). 
Although increasing knowledge of diabetes and its management are core components in 
diabetes education programs, as previously discussed there is a growing focus on the psycho-
social aspects of disease management as well, which encompasses the acquisition of coping 
skills and positive family relationships (281). A systematic review published by the National 
Health Service Technology Assessment in 2000 (NHS HTA) (239) looking at the effectiveness 
of psycho-educational interventions in adolescents identified the need for more rigorously 
designed studies as those reviewed had several methodological flaws. Since then, there have 
been a number of reviews published that have looked at the effectiveness of these interventions 
in children (275-281, 296, 297). The reviews found little evidence to support educational 
intervention alone and identified the combination of psycho-social interventions with education 
as having more favorable outcomes (281). Furthermore, studies with a theoretical basis to their 
interventions appear to be more effective (277, 281). However the diversity of the studies and 
their inherent interventions makes interpretation difficult, with reviewers highlighting the need 
for randomized control trials of good quality undertaken in accordance with the CONSORT 
standards (278). In 2010, Savage et al (281) reviewed randomized control trials of interventions 
for children with T1DM, acknowledging  the great advancement made in the development of  
psycho-social interventions since earlier reviews; however the authors again highlighted the need 
for greater scientific rigor in the assessment of interventions and a more systematic approach so 
as to establish effective interventions. 
The results of the focus groups discussed in Chapter 5 have highlighted the need locally 
in Bahrain, as described by the healthcare team and the parents of children with diabetes, to 
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focus on adolescents and to assess the feasibility of putting into place a structured intervention 
program that is translatable into routine care.  
7.2 SEARCH METHODS  
7.2.1 DATA SOURCES 
 
The following electronic databases were searched from January 2008-February 2015: 
MEDLINE, Psych INFO, Child Development and Adolescent Studies, CINAHL, British 
Education Index, Psychology and Behavioral Sciences Collection, PsycARTICLES, Centers for 
Reviews & Dissemination (CRD), SCI-EXPANDED, PubMed, Embase, and Scopus.   
The search terms used were synonyms of the following: type 1 diabetes AND children 
AND educational interventions/programs.  For example the synonyms used for diabetes included 
―type 1 diabetes‖ OR ―diabetes mellitus‖ OR ―insulin dependent diabetes‖. The synonyms used 
for young people were ―children/ child OR teen/teenager OR youth OR adolescent/adolescence.‖ 
Educational interventions or programs was more broadly defined and included psycho-social 
education or support or training including individual or family counseling (Table 28). The search 
terms were used as text words and any potential papers with full text were assessed for 
eligibility.  
Inclusion Criteria  
The inclusion criteria were randomised control trials (RCTs) that involved an 
intervention for managing any aspect of T1DM for a sample of children or youths aged between 
6-18 years of age and/or their families. Only trials in the English language were included. 
Furthermore, although databases were searched from  Jan 2008-Feb 2015,  only studies from Jan 
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2010 to June 2015 were included in this review as the last published review in this subject was in 
2010 (281). 
Studies were excluded if they were not RCT‘s or pilot studies and were excluded if they 
did not have an educational, psycho-social or family component to the intervention. Studies that 
looked solely at carbohydrate counting were also excluded as were interventions that involved 
technology such as telehealth.  
Table 28 List of search terms used in systematic review 
 
Education 
Programs 
Type 1 Diabetes Children Interventions 
Education*(al) T1D*(M) Child*(ren or hood) Intervention*(s) 
Program*(s or mes) Type I Diabetes Young*(er) person Psychological 
Package*(s) Insulin-dependent Young*(er) people Psychosocial 
Toolkit IDDM  Youth Family therapy 
Teach* (ing)  Adolescent*(s) 
Behavioural/ 
behavioral 
Train*(ing)  Adolescence  
  Teen  
  Juvenile  
  Puberty  
  Boy(s)  
  Girl(s)  
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7.2.2 SEARCH OUTCOMES 
 
 The initial search identified 2269 electronic records after removal of duplicates. After 
screening the title and abstracts only 22 papers were found suitable for inclusion. An additional 
search for related papers in June 2015 yielded a further 5 papers. In total 17 studies were found 
to be suitable for review. Figure 8 summarizes the search process and output which includes the 
reason for the exclusion of papers.  
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Figure 8  Flow Diagram of search process and output
Reviewed by 
Researcher # 3 
Records identified through 
database searches 
(n=1,345) 
Records for screening after 
removal of duplicates 
(n=482) 
Articles deemed suitable 
for inclusion (n=5) 
Records excluded after 
screening of titles and/or 
abstracts 
 (n=424) 
Reasons 
- Not RCTs 
- Type 2 diabetes 
- Adults 
- No relevance  
- Animal studies 
- Not an intervention 
study 
- Protocol only 
- Pilot study 
- Describes the same 
study as another 
paper 
*Final articles for inclusion after 
removal of duplicates or two papers 
reporting on the same study 
(n=17) 
Articles deemed suitable for 
inclusion (n=22) 
 
Records identified through 
database searches  
(n=3064) 
Records for screening after 
removal of duplicates 
(n=2269) 
Records excluded 
after screening of 
titles and/or abstracts 
 (n=2247) 
Reasons 
- Not RCT’s 
- Type 2 diabetes 
- No relevance 
- Protocol only 
- Pilot Study  
 
 
 
 
 
  
First Search in February 2015 
run by Researcher # 1 
 
Second Search in June 2015 
run by Researcher # 2 
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7.3 RESULTS  
 
The studies included in the review were categorized according to whether they were i) 
educational based, ii) psycho-social or iii) family interventions. As shown in Table 29, two of the 
studies were education based studies alone (298, 299), five were psycho-social interventions 
(300-304) all aimed at adolescents alone, and ten studies involved a family intervention (291, 
305-313). All of the family interventions had a psycho-education aspect although some had an 
education component as a control (308, 311, 314). A meta-analysis could not be undertaken as 
the studies and outcome data did not provide sufficient homogeneity to allow for such an 
analysis.  
7.3.1 STUDY CHARACTERISTICS  
 
Seventeen RCT‘s conducted over a 5-year period were analyzed. Collectively, these 
studies recruited a total of 2936 participants. Two interventions were educational (n=428), five 
were psycho-social (n=614), and ten family interventions (n=1453) (see Table 29). Four 
interventions were web-based (n=502), four studies were integrated in the hospital diabetes 
clinics (n=390) and six studies were conducted within the hospital premises (n= 1239) but did 
not explicitly state where in the hospital e.g. in- or outpatient setting. Three studies (n=530) did 
not explicitly state where the intervention took place. Three studies exclusively involved a 
parent(s) of children with T1DM (305, 306, 314) as opposed to solely focusing on the child or on 
the child and parent together. 
The studies took place in the United States, United Kingdom, Canadian, Australian, Irish 
and Danish jurisdictions with the majority based in the  U.S (n=8) followed by the United 
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Kingdom (n=5) and Australia (n=2).  The majority involved  multiple centers (291, 298, 299, 
302, 311-314) with two studies (308, 309) involving only two centers.
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Table 29 Systematic review of studies investigating the differential effects of education programs on various outcomes related 
to T1DM 
 
Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Christie et al.  
2014 
UK 
CASCADE 
Study 
(291) 
 
 
 
362 
8-16yrs 
Type of Study: Cluster randomized controlled trial 
 
Intervention: (n=70) 
Description: Structured Diabetes Education 
Program consisting of 12 hours of education over 
4 weeks in 3 hourly interactive group based 
sessions with 3-4 families 
Theory/general principle (if provided): Interactive 
group education 
Duration: 4 weeks 
 
Control: (n=65) 
Description: Standard diabetes care 
Outcome measures: HbA1c 
Secondary outcome measures: hypoglycemic episodes, hospital 
admissions, diabetes regimen, knowledge and skills of diabetes 
management, responsibility, compliance, clinic utilization, 
emotional and behavioral adjustment, diabetes specific quality of 
life. 
 
Findings: Intervention had no effect on HbA1c at 12 months (p = 
0.584] or 24 months (p = 0.891).  
 
Half (50%) of the young people in the Intervention group 
reported that the groups had made them want to try harder and 
that they had carried on trying at 24 months.  
 
Intervention group parents at 12 months and young people at 24 
months had higher scores on the diabetes family responsibility 
questionnaire. 
 
Young people reported reduced happiness with body weight at 12 
months  
 
Notes: Only 68% of groups were run.  
Of the 180 families recruited, only 53% attended at least one 
module. 
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Coates et al. 
2013 
Northern-
Ireland 
CHOICE 
Study 
(299) 
 
 
 
135 
13-19yrs 
Type of Study: Randomized controlled trial 
 
Intervention: (n=70) 
Description: Structured diabetes education (12 
hours education over 4 weeks, in 3 hourly 
interactive, group based sessions). 
Theory/general principle (if provided): Interactive 
group education 
Duration: 4 weeks 
 
Control: (n=65) 
Description: Routine care – 3 month review at 
clinic using a problem-solving approach. 
Outcome measures: HbA1c 
Secondary outcome measures: BMI, hyper/hypoglycemia, 
dietary adherence 
 
Findings:  
Significant difference in HbA1c at 24 months (Intervention 
81mmol/mol vs. control 75mmol/mol). 
 
The mean BMI remained the same in the intervention and 
Control groups from baseline to 6 months.  
 
No difference in reported hyper or hypoglycemic episodes. 
 
Better dietary adherence at 1, 3 and 6 months in the Intervention 
group but return to baseline at 24 months.  
Doherty et al.  
2013 
UK 
(305) 
 
79 
Parents of 
11-17yrs 
Type of Study: Randomized controlled trial 
 
Intervention: (n=42) 
Description: Web-based, self-directed Teen Triple 
P (positive parenting program) workbook (10 x 1 
hr modules) plus chronic illness tip sheet 
Theory/general principle (if provided): Social 
learning principle 
Duration: 10 weeks 
 
Control: (n=37) 
Description: Usual care 
Outcome measures: diabetes-related conflict, parental stress 
Secondary outcome measures: parental perceptions of child‘s 
behavior, feelings about parent, parenting style 
 
Findings: The Intervention group showed significantly improved 
diabetes-related conflict ( p=0.008) but not parental stress when 
compared to Control group. 
 
Significant improvement in the Intervention group for disruptive 
behavior problems, productive parenting strategies and self-
confidence in parenting skills.  
 
Notes: All outcome measures were self-reported.  
Subject retention was 68%.  
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Gregory et al. 
2011 
UK 
DEPICTED 
STUDY 
(313) 
 
 
 
 
 
 
693 (657 
had follow-
up 
analyses) 
children 
and 1 of 
their carers 
4-15yrs 
Type of Study: Cluster randomized controlled trial 
 
Intervention: (n=318) 
Description: “Talking diabetes” psychosocial 
intervention delivered by trained healthcare 
professional which involves flexible consultation 
styles, balancing multiple health behaviors, 
negotiating behavior change, targeting 
interventions to individual needs 
Theory/general principle (if provided):Behavior-
change theory 
Duration: regular appointments over 12 months 
 
Control: (n=339) 
Description: Standard care delivered by non-
“Talking-diabetes”-trained healthcare 
professional 
 
Notes:  
Phase 1 – Training of health-care staff 
Phase 2 – Trial of training program 
 
Phase 2 Outcome measures: HbA1c over 12 month study period 
Secondary outcome measures: Patient - Quality of life, BMI 
and psychosocial measures, self-care activities, service usage 
measures 
Carer – Quality of life 
Professionals – performance of training techniques 
 
Findings:  
HbA1c levels increased by a similar amount from baseline to 
follow-up in intervention and control arms.  
 
A non-significant 1% increase occurred in HbA1c levels in the 
intervention arm compared to Control group. 
 
There was no effect of healthcare professionals’ training on 
HbA1c level in patients attending their services (p = 0.5). 
 
Intervention group experienced a loss of confidence in their 
ability to manage diabetes. 
 
Controls showed reduced barriers (p = 0.03) and improved 
adherence (p = 0.05). 
  
Patients in intervention arm reported short-term increased ability 
to cope with diabetes (p = 0.04).  
 
Carers in the intervention arm experienced greater excitement 
about clinic visits (p = 0.03) and improved continuity of care 
(p = 0.01). 
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Grey et al.  
2011 
USA 
(314) 
 
 
 
181 
Up to 12 
years 
Type of Study: Randomized controlled trial 
 
Intervention: (n=75) 
Description: Coping skills training – six 1.5hr 
interactive sessions delivered by a health 
professional, each focusing on a coping skill 
delivered to groups of 2-5 and parents were 
encouraged to attend 
Theory/general principle (if provided): Social 
cognitive theory 
Duration: Six sessions 
 
Control: (n=106) 
Description: Group education – equal attention 
group education providing updates in care of 
T1DM focusing on insulin regimens, carb 
counting, sick days, sports 
Outcome measures: HbA1c, parental coping, quality of life, 
parental responsibility (proxy for child responsibility level), 
diabetes-related conflict.  
 
Findings: There were no significant treatment effects on any 
outcome variable. 
 
When rates of change over time were examined across both 
groups, there was improvement in parental coping (p < 0.001) 
and quality of life (p = 0.005).  
 
Significant decrease in parental responsibility for diabetes-
related tasks over 12 months (p<0.001) in intervention and 
control arms. 
 
Significant increase over time in children’s HbA1c levels in 
intervention and control arm (p<0 .001).  
 
No significant changes in diabetes-related conflict.  
 
Notes: Number of sessions attended was not related significantly 
to changes in outcomes. 
166 
 
 
 
 
 
 
Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Grey et al.  
2013 
USA 
(302) 
 
 
320 
11-14yrs 
Type of Study: Multisite randomized parallel 
group trial 
 
Program 1: (n=42) 
Description: Internet coping training skills 
program (TeenCope) used characters whom had 
T1DM in videos to model problematic social 
situations and coping skills 
Theory/general principle (if provided): Social 
cognitive theory 
Duration: 5 weeks 
 
Program 2: (n=41) 
Description: Internet diabetes health education 
program (Managing Diabetes) problem solving 
program using visuals and an interactive interface 
to teach youth about healthy eating, physical 
activity, glucose control, sick days and diabetes 
technology 
 
Program 1 followed by 2: (n=65) 
Program 2 followed by 1: (n=57) 
Program 1 OR 2 completed only: (n=83) 
Outcome measures: HbA1c and quality of life 
Secondary outcomes: Stress and coping, self-efficacy, self-
management, social competence, family conflict 
 
Findings: 
Stable quality of life and minimal increases in HbA1c levels over 
12 months in program 1 and 2 and no significant differences 
between the groups.  
 
After 18 months, those who completed programs 1 and 2 had 
lower HbA1c (p=0.04), higher QOL (p=0.02), social acceptance 
(p=0.01), and self-efficacy (p=0.03) and lower perceived stress 
(p=0.02) and diabetes family conflict (p=0.02) compared with 
those who completed only program 1 OR 2.  
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Author 
Year 
Country 
Study name (if 
provided) 
Number 
randomized 
and age 
Study details 
(n=number allocated) 
Outcomes 
Holmes et al.  
2014 
USA 
(308) 
 
 
Families of 
226 
11-14yrs 
Type of Study: Randomized clinical trial 
 
Intervention (n=137 enrolled, 80 in final 
assessment) 
Description: Four brief family teamwork Coping 
skills sessions in addition to quarterly medical 
appointments 
Theory/general principle (if provided): Coping 
skills training 
Duration: 18 months 
 
Control: (n=89 enrolled, 56 in final assessment) 
Description: Diabetes education in addition to 
quarterly medical appointments 
Outcome measure: Glycemic control 
 
Findings: 
Both treatment groups prevented deterioration in adolescent 
disease care and improved quality of life in adults and 
adolescents without an increase in family conflict.  
 
Over the 3-year follow-up period, the Control group 
improved disease adherence and glycemic control more 
effectively than the Intervention group.  
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Husted et al.  
2014 
Denmark 
(309) 
 
 
 
71 
13-18yrs 
Type of Study: Randomized clinical trial 
 
Intervention: (n=37) 
Description: Guided self-determination in youth - 
8 sessions scheduled over an 8-12 month period 
involving 18 semi-structured reflection sheets to be 
completed by the child using their own words or 
drawings, 5 sheets for the parents and 6 if the child 
was visiting a dietitian to be completed between 
sessions 
Theory/general principle (if provided): Self-
determination theory 
Duration: 8-12 months 
 
Control: (n=34) 
Description: Treatment as usual 
Outcome measure: HbA1c measured at baseline and every 3 
months 
Secondary measures: Multiple measures indicating development 
of life-skills 
 
Findings 
Intervention had no significant effect on HbA1c (p=0.85).  
Intervention significantly reduced the lack of motivation for 
diabetes self-management after adjusting for the baseline value 
(p=0.001).  
 
Compared with the Control group, the intervention time to 
completion was longer in the Intervention group (p<0.001) and 
had a higher rate of non-attendance (p=0.01). 
  
Intervention group parents participated in fewer of the 
adolescents’ visits (p=0.05) compared with control parents. 
 
Notes: 80% completed the trial, and 75% completed a six-month 
post-treatment follow-up. 
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomiz
ed and 
age 
Study details 
(n=number allocated) 
Outcomes 
Katz et al.  
2014 
USA 
(310) 
 
 
 
 
153 
8-16yrs 
Type of Study: Randomized clinical trial 
 
Intervention 1: (n=52) 
Description: monthly outreach by a care 
ambassador whose role included outreach to 
families to schedule clinic appointments or to 
relay family concerns to medical providers 
 
Intervention 2: (n=50) 
Description: Monthly outreach by a care 
ambassador plus a quarterly clinic-based 30 
minute psychoeducational intervention also 
delivered by the care ambassador who 
facilitated problem solving and role-play 
exercises 
 
Duration: 2 years 
Theory/general principle (if provided): Care 
ambassador 
 
Control group (n=51) 
Description: Standard care 
 
Outcome measures: HbA1c 
 
Findings:  
No differences in HbA1c were detected among the three 
groups at 2 years.  
 
Intervention 2 was effective in maintaining or improving 
HbA1c and parent involvement in children with suboptimal 
baseline glycemic control. 
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomiz
ed and 
age 
Study details 
(n=number allocated) 
Outcomes 
Mulvaney et 
al.  
2010 
USA 
(303) 
 
 
72 
13-17yrs 
Type of Study: Randomized controlled trial 
 
Intervention: (n=34) 
Description: Usual care plus intervention 
support in the form of six multi-media stories 
accessed via the “YourWay” website, focusing 
on psychosocial barriers to self-management, 
coping and problem-solving. (There is also 
access to personalized homepage, multimedia 
presentations, social networking via a forum 
and help from experts and weekly emails) 
Theory/general principle (if provided): 
Learning, social-cognitive and self-
determination theories 
Duration: 11 weeks 
 
Control: (n=18) 
Description: Usual care 
Outcome measure: HbA1c, self-management, problem-
solving 
 
Findings: 
Using intention-to-treat analyses, group differences were 
not significant, however using as-treated analyses, the 
Intervention group significant improved in self-management 
(p=0.02), and showed some improvements in problem-
solving (p=0.23)  
 
Unlike the Control group whose mean HbA1c increased, the 
Intervention group remained constant HbA1c (p=0.27).  
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Author 
Year 
Country 
Study name (if 
provided) 
Number 
randomized 
and age 
Study details 
(n=number allocated) 
Outcomes 
Murphy et al.  
2012 
UK 
FACTS 
(311) 
 
 
305 
11-16yrs 
Type of Study: Randomized clinical trial 
 
Intervention: (n=158, however only 75 
attended sessions) 
Description: Families and Adolescents 
Communication and Teamwork Study 
(FACTS) education program (6 90 minute 
sessions for parents and adolescents per month 
focusing on skills training and teamwork)   
Theory/general principle (if provided): 
Skills training 
Duration:6 months 
 
Control: (n=147) 
Description: Conventional clinical care 
 
 
 
 
Outcome measure: HbA1c, parental input 
 
Findings: All biomedical and psychosocial outcomes were 
comparable between groups.  
 
At 18 months HbA1c was not significantly different in 
either group or between groups over time.   
 
At 12 months, adolescents did not perceive any changes in 
parental input.  
 
Notes: Session attendance was poor: 30.4% families did not 
attend any sessions and 47.5% families attended 4 or more 
group sessions.  
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Nansel et al.  
2012 
USA 
(312) 
 
 
 
 
390 
families 
9-14.9yrs 
Type of Study: Randomized clinical trial – 
multicenter parallel group study 
 
Intervention: (n=201) 
Description: Clinic-integrated behavioral 
Intervention focusing on family management of 
diabetes - ”WE-CAN manage diabetes” 
Theory/general principle (if provided): Social 
cognitive theory, self-regulation models and 
systems theory 
Duration: 2 years 
 
Control: (n=189) 
Description: Standard care 
Outcome measure: Glycemic control 
 
Findings: The intervention had a significant effect (p=0.03) on 
glycemic control from baseline to 24 months.  
Participants aged 12-14 decreased their HbA1c significantly 
(p=0.009) over 24 months from baseline but no such effect was 
seen in those aged 9-11yrs.  
Adherence was not affected by the intervention.   
 
Nicholas et al. 
2012 
Canada 
(304) 
 
 
 
 
31 
12-17yrs 
Type of Study: Randomized controlled trial 
 
Intervention (n=15) 
Description: Web-based intervention comprised of 
diabetes-based information, interactive learning 
activities and relevant discussion topics whereby 
patients accessed the internet every day for 2 hours 
per day (on average) 
Theory/general principle (if provided): Web-based 
peer support and McCracken’s** (long interview) 
approach 
Duration: 8 weeks 
 
Control: (n=16) 
Description: Had access to the website following 
trial completion 
 
Outcome measures: Social support 
 
Findings: The intervention lead to social support benefits 
approaching statistical significance. 
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Noyes et al. 
2014 
EPIC 
UK 
(298) 
 
 
 
 
293 
6-18yrs 
Type of Study: Randomized controlled trial 
 
Intervention (n=223, 190 analyzed) 
Description: Age-appropriate Evidence into 
Practice Information Counts (EPIC) Diabetes 
diaries and information packs to support decision-
making and self-care. 
Theory/general principle (if provided): Social 
learning theory and developmental theory 
Duration: 6 months 
 
Control: (n= 114, 103 analyzed) 
Description: Routine clinical practice 
Outcome measure: Diabetes self-efficacy and quality of life (via 
PedsQL),  
Secondary measure: HbA1c  
 
Findings:  
No significant difference was found in the mean quality of life 
scores between groups at baseline, 3 or 6 months for either the 
child-reported or parent-reported measure. 
 
These values were also similar across all three time points within 
the Intervention group and within the Control group.  
 
Both groups had a range of recorded HbA1c levels, which 
required improvement to reach levels recommended by the 
Institute for Health and Care Excellence guidance. 
 
Notes: This study was the third stage of a four-stage study.  
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Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Serlachius et 
al.  
2014 
Australia/New
-Zealand 
(300) 
 
 
 
147 
13-16yrs 
Type of Study: Randomized controlled trial 
 
Intervention (n=73 intent-to-treat, 30 analyzed) 
Description: 5 2 hour sessions carried out over 5 
weeks of Best of Coping (BOC) cognitive 
behavioral therapy involving coping strategies, 
goal setting, self-talk, problem solving and conflict 
resolution 
Theory/general principle (if provided): Cognitive 
behavioral therapy 
Duration:5 weeks 
 
Control: (n=74) 
Description: Standard care 
Outcome measure: HbA1c at 3 and 12 months 
Secondary outcome measures: stress, self-efficacy, quality of 
life 
 
Findings: 
HbA1c - little evidence of a group difference at 3 months or 12 
months via intent-to-treat or per protocol analysis.  
 
Stress – at 3 months, significantly less stress in Intervention 
group than Control group (p=0.0.019) however this was not 
sustained at 12 months. 
 
Self-efficacy - consistently higher in Intervention group compared 
to Control group (p<0.05) at 3 and 12 months.  
 
Quality of life – better in Intervention group at 3 months 
(p=0.008) but not maintained to 12 months.  
Wang et al.  
2010 
USA 
(301) 
 
 
44 
12-18yrs 
Type of Study: Randomized controlled trial 
 
Intervention 1: (n=21) 
Description: Motivational interviewing at baseline 
and 3 months. 
Theory/general principle (if provided): 
Motivational Interviewing  
Duration: 3 months 
 
Intervention 2: (n=23) 
Description: Structured diabetes education at 
baseline and 3 months.  
Outcome measure: HbA1c  
 
Findings: The intervention 2 group over the 6 months of follow-
up had lower adjusted mean HbA1c levels than the intervention 1 
group (p= 0.03).  
There were no differences in any of the psychosocial measures. 
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*Forman, SG. (1993) Coping Skills Interventions for Children and Adolescents. San Francisco, CA: Jossey-Bass. 
** MCCRACKEN, K. (1988) THE LONG INTERVIEW. NEW YORK: SAGE
Author 
Year 
Country 
Study name 
(if provided) 
Number 
randomize
d and age 
Study details 
(n=number allocated) 
Outcomes 
Westrupp et al.  
2014 
Australia 
(306) 
 
 
76 
4-12 yrs. 
Type of Study: Randomized controlled trial 
 
Intervention: (n=38) 
Description: Ten 1h weekly sessions with a clinical 
psychologist. Triple-P teaches 17 strategies some 
of which promote children’s competence and 
development and some of which help behavior 
management. Two books were given – a workbook 
and a parenting advice book. All parents received 
standard diabetes care. 
Theory/general principle (if provided): Social 
learning principle 
Duration: 3 months 
 
Control:(n=38) 
Description: Standard diabetes care 
Outcome measures: Child internalizing and externalizing 
behavior problems measured at 3 and 12 months.  
Secondary outcome measures: glycemic control, parent mental 
health, parenting skills, family function.  
 
Findings: At three months, parental mental health, parenting 
skills and family function significantly improved (p<0.05) 
following the intervention.  
Child mental health and glycemic control showed very little 
change at 12 months.  
 
Child mental health, parent mental health, parenting skills and 
diabetes family conflict in children or families of children with 
pre-existing internalizing or externalizing behavior problems 
showed greater improvements at 3 months (p<0.05) however 
parenting self-efficacy worsened. Parent mental health and 
parenting competency improvements were sustained over 12 
months in this group. 
176 
 
7.3.2 THEORETICAL COMPONENTS  
 
The majority of the studies in the review were explicitly theory based (n=12). Four 
studies were based on social cognitive theory (SCT) (302, 308, 312, 314) with one study being 
based on both social cognitive and self-determination theories (303). One study was based on 
cognitive behavioral therapy (CBT) (300), two based on social learning theory (SLT) (305, 306) 
in the context of the Teen Triple P (positive parenting program). One study was exclusively 
based on the self-determination theory (309), two involved motivational interviewing (MI) (301, 
313) and one structured educational program involved both motivational interviewing and 
solution focused brief therapy (SFBT) (291).  
 Fidelity to theory was evident in most of the theoretical based interventions between the 
outcomes and underpinning theories. In the ―WE CAN manage diabetes‖ Nansel et al‘s 
intervention was designed to help families improve diabetes management by improving self-
efficacy underpinned by social cognitive theory.  One education based intervention explicitly 
stated the dominant ‗normalization‘ theory underpinning  the Evidence into Practice Information 
Counts (EPIC) packs and diabetes diaries (298). 
7.3.3 EFFECTIVENESS OF INTERVENTION AND OUTCOME MEASURES 
 
Outcomes were measured at several points in most of the trials ranging from 3 months to 
24 months (see Table 30). All the studies, with the exception of two (304, 305), reported on 
HbA1C as an outcome measure. In fact HbA1C was the primary outcome measured across 
thirteen of the studies and was a secondary outcome in three of the studies (298, 306). A 
significant improvement in HbA1C was reported in four of the studies, one was a structured 
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educational program (299), one was a family intervention (312) and two were psycho-social 
interventions (301, 302). Nansel et al (312) examined the effect of a clinic-integrated behavioral 
intervention focusing on family management of diabetes and found a significant improvement in 
glycemic control with improvement in mean HbA1c (0.44 in intervention group and 0.76 in 
usual care group; p=0.03) from baseline to 24 months in the intervention arm group. Wang et al 
compared motivational interviewing to structured diabetes education in adolescents with HbA1C 
of ≥9%. They had hypothesized that lack of motivation rather than a lack of knowledge is what 
hinders good glycemic control however, they found a significant improvement in adjusted mean 
HbA1C in the group randomized to the structured diabetes education (p=0.03) (301). The authors 
conclude that motivational interviewing in the absence of previously establishing education level 
does not improve metabolic control but rather continuous education or re-education for children 
with poor control may have a beneficial impact on glycemic control (301).  
 The study conducted by Grey et al (302) was a study comparing the effect of two 
internet based psycho-educational programs:  TeenScope (program 1) which was designed based 
on cognitive-social learning principals and Manage Diabetes (program 2), a diabetes education 
and problem solving program designed as a control.  The study also looked at the combined 
effect of the programs with the adolescents invited to go on to complete the program they had 
not completed at the end of the first study phase. After 18 months the study results showed that 
those who completed both programs had a lower HbA1C (p=0.04) and higher quality of life 
scores (p=0.02), self-efficacy (p=0.03) social acceptance (p=0.01) and lower perceived stress 
(p=0.02) and diabetes family conflict (p=0.012) compared to those that completed either 
program alone. No significant difference was found between groups for satisfaction, or 
attendance and contrary to the authors‘ hypothesis there were no significant difference between 
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the two groups for any of the primary outcomes after 12 months using intent-to-treat analysis. 
HbA1c levels increased though not significantly in both groups. The group that had completed 
the Manage Diabetes program had less family conflict (p=0.02) than those in the TeenCope 
program.  
A decline in metabolic control is not surprising during pre- adolescents and adolescents 
and has previously been described (315). Two studies reported an increase in HbA1c (313, 314)  
and although the studies conducted by Mulvaney and Holmes et al show no improvement in 
glycemic control, they make the argument that their interventions nonetheless prevented 
deterioration of diabetes care.  Hence, no deterioration in glycemic control can be considered as 
a success.  
Quality of life (QoL) was the second most frequent outcome to be measured. It was 
measured in eight of the studies in the review (298, 300-302, 308, 310, 313, 314).  No significant 
difference over time was found in the mean quality of life scores in the studies reported by 
Noyes, Gregory, Wang and Katz (298, 301, 310, 313). Serlachius et al reported a significant 
improvement in QoL at 3 months (p=0.008) but this was not maintained after one year (300). In 
the study reported by Holmes and colleagues participants were randomized  into either an 
intervention group that included 4 quarterly coping skills sessions or a diabetes education session 
either prior to or after their regular quarterly medical visits. Those in the diabetes education arm 
of the study performed just as well or even better in quality of life improvements over time as 
those in the coping sessions. Furthermore, the education group adhered more to the follow-ups 
(p=0.014) compared to the coping group.  The authors suggest that both basic education and 
coping skills may be needed to improve blood sugar control (308).  Studies conducted by Grey 
and colleagues (302, 314) both  reported on significant and positive changes in QoL: one study 
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(302) which used the internet as a medium to run two programs (Internet coping skills program 
(TeenCope)  and an internet diabetes health education program (Managing Diabetes)  resulted in 
a higher QoL (p=0.02) after 18 months in the participants that had completed both the internet 
programs compared to those that did not complete both programs.  The earlier  study conducted 
by Grey and colleagues (314) involved training parents to use coping skills which resulted in an 
improvement in quality of life (p=0.005). Self-efficacy, family conflict, and parental stress, 
coping and parental skills, hyper/hypoglycemia‘s and BMI were some other outcomes measured.   
At the endpoint measurements (which ranged from 3 to 24 months), nine out of the ten 
family focused interventions demonstrated a positive effect on some outcomes with only one 
study conducted by Murphy et al (311) not showing any positive effects on any of the outcomes 
measured. Poor session attendance (30.4% of the families did not attend any session) and 
difficulty scheduling sessions were cited as possible reasons for the negative outcomes (311). 
One of the two education interventions showed a positive effect on the outcomes measured 
(299). Specifically, Coates and colleagues  reported a significant difference in HbA1C between  
the intervention group that received  structured diabetes education  as opposed to those  in the 
control arm receiving usual care (299).  No difference in mean BMI or reported hypo or 
hyperglycemia were shown although those in the intervention group had better dietary adherence 
for up to 6 months post intervention (299); four (300-304) of the five psycho-social interventions 
showed significantly positive outcomes on some measurements. 
Wang et al (301) report on a lower adjusted mean HbA1c in the group receiving 
structured diabetes education as compared to those receiving motivational interviewing whilst 
Mulvaney et al reported (303) a significant improvement in self-management (p=0.02). The fifth 
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study conducted by Nicholas et al reported improvements in the quality of relationships outside 
the family circle although this did not reach significance (304).
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Table 30 Outcome measurements across reviewed studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Noyes; B Coates; C Serlachious; D Wang; E Grey’13; F Mulvaney; G Nicholas; H Doherty; I Westrupp; J Grey’11;  K Holmes; L Husted; 
M Katz; N Murphy; O Nansel; P Christie; Q Gregory   
 Structured 
Educational  
Intervention  
 
Psychosocial Intervention  
 
Family Intervention  
 A B C D E F G H I J K L M N O P Q 
Physiological Outcomes     
HBA1c levels √ √ √ √ √ √   √ √ √ √ √ √ √ √ √ 
Hyper/hypoglycemia   √          √  √  √ √ 
Self-Monitoring Blood Glucose            √   √   
BMI   √               √ 
Diet  √                
Psycho-social Outcomes     
Quality of Life √  √* √ √**     √ √**  √ √  √ √ 
Self-Efficacy/Management √  √ √ √ √†     √      √ 
Stress    √  √   √          
Coping          √        
Empowerment                  
Motivation            √      
Social acceptance      √             
Social Support        √           
Problem-Solving       √†            
Family  Outcomes    
Family conflict     √   √  √ √  √     
Family Functioning         √        √ 
Family relationships                   
Parental perception of Child 
Behavior 
       √          
Parenting Skills        √ √         
Parental/ Family responsibility           √   √  √   
Parental Monitoring            √       
Life skills             √    √ √ 
Other Outcomes     
Cost                  √ 
√ Grey shading indicates significantly positive outcome(s) 
*significant improvement in QoL at 3 months but this was not maintained 
after one year 
 ** Significant improvement in those that completed both coping and 
education session together;  
†Significant improvement after using as treated analysis; 
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7.3.4 QUALITY OF RANDOMIZED CONTROL TRIALS 
 
One educational study (298) and three family therapy interventions were developed from 
pilot studies (277, 291, 313). The use of manuals,  in which written protocols and education  
material  are available to guide the  intervention, were reportedly used in both of the structured 
educational interventions (298, 299) and five of the family interventions (291, 305, 306, 311, 
313). Training of the interventionist or care provider was reported in eight of the interventions 
(291, 299, 301, 309-311, 313, 314) and continued supervision of interventionist in all but three 
studies which did not explicitly state this (299, 309, 311). Nine of the studies used the 
Consolidated Standards of Reporting Trials (CONSORT) diagram for reporting flow of 
participants thorough the trial (291, 298, 302, 305, 306, 308, 311, 313, 314).   
Quality of the studies were assessed using the Cochrane Collaboration's tool  for 
assessing risk of bias (316) which rates the risk of bias based on seven main criteria: random 
sequence generation, allocation concealment, blinding of participants and personnel, blinding of 
outcome measures; incomplete data, selective reporting and any other perceived bias (see Table 
31). The studies are rated as being low risk, high risk or unclear risk of bias based on whether or 
not they have met certain criteria described in the assessment tool.  All of the educational and 
family interventions (see Table 31) explicitly reported on attrition compared to only 2 of the 
psycho-social interventions (300, 302). Most of the studies used block randomization (299, 303, 
308, 309, 312, 314). Doherty and Serlachius et al (300, 305) used computer generated block 
randomization. Two other studies used a computerized allocation system to generate sequences 
but they did not report using blocks (302, 311). Noyes et al (298) reported using a web-based 
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randomized service. Wang et al (301) report randomizing based on a sex-stratified schedule, no 
further details were given.  
For allocation concealment measurements, six of the studies reported using sealed 
envelope techniques (300, 303, 306, 309, 312, 314). In terms of implementation, seven studies 
explicitly reported blinding of research assistants or the use of an independent statistician in 
randomization (291, 300, 301, 305, 306, 311, 312, 314).  Gregory et al (313) report that although 
they aimed to recruit subjects before the allocation of centers was revealed, this was not always 
possible. 
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Table 31 Quality of randomized intervention studies  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Noyes; B Coates; C Serlachious; D Wang; E Grey; F Mulvaney; G Nicholas; H Doherty; I Westrupp; J Grey;  K Holmes; L 
Husted; M Katz; N Murphy; O Nansel; P Christie; Q Gregory 
 
 Structured 
Educational  
Intervention  
 
Psychosocial Intervention  
 
Family Intervention  
 A B C D E F G H I J K L M N O P 
 
Q 
Random 
Sequence 
generation  
LR LR LR LR LR LR UR LR LR LR LR LR UR LR LR LR LR 
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7.4 DISCUSSION  
 
It has been well documented that theory based studies appear more effective than non-
theoretical based interventions.  Four (299, 304, 310, 311)  of the studies reviewed here did not 
explicitly document a theory behind the intervention of which only one study by Coates et al 
(299) reported positive changes in any of the outcomes measured. Of the remaining 13 studies 
whose intervention was theory based, three studies (291, 298, 306) did not report positive 
changes in any of the outcomes measured. The majority of the selected theories in this review 
were based on Albert Bandura‘s work on social learning principals and social cognitive behavior 
which clearly underpinned the components of the interventions. Self-determination theory, 
motivational interviewing and solution-focused brief therapy were other theories applied in the 
studies reviewed.  
7.4.1 MAIN THEORIES IN REVIEWED STUDIES  
 
The social learning principals promoted by Albert Bandura postulate that learning is a 
cognitive process that occurs through direct observation in a social context (317).  In his famous 
studies, known as the Bobo doll experiments, which took place between 1961 and 1963, he 
observed children watching an adult model aggressive behavior towards a doll, and demonstrated 
the powerful effect modeling has on  the ability to acquire a particular behavior, whether positive 
or negative (317). In 1977, Bandura expanded on this early work to develop the concept of social 
learning theory (318), positing a direct relationship between an individual‘s perceived self-
efficacy and behavioral change (318). In 1986, Bandura renamed his original theory to what  is 
today known as the social cognitive theory (319) where he claims that behavior is influenced by 
personal, behavioral and environmental factors (319). Interestingly, the studies in this review 
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with the greatest significantly positive outcomes were those in which social cognitive theory was 
the underlining theory (302,305, 314). In 2001, Bandura  identified ―symbolic modeling‖ as a 
process that could influence learning, motivation and personal actions (320). It is Bandura‘s 
article on ―Principals of Behavioral Modifications‖ (321) that set the foundation for what has 
ultimately became  known as cognitive behavioral therapy (322). 
Cognitive behavioral therapy (CBT) is a form of psychotherapy that focuses on problem 
solving in order to change an individual‘s negative pattern of thinking (323). It has been used for 
over 50 years to treat a number of mental health disorders ranging from phobias to alcoholism 
(324). CBT therapy can be applied in an individual or group setting with lessons lasting for 
approximately 60 minutes. The aim of the therapy is to aid the recipient of the treatment to 
acquire skills that can be applied in daily life to tackle problems and negative thoughts (325).  
One of the earliest forms of CBT was the Rational Emotive Behavioral Therapy (REBT), 
developed by Albert Ellis using an ABC model approach (326, 327) to exemplify how our 
beliefs influence our emotions and our behavioral response to an outside stimulus. A- is the 
activating agent or an external stimuli that triggers and emotion; B- is our beliefs regarding the 
situation; C- are the consequence or the emotional reaction to that belief. Whilst using the ABC 
model for CBT, it has been expanded to include D for discussing ways  in which negative beliefs 
and reactions can be changed into a desired effect known as E, which leads to less negative 
behaviors by acquiring effective coping skills (325).  
Self- determination theory (SDT) simply put is a theory about human motivation. SDT 
evolved from a study (328) looking at how external (extrinsic) factors such as money and 
internal (intrinsic) factors such as self-satisfaction, independence or the thirst for knowledge 
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motivate the human being. However, it was not until the works of Edward Deci (329) and 
Richard Ryan (330) that the theory gained popularity and acceptance. According to Deci and 
Ryan, there are three innate psychological needs that people need to experience in order to be 
self-determined and to be intrinsically motivated to change and these include a sense of 
competence, autonomy, and relatedness or a sense of belonging or attachment (331).  
SDT is believed to provide the theoretical framework for motivational interviewing (MI) 
(332) with a  patient-centered focus that attempts to motivate a patient to change. It was initially 
used to treat addictions (333) although it is now widely used for a range of problems.  
Solution focused brief therapy (SFBT) is a form of psychotherapy that relies on focusing 
on trying to find solution rather than on problem solving. It was developed at the Brief Family 
Therapy Center in Milwaukee, in the United States by Steve de Shazer in 1986 (334). It has been 
reportedly used effectively in addressing a range of issues including substance/ drug abuse and 
mental health issues (335, 336).  
7.4.2 REVIEW OF STUDY FINDINGS  
 
Previous systematic reviews have highlighted the need to improve the quality of 
randomized control trials of interventions (239, 278). They also highlighted the need for RCT‘s 
to adhere to the Consolidated Standards of Reporting Trials (CONSORT) statement and to assess 
the scientific development of the interventions (281). The CONSORT statement is a set of 
evidence-based recommendations which includes a flow diagram and a checklist (updated in 
2010) for reporting on RCT‘s. Its main purpose is to allow for transparent and complete 
reporting in order to facilitate interpretation and critical appraisal of studies (337).  The checklist 
requires scientific background and explanation of rational; an explicit description of the trial; 
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details on the intervention, the comparator, and a description of the intervention components; 
detailed description of randomization methods, including sequence generation and allocation 
concealment and implementation methods (338). The CONSORT diagram specifies enrollment, 
allocation, follow-up and analysis in a standardized method.  In this review an improvement in 
the quality of RCT‘s has been noted, of which more than half of the studies adhered to, greatly 
facilitating their interpretation.   
Half of the studies in the current review had manuals or protocols to guide the 
interventions. The development and use of manuals in interventions helps ensure intervention 
fidelity (339) and strengthens the impact of the study. In fact well developed manuals or 
protocols are considered the gold standard of any intervention therapy (340).  The manuals 
should contain clear objectives, content, and information about the sessions as well as the time 
allotted per session; a process evaluation of strategies used to test knowledge transfer or 
understanding or role-play behavior should be mentioned (339).  
Research funders, grant providers, and even taxpayers are increasingly looking for 
quality assurance and cost effectiveness of potential research. Process evaluation, although not a 
new concept, has gained momentum in the past two decades as a means of evaluating whether a 
program intervention is successful by looking to explain the how and why of any of these 
outcomes (341). In particular the growing number of complex, multiple cited studies require a 
thoughtful process evaluation to explain the results achieved especially in regards to 
interventions with positive and significant outcomes (341). Clinical trials that fail to include 
details of processes and mechanisms obscure critical appraisal of the research study (342). In the 
UK, the Medical Research Council framework was developed to address precisely such issues 
(343, 344). The context of the environment in which the intervention occurs has been cited as 
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being critical to determining intervention design (341, 342). Linnan and Steckler determined that 
the process evaluation should contain at least four main domains which include data to determine 
the context, the reach, the dose of the intervention i.e. who should deliver and who are the 
intended recipients, as well as the fidelity of the intervention (341). By fidelity to the 
intervention, the authors refer to it as being the quality of the implementation and although this 
may seem straightforward, fidelity is not easy to measure or calculate (341). Developing 
checklists, or a list of minimum requirements may help to increase the fidelity of an intervention 
(345) or by observing the intervention using structured guidelines (346). In this review two 
major studies the DEPICTED study (313) and the EPIC (298) study followed the MRC 
framework for designing complex interventions which included a comprehensive process 
evaluation. Unfortunately, none of these studies described in Table 29 resulted in significant 
improvements although patients in the intervention arm of the DEPICTED study did experience 
greater excitement about their clinic visits (p=0.03), improved continuity of care (p=0.01) and 
short term increased ability to cope with diabetes (p=0.04).   
7.4.3 DIFFERENCES FROM PREVIOUS REVIEWS 
 
This review clearly highlights the shift from purely educational and psychosocial 
intervention to interventions that encompass the family as a whole. Recent interventions have 
integrated either an educational, psychosocial, or both components in their study design. More 
than half of the studies in this review were family focused as opposed to only three studies in the 
last review by Savage and colleagues (281).  
The management of children with diabetes is a triad involving the child, the child‘s 
parent(s), and the health care workers. Psycho-social and family based interventions appear to 
190 
 
improve glycemic control, self-efficacy in management and family relationships (347, 348). 
Earlier work by Laffel et al has shown an increase in family involvement and prevention of the 
deterioration of glycemic control in a family focused teamwork intervention (349). Studies by 
Murphy et al have  shown the potential benefits of parental involvement on metabolic control 
(350) although  the integration of the program into a real clinical setting proved to be a challenge 
(311). De Wit and colleagues also demonstrated improvement in psycho-social well-being, 
mainly behavioral after clinic integrated consultations on health related quality of life. De Wit 
and colleagues did not however find a significant difference in HbA1c (351) although studies by 
Wysocki (279, 352, 353)  looking at the impact of behavioral family systems therapy were able 
to show a significant decrease in HbA1C. However, the study by Ellis and colleagues looking at 
a multi-systemic therapy intervention were not able to maintain initial post-treatment 
improvement in HbA1c (354) when the participants were followed up at 6 months post 
completion of the intervention. 
Although most studies have previously focused on face-to-face intervention, this review 
has highlighted the increasing importance of utilizing alternative methods of intervention 
delivery, namely online and via websites. All but one web-based study in this review resulted in 
significant improvements in on or more outcome measurement(s) with one further study 
approaching significance for the change in quality of relationships with those other than family 
members (304). Grey et al were able to demonstrate a significant decrease in HbA1C as well as 
an increase in quality of life in participants that completed both of their online programs (302).  
The advantages of internet based intervention are numerous and include an increase in 
accessibility to a potentially diverse number of children with diabetes and their families and it 
can prove to be a more efficient means of utilizing resources as geographic boundaries and 
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scheduling no longer pose barriers. Previous psycho-educational studies that have used the 
Internet have shown some promising results in children of varying ages and health conditions 
(355-357). Access to internet has increased drastically in the past decade with its use in the 
home, at school and in libraries as well as on smartphones. In the United States approximately 
95% of teenagers access the Internet on a regular basis (358) and in Canada 24% of teenagers 
report on average spending 3 hours online each day (359). Furthermore, in a study looking at 
Internet use in children and adolescents with diabetes, 42% reported searching for diabetes 
information on the Internet (360). In Bahrain, the Internet World Stats reports that 96.4% of the 
population had access to the Internet in the year 2015, the highest rate of access compared to 
other Middle Eastern regions (361). Hence the Internet presents an attractive platform from 
which such interventions can be developed as the program can easily be updated, modified and 
standardized via a website. The downside of the Internet is that access is still not universal and 
information conveyed in this way is open to misinterpretation although again as the technology 
advances the opportunities for content tailored to the individual are growing.   
7.4.4 LIMITATION OF STUDY 
 
The lack of homogeneity in the studies and their outcomes made it difficult to undertake 
a meta-analysis. This was due to the large differences in the type and quality of the studies 
reviewed including the cultural and environmental context, as well as the varying sample sizes 
and types of interventions.  
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7.5 CONCLUSION 
 
This review was helpful in identifying some of the facilitators of successful interventions 
aimed at children and adolescents with T1DM. Theoretical based interventions appear to 
demonstrate more effectiveness as highlighted by more positive changes to outcome measures 
and as such this should be considered in the development of an intervention. The theory behind 
the intervention, whether it is based on social cognitive theory, cognitive behavioral therapy or 
motivational interviewing should be left at the discretion of the researchers, ideally in 
conjunction with key stakeholders.  A combination of both educational and psycho-social family 
targeted intervention need to be further researched. The use of web-based interventions is an 
attractive and promising alternative which can help improve adherence and reduce scheduling 
conflicts.  
A key barrier identified is the real-life integration of such interventions which, when 
piloted show positive results, but in actual clinical and wide-spread settings fail to do so. The key 
unresolved issue remains what would in reality work to improve children‘s HbA1C and diabetes 
self-management. Interventions with an integrated process evaluation therefore remain important 
in identifying features that contribute to the success or failure of interventions and further work 
is required focusing on intervention cost-effectiveness and sustainability alongside clinical 
effectiveness. 
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8.0 DEVELOPMENT AND FEASIBILITY STUDY FOR A TRANSITIONAL CARE 
PROGRAM FOR ADOLESCENTS WITH T1DM  
 
 
8.1 INTRODUCTION 
 
This chapter reports on the development of a structured transition care program for 
adolescents with T1DM and the proposed feasibility testing of this within the SMC hospital. In a 
country that ranks 5
th
 worldwide for diabetes prevalence (3), foresight  into future  health care 
provision of this population that will ultimately spill into an already taxed adult care service, is 
urgently required. The results of a qualitative study detailed in Chapter 5 have highlighted the 
need, both globally and more locally, to provide more specialized care to adolescents, which are 
considered a challenging group, prior to transitioning to adult diabetes clinic.  Currently, children 
at the pediatric clinic at the SMC are transferred to the adult clinic at the age of 14 years; no 
transition support is provided.  
8.1.2 SYSTEMATIC REVIEW OF RANDOMIZED CONTROL TRIAL INTERVENTIONS FOR 
CHILDREN AND ADOLESCENTS WITH T1DM 
 
  The results of a systematic review of randomized control interventions for children and 
adolescents with T1DM described in Chapter 7 has shown that theoretically based interventions 
appear to be more efficacious and hence should be considered in the development of any 
intervention.  Furthermore, the combination of both educational and psycho-social interventions 
that targets the family group rather than the individual alone show promising results. Developing 
interventions with an integrated process evaluation is essential component for identifying 
features that contribute to the failure or success of the proposed intervention (341).   
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8.1.3 REVIEW OF TRANSITIONAL PROGRAMS FOR ADOLESCENTS WITH T1DM  
 
8.1.3.1 GUIDELINES FOR THE TRANSITION OF ADOLESCENTS AND YOUTHS FROM PEDIATRIC TO 
ADULT SERVICES  
 
In the United States, a consensus on health care transition for young adults with special 
health care needs was approved as a policy by the American Academy of Pediatrics, the 
American Academy of Family Physicians, and the American Society of Internal Medicine in 
2002. The goal of this policy was to have implemented, by 2010, a structured plan for health care 
transition for young adults from the pediatric to adult care so as to ―maximize lifelong 
functioning and potential through the provision of high-quality, developmentally appropriate 
health care services that continue uninterrupted as the individual moves from adolescence to 
adulthood‖ (362). In 2002, the International Society for Pediatric and Adolescent Diabetes 
(ISPAD), in their consensus guideline for the management of T1DM in Children and 
Adolescents (160) recommended joint adolescent or young adult clinics between pediatric and 
adult care providers before transition (160).  
 In March 2010 The American Diabetes Association (ADA), in collaboration with experts 
and individuals with diabetes, put forth a set of evidence-based recommendations for the care of 
emerging adults with T1DM  in transit from pediatric health care to the adult health care services 
(363). Amongst other recommendations, they advocated for: a gradual shift of responsibility 
from parents to the adolescents; information on differences between the pediatric and adult 
services; written medical summary which includes medication used, glycemic control, and self-
diabetes care. In 2014, the ADA‘s position statement on standards of care in diabetes  
recommended that both pediatric and adult care health providers provide support and resource 
links to young adults who are in transit (252).  
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In the U.K the National Institute for Healthcare and Excellence (NICE) 2015 guidelines 
for the management of diabetes in children and young adults (364, 365) recommended age 
specific protocols for the transfer from pediatric to adult clinics and the use of evidence of 
physical development and maturity level to decide on the age to transfer. They also recommend 
that young adults and their families become familiar with the transfer process as a means to 
increase attendance post-transfer.  
8.1.3.2 TRANSITIONING FROM PEDIATRIC CARE TO ADULT CARE  
 
There have been a number of reviews published recently on the transitioning of 
adolescents and young adults with T1DM from pediatric to adult healthcare (366-371). Blum 
describes the period of transition as ―purposeful, planned movement of adolescents and young 
adults with chronic physical and medical conditions from child-centered to adult-oriented health 
care systems‖ (372). The transition period can be a turbulent one as it is a period in which 
adolescents are emerging as young adults struggling to define their identity and balancing the 
need for independence and dependence from their parents (373); dealing with a chronic illness 
complicates matters further. The age at transition from a pediatric health care system to an adult 
health care system varies from country to country and between institutions largely due to 
institutional policies or even state legislature which dictate age of transfer (374). In a review by 
Fegran et al (366) examining the transition experience of adolescents moving from pediatric to 
adult care, the average age of transfer varied from 14-22 years.  
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8.1.3.3 OUTCOMES OF ADOLESCENT TRANSITIONING TO ADULT CARE SERVICES  
 
Attendance Rate 
One of the greatest challenges faced by healthcare professionals is maintaining a good 
attendance rate post-transfer as this has been found to decrease after transition (375-377). 
When patients achieve a good attendance rate at a specialist center for T1DM studies have 
shown a decrease in frequency of hospitalization and diabetic ketoacidosis (378, 379). 
Furthermore, studies have demonstrated that a higher rate of attendance whilst under pediatric 
care often correlates with a good attendance rate in adult care services (380, 381). 
 A study in the United Kingdom looking at the transfer mode of young people with 
T1DM into adult services demonstrated a higher rate of clinic attendance in young people that 
had had the opportunity to meet with an adult diabetes consultant prior to transfer and who had 
attended a joint adult/pediatric clinic before transfer to an adult clinic (375). The mean HbA1c 
levels during the 2 years prior to transfer was significantly higher in those that did not attend 
hospital clinic visits in the 2 years after the transfer compared to those regularly attending clinic.  
It has been well documented that adolescents with higher  HbA1C  levels prior to transitioning 
are also less likely to attend adult clinic care (377, 382). Furthermore, some studies report that 
adolescents who did not receive adequate support or information prior to the transitioning were 
unlikely to attend diabetes adult clinic (276, 379, 383, 384).  
As a result of the shift of parental responsibility of clinic attendance to the adolescents, a 
decline in clinic attendance can occur due to this change in supervision (385); nonetheless, 
promoting a routine of regular attendance supervised by the parents whilst under the pediatric 
care can aid in  maintaining attendance rates in subsequent adult clinic (386).  
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Glycemic Control  
The transition‘s impact on glycemic control has shown mixed results. Sparud-Lundin and 
colleagues conducted  a retrospective longitudinal study of adolescents (n=104) during transition 
to adult care and reported a decrease in HbA1c in females (p=0.004) but not in males (385). The 
higher frequency of visits by the females to the adult clinic may be a contributing factor however 
the authors conclude this gender difference warrants further investigation (385). 
Some studies have reported no significant change in HbA1c during this period (378, 380, 
387, 388) whilst the SEARCH for Diabetes in Youth group reported that a higher HbA1c level 
prior to transition predicted poor glycemic control in the adult care setting (389). In fact, the 
study describes 2.5 times greater odds of having poor glycemic control after transition to adult 
care if levels were higher during the pre-transition period (389). However when viewed 
prospectively the changes appear less dramatic with one study which followed the glycemic 
control of 82 adolescents with T1DM finding no significant change in HbA1c pre- to post 
transition (390). This was confirmed by another study which found no significant change in 
HbA1c post transfer (374). Despite these potentially positive findings, a recent systematic review 
assessing the impact of transitioning from pediatric to adult clinics once again reported mixed 
results for studies of glycemic control as assessed by HbA1c.  Of the 24 studies included in the 
review, 19 assessed the impact of transition on HbA1c levels. From nine observational studies, 5 
reported no change in HbA1c and only the study conducted by Sparud-Lundin (385), as 
mentioned previously, reported a change in females but not males. Of the remaining 10 studies 
that specifically examined transitional programs or an intervention, 6 reported improvement in 
HbA1c and 4 reported no change (369).  
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Follow-Up Losses 
Studies reporting on potential reason for losing patients to follow up cite relocation, 
transfer to a different center and follow-up by a general practitioner or at an obstetrics clinic 
(391). In a more recent prospective study conducted by Mistry and colleagues which included 
136 participants and explored the predictors of successful transition, high HbA1c levels were 
found to be predictive of poor follow up (381). Loss to follow up was also more prevalent within 
that cohort if the adolescents were diagnosed before the age of 12, if they were using multiple 
daily injections or if they were on a pump, and in those who had fewer visits to the pediatric 
endocrinologist prior to the transition (381). The authors did however identify that older children 
who had met with the adult physician prior to transitioning were less likely to be lost to follow-
up.  
In a retrospective study conducted by Bryden et al, following adolescents and young 
adults who had transitioned to adult care, the authors identified that 75% were attending 
specialist care, 19% were being followed by a general physician and 3% were not receiving any 
form of follow-up (392). Northam et al found that 38% of individuals with T1DM, after 12 years 
of diagnosis, (n=110; mean age of 20.7 years) were not receiving any specialist care (393).  
8.1.3.4 FEEDBACK FROM ADOLESCENTS AND YOUTHS ON WHAT IS WANTED FROM A 
TRANSITION PROGRAM 
 
 Several studies have reported on the experiences, either via focus groups or 
questionnaires, of adolescents undergoing service transition from pediatric to adult care (382, 
394-400). Table 32 highlights some of the factors within the transition process that appear to 
impact on a successful transition according to the adolescents themselves.  Youth  often describe 
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a feeling of unpreparedness for the focus on an older population and describe a sense of ―shock‖ 
and ―surprise‖  at the unexpected difference between the pediatric and adult setting (400).  
Table 32 Feedback from adolescents and youths of the facilitators of the transitioning 
process 
 
 
8.1.4 PREDICTORS OF SUCCESSFUL TRANSITIONING  
 
8.1.4.1 FAMILIARITY WITH THE ADULT CLINIC AND PHYSICIAN 
 
Kipps and colleagues were the first to describe a higher rate of clinic attendance in young 
people who had the opportunity to meet with the an adult diabetes consultant prior to transfer 
(375). This was followed by a large retrospective cohort study (n=1507), conducted by Nakhla et 
al who described the different methods of transfer of care and their impact on health outcomes. 
The results of that study revealed that those who transferred with no change to the physician 
Facilitators of Transition Process Studies 
Early preparation for transfer (399, 400) 
Provision of transition specific information (394, 395, 397, 400) 
Continuity of provider care during the transfer process (396) 
Meeting with adult provider whilst  under pediatric care (399, 401) 
Organized transition process (395, 397, 398) 
Flexible (382, 398) 
Short waiting periods (394, 395) 
Support scheduling and  re-scheduling appointments (400) 
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were 77% less likely to be hospitalized as compared to those who were transitioned with a new 
physician (402).  
8.1.4.2 TRANSITION COORDINATOR 
 
Holmes-Walker and colleagues (378) introduced a transition coordinator in a transition 
support program for youths (n=191) attending a specialist clinic with the aim of improving 
metabolic control and rate of hospitalization with diabetic ketoacidosis (DKA). The role of the 
transition coordinator or diabetes educator was to arrange booking and re-booking of 
appointments and to provide phone support service after working hours. The results were 
promising as there was a significant reduction in DKA related hospitalization (p=0.05) and 
HbA1C significantly improved (p < 0.001), with the greatest improvement seen in those with an 
HbA1c > 11% (−2.5 ± 2.3%, p< 0.001). Furthermore, there was an 82% attendance rate which 
was deemed as ‗good‘ 6 months after the initiation of the program. Interestingly, the cost saved 
from repeated admissions was used to cover the cost of the program itself. A major limitation of 
the study however, is the absence of a comparison group which makes it difficult to determine 
which components of the program contributed to the positive outcome and to what extent the 
changes seen were a result of the intervention itself.  
8.1.4.3 TRANSFER TO ADULT CLINIC IN THE SAME HOSPITAL 
 
Transfer of children to adult clinics within the same hospital depends largely on the 
availability of this service. In Bahrain, for example, transition to adult clinic occurs within the 
same hospital although this varies not only across countries but even within different provinces, 
states, or jurisdictions. In the United States young people may continue to see their pediatric 
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endocrinologist well into their early adulthood whereas transfer is usually mandated in other 
countries by 18 years of age (369).  
Vanelli and colleagues report on a retrospective study over an 8 year period which 
studied the effect of a structured transition  process in which the transition of adolescents (n=73) 
occurred  in the same hospital (403). The adolescents in the uninterrupted process had a clinic 
attendance rate which ranged between 92 and 100% although there was no control or comparator 
group. Cadario and colleagues (388) describe an observational study of adolescents (n=62) over 
10 years in which a structured transition process was put into place and led by a transition 
coordinator.  The transition coordinator followed the adolescents in the pediatric clinic during the 
patient‘s last year after which a provider sent a letter informing the adolescent about the 
transition at the second last pediatric visit; the last pediatric and first adult visit was run jointly 
between the pediatric and adult endocrinologists in the presence of the parents. The results for 
the participants (n=30) in the transition program revealed a higher rate of attendance in the adult 
clinic (80% vs. 57 p<0.05), a shorter mean review time between last pediatric and first adult 
clinic (0.8 years vs 4.6 years p< 0.001), and a lower HbA1c level after one year as compared to 
those that did not participate (n=32) in the program.  
8.1.4.4 YOUNG ADULT DIABETES CLINIC 
 
Several studies have reported on the experience of a ‗young adult‘ diabetes clinic as an 
interim phase between the standard pediatric and adult settings (380, 387, 404, 405). In Belfast, 
Ireland, the Young Persons‘ Clinic, setup to facilitate the transfer of adolescents with T1DM 
from pediatric to adult services, was audited. Attendance was rated as good in only 36% of the 
participants (n=33) with 6 of the participants having attended all scheduled appointments over 
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the two year period (380). Attendance was rated as being moderate in 33% and poor in 30% and 
the percentage of those with good attendance prior to transfer also had the highest attendance 
rate after transfer compared to those with poor attendance prior to transfer (380). The authors did 
not find a relationship between glycemic control and attendance rate and state that although they 
were not surprised by the results obtained, they were disappointed considering the great effort 
that was needed to set up these clinics. They conclude that possible factors contributing to the 
disappointing results could have been the lack of flexibility in clinic timings, the need to target 
more socially deprived patient as well as the relatively late age of transfer (mean 17 years) (380). 
 In a more recent observational study conducted by Johnson and colleagues in the UK 
involving two diabetes clinics for young adults the authors reported improved screening rates 
and lower non-attendance. However, mean HbA1c of participants in this study, which were 
compared to a previous audit of the centers by Wills et al (406), remained higher than 
recommended (< 58 mmol/mol or 7.5%) (405) suggesting that, whilst the special clinic may 
improve engagement and subsequently screening for complications in this high risk population, 
it has yet to translate into significantly improved metabolic outcomes.  
8.1.4.5 NEW APPROACHES AND TECHNOLOGIES 
 
―Maestro‖ is an innovative systems navigator service developed with the aim of 
increasing medical contact with youths transferring from pediatric to adult care. (383). Maestro 
was developed in Canada by the Winnipeg Regional Health Authority and the Child Health 
Program in 2002. A report released by Health Canada in 2008 placed the development of a 
transition care strategy for children with chronic disease from pediatric to adult clinic as one of 
the top priorities for the national public policy (407).  Maestro keeps a log of the telephone and 
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e-mail contact of youths so as to provide support in accessing healthcare service. Resources 
within this novel approach include provision of a comprehensive website, newsletter, 
announcement of casual group and educational events. In total, 64 participants and 101 controls 
have been involved in pilot testing to date. The results revealed no statistically significant 
difference in hospitalization for DKA or severe hypoglycemia; however, only 11% of system 
users versus 40% of the controls dropped out of adult care. After having been given access to the 
Maestro services, the control group increased their use of the healthcare services from 59.4% 
prior to Maestro to 73.3% after being given access to Maestro.  
8.2 DEVELOPMENT OF PROPOSED INTERVENTION 
 
The current intervention was borne out of discussions with service users and service 
providers as discussed in Chapter 6 and was developed based on the results of the systematic 
review described in Chapter 7 and the evidence review of transition programs for youths with 
T1DM moving from pediatric to adult clinic described above. Specifically, the intervention was 
based on cognitive behavioral therapy, as interventions with an explicit theoretical basis have 
been found to be more effective as mentioned in the systematic review. Elements of what youths 
themselves have found to ease transition were included such as preparation for transition one 
year prior, provision of transition specific information, scheduling appointments and setting up a 
framework for an organized transition process by means of a transition coordinator as a 
facilitator. Lesson plans such as those focused on managing blood sugar, coping with diabetes on 
a day to day basis, and effectively managing diabetes are all topics that are regularly taught as 
part of the current education received. However, unlike the current structured education the 
patients receive, this intervention uses a psycho-social approach.  Family support, conflict and 
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communication, although subjects frequently discussed during routine visits, are not part of the 
structured education and were therefore made explicit within the suggested transition program. 
Cognitive behavioral therapy, which stems from Albert Bandura‘s social learning principal 
theory, was selected as the form of psychotherapy as it focuses on problem solving in order to 
change negative thoughts or actions into positive or desired effects (323). It also aims to engage 
the patient directly giving them a sense of autonomy whilst encouraging them to assume 
responsibility and control of their condition (325).  
The intervention will be led by a pediatric nurse educator whose role includes the 
following:  
 Meeting quarterly with the patient and parent(s) or legal guardian during routine visits to the 
endocrinologist for a period of 15 months or 4 visits (see figures 9 and 10). 
 Conducting psycho-educational sessions with adolescents in the presence of their parent or 
legal guardian before/after medical appointments for a period of approximately 30 mins at a 
time. Four separate sessions have been designed:  
i) How to manage blood sugar for the long term 
ii) How to manage diabetes effectively  
iii) How to cope with diabetes day-by-day  
iv) Family support, conflict and communication  
 
The content of these sessions can be viewed in Appendix 13 and are based on the A-B-C 
Model of Cognitive Behavior Therapy. After each visit, families will receive a brochure 
summarizing the major session points to reinforce the verbal education and act as a resource for 
the future. 
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The proposed primary outcomes measures will be improvements in quality of life and 
problem areas that adolescents face with managing their diabetes; a secondary outcome measure 
will be improvement in HbA1c levels. Pre-existing questionnaires from The Diabetes Attitudes, 
Wishes, and Needs (DAWN) Study will be used to assess these outcomes (Appendix 11 & 12) 
and HbA1C levels routinely tested in the hospital laboratory will be used.  
8.3 PHASE I: FEASIBILITY AND ACCEPTABILITY OF PROPOSED INTERVENTION 
 
8.3.1 INTRODUCTION  
 
Prior to commencing any study it is crucial to assess the feasibility issues affecting the 
full study and to determine if the proposed intervention is relevant and sustainable in the given 
environment. Many highly controlled, well designed, randomized control trials allow 
researchers‘ to draw out causal inferences; however such interventions often fail in real-world 
settings because the focus on internal validity reduces the relevance of the intervention in a 
particular setting (408). Furthermore, the growing financial and resource constraints means that 
not all interventions will have sufficient funding to be tried.   
8.3.2 FEEDBACK FROM PEDIATRIC NURSE EDUCATORS & ADOLESCENTS WITH TIDM ON 
CONTENT, FEASIBILITY AND ACCEPTABILITY OF PROPOSED INTERVENTION 
Feedback from the pediatric nurse educators was overall positive. In terms of the content 
of the material used and the lesson plans, they felt that the material and the CBT questions were 
very relevant and appropriate to the adolescents in the clinic. In principal they agreed with the 
proposed lesson plans but did not rule out the possibility of making changes largely dependent 
on the results of the feasibility assessment. With regards to the use of a discharge summary chart 
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before transitioning, the nurses felt that it was a very essential and something they wished to 
implement immediately after obtaining approval from the pediatric diabetes consultants. 
As for the feasibility of the program, they voiced their concerns regarding the time 
proposed to be spent with youths and preferred it be cut down from the proposed 30-45 mins to 
20 mins with 5-10 mins in the end to allow the patient to fill out the questionnaires. They also 
voiced concerns regarding the additional work load this would be on just one nurse and felt that 
perhaps dividing the workload amongst the three nurses would decrease the load. They felt that 
ideally the implementation of the program would require the undivided attention of just once 
nurse whose role was to act as a transition coordinator; however they acknowledged that due to 
the less than ideal circumstances and financial restraints this would not be possible initially.  
Finally, when asked about whether they felt that the program would be accepted by the 
patients, the nurses stated that in their opinion the integration of the program into clinic setting 
would be appreciated as would the extra attention focused on the adolescents. They felt that the 
adolescent as well as their caregivers are more likely than not to appreciate the extra time and 
information they will receive to help the transition.  
Feedback from a couple of adolescents with T1DM was encouraging as they showed 
keen interest in participating in such a program. The content of the program they felt was 
relevant to their real life struggles with diabetes. However, one adolescent expressed his wish 
that more time be focused on the CBT subjects rather than the educational aspect which in his 
opinion he has ―all heard before‖ and felt it to be redundant.  Both adolescents appreciated that 
the program was integrated into clinical setting which meant that they did not need to miss out 
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on school time and were quite happy to stay an additional 30 minutes with the designated 
transition coordinator during their routine visits. 
8.4 PROTOCOL FOR FULL FEASIBILITY TESTING  
8.4.1 INTRODUCTION: 
As there is currently no transitional care program available for children with T1DM in the 
Salmaniya Medical Complex prior to transitioning into adult health care services within the 
hospital, a transition care program was developed. Thus the aim of this study is to assess the 
feasibility and acceptability of the proposed program.  
8.4.2 SPECIFIC AIMS OF THE STUDY: 
1. To assess the ease and efficacy of integrating the proposed transition care program 
into routine clinical setting. 
2. To assess the patient and healthcare workers acceptability of such program. 
8.4.3 STUDY AREA/SETTING: 
  
The proposed transition program with the use of a newly defined ‗transition coordinator‘ 
will be conducted in the out-patient pediatric clinic in the Pediatric Endocrine and Diabetes 
Clinic of SMC. The parent(s) or legal guardian of adolescents will be approached for consent 
four months prior to their entering the final year in pediatric care. For those who agree to 
participate, baseline demographic information will be collected prior to commencement of the 
intervention.   
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8.4.4 STUDY SUBJECTS: 
Study subjects will be children with diabetes aged 13 years of age. This age group was 
deemed appropriate since children are transferred to the adult clinic in SMC once they turn 14 
years and one day.  
The inclusion criteria are the following: 
 Children with T1DM entering their final year in the pediatric diabetes care   
              Exclusion Criteria  
 Children with T1DM with a history of psychiatric disorders  
 Children with T1DM being followed by a psychologist or psychiatrist  
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Recruitment of 
volunteer 
adolescents 4 
months prior to 
entering final 
year in Pediatric 
Clinic (PC) 
Scheduling of 
appointments by 
transition coordinator: 
 Appointments q 4 months 
in PC (3 appointments) 
 First appointment post- 
transfer in Adult Clinic 
(AC) 
2
nd
 appointment in final 
year of PCC 
 Meet with 
Endocrinologist as 
usual 
 Meet with PDN as 
usual 
 Meet with Dietician 
 Meet with (20-30 
mins) 
 
1
st
 appointment in final 
year of PCC 
 Meet with 
Endocrinologist as 
usual 
 Meet with PDN as 
usual 
 Introduction to 
Transition 
Coordinator (TC)  
(20-30 mins) 
After 4 months  
3
rd
 appointment in final 
year of PCC 
 Meet with 
Endocrinologist as 
usual; obtain 
summary file  
 Meet with PDN as 
usual 
 Meet with TC (20-
30 mins) 
 
After 4 months  
1
nd
 appointment in 
Adult Clinic  
 TC facilitates meeting 
with Adult 
Endocrinologist and 
nurse educator 
 TC hands over patient 
summary file 
 Brief meeting with 
TC after 1
st
 AC 
appointment (20-30 
mins) 
 
After 4 months  
Follow up Phone 
Call after 6 
weeks 
Referral to 
other 
healthcare 
providers if 
needed 
PCC: Pediatric Clinic Care 
AC: Adult Care  
PC: Pediatric Clinic  
PDN: Pediatric Nurse Educator  
TC: Transition Coordinator  
Reminder of 
appointment 
by TC one 
week prior  
Reminder of 
appointment 
by TC one 
week prior  
Reminder of appointment 
by TC one week prior  
Figure 9 Flow diagram of proposed intervention for adolescents in final year of 
pediatric diabetes care   
 
210 
 
 
8.4.5 RECRUITMENT: 
The Pediatric Nurse Educators will submit a list of patients that meet the criteria. These 
children and their parent(s) will be approached for consent to participate in the feasibility study.  
8.4.6 SAMPLE SIZE: 
 
Approximately 10-15 adolescents are transferred yearly according to the pediatric 
diabetes nurse educators as official statistics on transfer number are currently not available at the 
pediatric diabetes clinic in the SMC (409). A convenience sample of participants will be 
recruited to assess the feasibility of implementing the intervention.  
8.4.7 DATA COLLECTION METHODS: 
 
Upon obtaining consent, demographic information will be collected as well as 
anthropometric measurements such as the child's weight, height, BMI, and waist circumference 
(see Figure 10). Participants will also be asked to complete at baseline and at every visit the 
Diabetes Quality of Life Youth Questionnaire (DQOLY) (Appendix 11) and the Problem Areas 
in Diabetes Questionnaire (PAID) questionnaire (Appendix 12).  The DAWN Study was initiated 
in 2001 by the pharmaceutical company Novo Nordisk and the International Diabetes Federation 
with the purpose of improving diabetes care at an International level (410). The aim of the 
DAWN qualitative study was to explore the attitudes of  people with diabetes as well as their  
care providers towards health care provision and to identify  their needs and wishes (410). The 
study involved 13 countries and over 5000 participants with type 1 and type 2 diabetes and was 
overseen by an international expert panel (411).  Since the initial study, the DAWN project has 
expanded considerably with the aim of implementing best practices in the management of 
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diabetes at a global level and has partnered with the ISPAD to develop the DAWN youth 
program. This initiative stems from a qualitative study looking at the attitudes, wishes, and needs 
of young people with diabetes, their parents, and healthcare providers (412). In an effort to 
improve the standards  of care for youths with T1DM, the DAWN youth project uses the 
Diabetes Quality of Life Youth Questionnaire (DQOLY) to assess QoL (413). QoL  has been 
recognized as a central outcome of health care (414) and  has been associated with lower HbA1c 
in adolescents with T1DM (415). The PAID questionnaire which will also be used has been 
found to not only correlate with the youths health beliefs‘, depression, social support and coping 
style (416, 417) but it can also be used to predict future blood glucose control (418). Response 
from these questionnaires at each interval of the transition program can help the clinicians assess 
improvements in the specified outcomes as a result of the proposed intervention. It can also be 
used to allow the healthcare providers to identify problem areas adolescents so as to tailor the 
most appropriate intervention such as the need for more individual vs. family centered 
intervention or even the need to refer to other healthcare professionals.  
8.4.8 DATA MANAGEMENT AND ANALYSIS PLAN:  
 
The Diabetes Quality of Life Youth Questionnaire (DQOLY))  and the Problem Areas in 
Diabetes Questionnaire (PAID) questionnaire will be completed prior to commencing the study 
as well as at the end of each visit to serve as a control.  The time taken at each visit and with the 
nurses, physicians, and transition coordinator will be noted as will the time taken to complete the 
questionnaires. Any difficulties or challenges that are faced by either the transition coordinator, 
the participants themselves or the physicians will be noted at each visit. At the end of the 
intervention, focus groups will be planned for the participants to obtain feedback on the program 
and areas of perceived strengths and areas where there is a need for improvement. Separate focus 
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groups will be planned for the healthcare members that participated including the transition 
coordinator. Themes produced from these focus groups as well as the notes taken during the 
intervention program itself will be used to help further develop the intervention program.  
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c
Once volunteers 
identified: 
 TC Schedules 
appointments by 
block   
 Check to see pt. has a 
completed  diabetes 
Registry Form (if not 
complete by phone )  
 Complete DQOLY 
and PAID 
questionnaire prior to 
commencing study 
 
1
st
 appointment with TC in PC 
 Complete Consent Forms  
 Explain role of TC and purpose 
of study 
 Record anthropometric 
measurements such as the child's 
weight, height, BMI, and waist 
circumference 
  Record BG readings 
 Lesson 1: How to manage 
blood sugar for the long term 
 Conclude and  gather data DQOLY 
and PAID questionnaire 
After 4 
months  
2
nd
 appointment with TC in PC 
 Record Anthropometrics/BG 
readings 
 Review previous session 
discussions  
 Lesson 2: How to cope with 
diabetes effectively 
 Conclude and  gather data DQOLY 
and PAID questionnaire 
  
After 4 months  
4
st
 appointment with TC 
in AC 
 Accompany  Pt  to first AC clinic  
 Handover summary file  
 Record Anthropometrics/BG readings 
 Review previous session discussions  
 Lesson 4 Family support, conflict  and 
communication  
 Conclude and  gather data from DQOLY 
and PAID questionnaire 
 
3
rd
 appointment with TC in PC 
 
 Complete and have signed pt. summary 
file 
 Record Anthropometrics/BG readings 
 Review previous session discussions  
 Lesson 3: How to cope with diabetes on 
a day to day basis 
 Conclude and  gather data from DQOLY 
and PAID questionnaire 
 Give Pt tour of AC and appointment desk  
 
 
Call after 6 
weeks to 
FUP  
After 4 
months  
Pt: Patient  
AC: Adult Care  
PC: Pediatric Clinic  
TC: Transition Coordinator 
BG: Blood Glucose  
 
Figure 10 Summary of Transition Coordinator’s role throughout the 
intervention 
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8.5 DISCUSSION 
 
The best practice approach to addressing the transitioning of adolescents and youths to 
adult clinics has come predominantly from professional bodies and is based primarily on expert 
opinion or consensus (252, 362-364). There is a consensus that a transition  program  should be 
well structured and well planned (368) but the details of the transition currently remain at the 
discretion of the institution or center.  
There is currently no transition program established at the Salmaniya Medical Complex 
and no formal information is given to the patient or their caregivers on the transition process. 
Qualitative data from focus groups has highlighted the demand for the development and 
implementation of a transition program from the perspective of the health care professionals as 
well as the parents of children with diabetes. One physician explains:  
“They need for us to spend more time with them, to try and deal with all these issues….you know 
especially when they transition to adult clinic they will feel lost …”  
The pediatric diabetes nurses have also highlighted the need to focus on adolescents with 
diabetes as they described them as being at a ―crisis age‖ and ―lost.” One nurse explains the 
dilemma they face when transferred adolescents want to return to pediatric diabetes care because 
of the lack of a structured support:  
“Ahh this period is very crisis period for the children. That they are newly diagnosed in this 
period they are teenagers they are not accepting sometimes. They are doing so many many 
things false from the disease. So they need support, they need very strong support so the patients 
when they are transferred to adult they are coming back to us because nobody is there for them.” 
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          The program was designed so as to be integrated into routine clinical setting to facilitate 
implementation and acceptability and to be cognizant of limited facilities and finances. The 
intervention was designed so as not to require additional staff or manpower; is applicable in 
clinical settings, and can be sustained without additional funds to maximize practicality although 
these factors will all be objectively assessed via the proposed feasibility study to assess whether 
this has been achieved.  
8.6 CONCLUSION  
 
              There is both a service-user demand from the families of children and adolescents with 
diabetes and a professional demand from the HCPs managing their care for such a program.  
Although the acceptability of the program has yet to be tested, the development of the program 
was based on evidence from the systematic review of interventions on children with T1DM and 
the literature review on the facilitators of successful adolescent and young adult transition 
programs. A feasibility study has been designed to ensure objective testing of the implementation 
and evaluation process, as well as the appropriateness of the program content to allow robust 
evaluation and ongoing development of the program. 
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9.0 CONCLUSION 
 
9.1 INTRODUCTORY COMMENTS  
 
 Diabetes has become a worldwide epidemic with the Middle Eastern and North African 
Region reporting some of the highest prevalence rates with far-reaching global and economic 
consequences (3). Bahrain, a small country in the heart of the Middle East has not escaped this 
burden. More alarming is the rise in T1DM in the pediatric population in the Kingdom.  
Within this context, this PhD program has comprised two key approaches to extending the 
knowledge base: 
1. Investigating the association between lifestyle, diet, and medical factors and the risk of 
T1DM in children in the Kingdom of Bahrain. 
2. Designing and developing an educational program for children with T1DM in Bahrain 
informed by an investigation of the local needs of the healthcare workers and families of 
children with T1DM and an assimilation of the evidence base. 
 
To the author‘s best knowledge, this study is the first of its kind to give insight into the 
lifestyle, dietary and medical factors associated with pediatric T1DM in the Kingdom. This study 
provides a platform for facilitating the implementation and adoption of existing international 
guidelines for children with T1DM (164) and for heeding the call for action made by the 
International Diabetes Federation (419).  
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The findings are summarized below with concluding remarks: 
 
1. Audit of a Pediatric Diabetes Registry available at the Salmaniya Medical Complex.  
(420) 
 
The Diabetes Registry Forms of 55 children with T1DM in the year 2009 and 2010 were 
audited to investigate whether any medical or lifestyle factors were associated with T1DM 
occurrence. The results showed that children with T1DM were significantly more likely to be 
Bahraini nationals than controls although with was no significant difference in self-reported race. 
Children with T1DM were significantly more likely to have suffered from an illness, than control 
children and significantly more likely to have undergone surgery prior to diagnosis than controls.  
Prenatal history identified mothers of T1DM children to be significantly more likely to have 
gestational diabetes with a trend towards greater maternal T2DM too. With prolonged 
breastfeeding prevalent in the Kingdom no association between reported infant feeding practices 
and T1DM was seen. 
In summary, whilst this audit could not prove causation due to the aforementioned 
limitations of the study design, they nonetheless appear to align with the infection 
hypotheses of T1DM pathophysiology as indicated by greater rates of early childhood 
illness and surgery in cases compared to non-diabetic controls. The preliminary findings 
have helped shed light on this under-researched population and have highlighted potential 
avenues for future country-specific prevention research. 
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2. Dietary intake of children with T1DM compared to healthy children as assessed by 
a single 24 food recall (421).  
 
The analysis of a 24-hr food recall revealed that children with T1DM consumed significantly 
more calories than the healthy controls. They also had significantly higher carbohydrate, fat and 
protein intakes when expressed as percentage of the RDA. Both children with T1DM and healthy 
controls consumed excess protein and sodium whereas fiber intake was below the RDA 
requirements as were the intakes of calcium and vitamin D.  
This study revealed that the diet of children with T1DM does appear to differ in some 
ways from that of apparently healthy (or at least diabetes-free) controls although both 
healthy and diabetic children of this age in the Kingdom are failing to meet many of their 
age and gender appropriate nutrient recommendations. This emphasizes the importance of 
continuing to promote adherence to existing ISPAD nutritional guidelines for children and 
adolescents with T1DM and perhaps highlights the need for a more general targeting of 
dietary intakes in school aged children in Bahrain.  
 
3. Vitamin D status of a small but representative sample of children with T1DM (422) 
 
Given the mounting evidence in regards to the link between vitamin D deficiency and the 
risk of developing T1DM, the authors investigated prospectively the vitamin D status of 18 
newly diagnosed children with T1DM.  Serum vitamin D levels were assessed using both the 
CLIA assay method and UPLC/MSMS. The results revealed that between 50% (UPLC/MSMS) 
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and 72% (CLIA) of the children had suboptimal levels of serum vitamin D according to accepted 
cutoffs. There was a statistically significant difference between the two assay methods (p= 
0.048.) and a poor agreement, with the CLIA assay method overestimating insufficiency.  
This study is the first of its kind to assess the vitamin D status of children with 
T1DM and has highlighted that, in line with previous studies in healthy children and adults 
in the Kingdom, suboptimal vitamin D levels are also common in children with T1DM. In 
light of the few but significant studies that have shown early childhood supplementation 
with vitamin D to reduce the risk of developing T1DM, vitamin D supplementation 
presents itself as potential prophylaxis against the development of T1DM. However, despite 
the subsequent interest in assessing and managing vitamin D levels in clinical populations, 
including those with diabetes, this study has highlighted the practical issues surrounding 
implementation in countries such as Bahrain, particularly limited access to robust 
screening methods and the potential methodological bias, and therefore misdiagnosis 
associated with some cheaper techniques. It is therefore essential that both resource issues 
and clinical efficacy are considered before implementing any new screening or 
supplementation program in the Kingdom to maximize impact. 
 
4. Prospective in-depth study on a small representative sample of children with T1DM 
 
Having identified potential lifestyle features associated with pediatric T1DM in the 
Kingdom, including differing dietary intakes, a more in depth prospective study was undertaken 
to confirm and hopefully extend these findings. In particular the study aimed to assess the dietary 
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intake of vitamin D as assessed by a vitamin D specific food frequency questionnaire and the 
average of three 24hr food recalls. Dietary intakes revealed similar trends to those described in 
the larger case-control study. Intake of dietary vitamin D as reported by a FFQ and 24hr food 
recalls were not sufficient to meet the requirements. A lifestyle and sunlight questionnaire 
revealed a trend towards an association between reported sunlight exposure and vitamin D with 
those exposed to more than 30 minutes per day having higher 25(OH) D levels (p=0.057). The 
children were not achieving the physical activity guidelines as assessed by the CPAQ 
questionnaire.  
It would appear that factors such as dietary intake, sunlight exposure and physical 
activity may to some extent impact the vitamin D status of children with T1DM. Dietary 
intake of vitamin D alone does not appear sufficient to meet the recommended RDA values 
and in light of the suboptimal serum vitamin D levels of a significant number of children in 
this cohort, there is an urgent need for consensus guidelines and recommendations 
specifically targeted for children with T1DM that encourages outdoor activity and sunlight 
exposure as well as a unified policy on vitamin D supplementation.     
5. Qualitative pediatric diabetes study  
 
Focus groups were set up in order to further investigate the beliefs and attitude of a sample of 
children with diabetes and their care givers in relation to the etiology and the management of 
their diabetes. With an overarching aim of this PhD being to improve diabetes services in the 
clinic it was felt essential to place the service-users at the center of the project and to seek their 
views before deciding on the focus of any service developments. Topics ranging from the 
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admission and educational process, to barriers to change and future recommendations were 
discussed yielding a number of key themes including fears of social stigma, impact of their 
condition on future marriage, and the fear of complications. Overall the educational process and 
services were described positively although these did not conform to current best practice as 
described in the international literature. Healthcare providers as well as the caregivers 
themselves highlighted the need for more support especially during adolescence and when 
transitioning to adult care services.  
These focus groups were unique in providing an in depth insight into the beliefs and 
attitudes of children with diabetes and their carers (both family members and 
professionals). All stakeholders agreed with the need to make improvements to facilities 
and to solve logistical issues in order to provide better services. Finally, the focus group 
highlighted the need to provide specialized care to adolescents in order to tackle the issues 
of this challenging group, directing the remaining research within this PhD.  
 
6. Systematic Review of Randomized Control Interventions in Children and 
Adolescents with T1DM 
 
A systematic review of interventions conducted in clinical settings seeking to improve the 
management of children and adolescents with T1DM was undertaken to further inform the 
service development work.  This included papers published between January 2010 (when a 
previous review was published) and June 2015.  In total 17 studies were included with the 
suggestion that study quality has improved from previous reviews and a clear shift towards more 
family focused interventions, and the use of the Internet to deliver interventions. Theoretical 
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based interventions were identified as being more effective and so this approach was adopted 
along with other positive factors in the subsequent program design phase. 
In summary, a combination of both educational and psycho-social family targeted 
intervention appear promising in this age group and warrant further research. The use of 
web-based interventions is an attractive and promising alternative, which can help improve 
adherence and scheduling conflicts. A key barrier identified is the real-life integration of 
such interventions which, when piloted show positive results, but in actual clinical and 
wide-spread settings fail to do so. The key unresolved issue remains what would 
consistently improve children’s HbA1C and diabetes self-management. However 
facilitators of successful transitional programs such as early preparation for transfer and 
provision of transition specific information have been identified as key in any transitional 
program and will be incorporated into the planned service developments. 
 
7. Development of transition care program for children with T1DM 
An intervention package was developed and a transition care program designed to 
incorporate key characteristics of successful interventions informed by the literature and 
cognizant of the needs assessment and client needs identified earlier in the project. Specifically 
the intervention package was based on a series of psycho-educational sessions grounded on 
cognitive behavioral theory. The design of the package offers a structured program that aims to 
prepare the adolescents to transition to adult services by providing transition specific 
information, continuity of care,  a health summary sheet, and an opportunity to tour the adult 
clinic prior to the transition.   
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 In summary, a transition care program has been developed as a direct result of an 
identified local demand from the service users (children and adolescents with diabetes and 
their families) and healthcare workers and grounded in the existing evidence base. A 
protocol for feasibility testing has been developed to assess acceptability and 
implementation of the program for the SMC pediatric endocrine outpatient clinic.   
9.2 FUTURE RESEARCH 
 
Future work should focus on redesigning the study using a probability sample that is 
adequately powered and that involves multiple centers.  There is also a need to design 
prospective and intervention trials that aim to improve the diet and lifestyle behaviors of 
Bahraini children with and without T1DM since there appears to be widespread deviation from 
the recommendations in this age group. Furthermore, there is a need for larger more adequately 
powered confirmatory studies to investigate the relationship between dietary intakes of vitamin 
D, sunlight exposure, and exercise on children with T1DM as compared to healthy children. The 
development of public health campaigns which encourage sensible sun exposure as a health 
recommendation should be explored especially in light of the abundance of sunlight that Bahrain 
enjoys. A larger mother and child cohort should be sought. Although no strong conclusion can be 
made in regards to the potential role of infection as a possible trigger or accelerator of T1DM 
development in high risk children, the results of our study warrant further investigation 
especially in light of the substantial evidence and the current research into potential vaccines 
which aim either to procure immunity against suspect viruses or by means of 
immunomodulation.   
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In relation to practical service delivery further work needs to be undertaken investigating 
the usage of the existing voicemail and hotline systems, the feasibility of putting into place a 
structured psychoeducational program for adolescents, and the delivery of partial home care as 
opposed to complete hospital care at diagnosis. There is also a need to acknowledge and address 
parental concerns besides the evident complications of the disease and use these to help leverage 
positive behavioral changes in the patients and their families as a whole.   
 Assessing the feasibility of implementing the proposed transition program by involving 
key and lay stakeholders is a top priority. Including a process evaluation is critical in order to 
explain the results achieved especially in regards to positive and significant outcomes.   
  
9.3 CONCLUDING REMARKS  
 
This thesis investigates the dietary, lifestyle and health risk factors of children with 
T1DM in the Kingdom of Bahrain. Children with diabetes do appear to differ from age matched 
controls with respect to medical history and socio-demographic characteristics. Larger 
confirmatory studies should be of importance as the Kingdom struggles with the health impact of 
the diabetes epidemic both in children and adults.  In the shorter term an evidence and needs-
based development of the diabetes service is being implemented and evaluated with the express 
aim of improving management and specifically transitioning of adolescents with T1DM in the 
Kingdom. 
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Control Group Questionnaire Form Date: ____/_____/_____ 
 
 
Local Health Center:  
CPR:  
Age:                             
Sex:  □ Male  □ Female  
                 
Nationality:                                      
 
Demographic Data & Current Medical Hx 
 
 
1) Birth Date: _____/____/______   Place of Birth: Country:___________ Area:_______ 
 
2) Race: □ Arab: ______________________ □ None-Arab  ____________________ 
 
3) Religion: □ Muslim □ Christian □ Jewish □ Hindu □ Other: ______________ 
 
 
 
4) Diagnosis of:        □ Hypothyroidism  □ ↓G6PD Act.  □ Celiac Disease  □ PCOS   
                               □ SCD/trait □ Thalassemia  □ Malignancies  □   Nephrotic Syndrome  
                               □ Obesity  □ Acanthosis: Location:__________________________ 
 
                                   □ Others: _______________________________________________   
 
 
5) Allergies: □ Unknown        □ Yes, __________________________________________  
 
 
6) Address:          Area: ___________________________  Block: ____________. 
    
 
7) Health Insurance: □ No    □ Yes, Specify,____________________________________    
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8) School: Attends School: □ Yes   □ No, explain ________________________________ 
 
Grade _____ 
 
Past Medical History 
 
9) Prenatal Hx: 
a. Pregnancy:  
i. Complications: □ Yes, ___________________________________  □ No       
ii. Gestational Diabetes: □ Yes, treatment______________________   □ No   
iii. HTN: □ Yes    □ No 
b. Use of medications/hormones: □ Yes, ___________________________   □ No 
c. Use of illicit drugs/alcohol/smoking: □ Yes (circle substance)   □ No  
d. Exposure to toxins/radiation: □ Yes, ____________________________  □ No 
 
10) Pre/Postnatal Hx:  
a. Labor onset: □ FT    □ Premature    
b. Delivery: □ NVD           □ C-section              □ Forceps/vacuum extraction                          □ 
Complications: ______________________________________ 
 
c. Birth Weight:_____________ kg                    Height:____________ cm  
 
d. Condition at Birth: Complications: □ No □ Yes, __________________________ 
11) Concerns about Growth & Development: □ No □ Yes, ________________________ 
12) Breast Feeding Hx:  □ Exclusively Breast Fed for ____wks/months  □ Bottle Fed  
                               □ Mix-Breast Fed & Bottle Fed 
13) Illness: □ Yes, ______________________________________________________ □ No 
 
14) Psychosocial Issues: □ Yes, __________________________________________   □ No 
 
15) Surgeries: □ Yes, ___________________________________________________  □ No 
 
16) Injuries: □ Yes, ____________________________________________________  □ No 
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17) Medication Taken: □ Yes, ___________________________________________  □ No 
 
18) Immunization: □ Up-to-date         □ Defaulter           
 
 
19) Family Hx of Type I Diabetes:   
a. Immediate Family:□ Mother   □ Father   □ Sibling    □ Identical Twin  □ None  
  
b. Maternal:□ G-Mother   □ G-Father   □ Aunt   □ Uncle   □ Cousin  □ None   
 
c. Paternal: □ G-Mother   □ G-Father   □ Aunt   □ Uncle   □ Cousin  □ None 
 
20) Family Hx of Type II Diabetes:   
a. Immediate Family:□ Mother   □ Father   □ Sibling   □ Identical Twin  □ None  
 
b. Maternal:□ G-Mother   □ G-Father   □ Aunt   □ Uncle   □ Cousin  □ None   
 
c. Paternal: □ G-Mother   □ G-Father   □ Aunt   □ Uncle   □ Cousin  □ None 
 
21) Family Hx of Gestational Diabetes: □ Mother   □ None 
 
 
 
 
 
 
 
 
 
 
Family History 
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22) Other Family Hx: 
 
 Mother Father Sibling MGM MGF PGM PGF 
Obesity         
Hyperthyroid        
Hypothyroid        
Celiac Disease         
Alopecia         
Vitiligo        
Addison's Disease        
Hypertension         
Hypercholesterolemia        
Stroke        
CAD/Angina/MI        
Kidney Disease        
Psychiatric        
Substance Abuse 
(drug/alcohol) 
 
       
Hypertension        
Others: 
□ 
 
       
 
Psychosocial History 
 
23) Support System: 
– Lives with both parents: □ Yes   □ No, explain ____________________________ 
– Total number of siblings: _______Brother(s) _______ Sister(s) _________ 
– Economic Situation: ___________________________________________________ 
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Healthcare Habits 
 
24) Current Healthcare Habits:  
 
a. Sleep Schedule: Schooldays:____ pm -_____ am  Holidays: _____ pm -_______ 
                                              
        Naps: ____________________       
 
b. Exercise/activity: __________________________________________________ 
 
c. Safety:____________________________________________________________ 
 
d. Healthcare visits: □ When needed    □ Routine____________________ 
 
 
 
25) Nutritional Habits:  
 
e. Weight: _________ Kg             Height: _________ cm                   BMI:_________ 
 
 
24 hour Food Recall 
 
Time Meal/Snack Examples 
 
Breakfast 
 
 
 
 
Snack 
 
 
Lunch 
 
 
 
 
Snack 
 
 
Dinner 
 
 
 
 
Snack 
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Sunlight Exposure & Lifestyle Questionnaire 
Living Conditions 
1. a) Do you live in a flat or house? 
       Flat □           House □ 
 
           If living in a house: 
1. b) Does it have a garden or patio (شوح)  
      Garden □                      Patio □                 None □      
1.  c) Does your child play in the patio or garden in your home?  
 
        Yes □              No □ 
Personal Practices 
2.  a) Does your child wear a head veil or scarf  (ب اجح) 
         Yes □                No □ 
2. b) When going outdoors which part of your child’s body is exposed and how 
often? 
 
Are the following body 
parts exposed      
 
   Always       Often      Sometimes       Rarely         Never 
Head Yes□        
No□ 
 
Hand  Yes□        
No□ 
 
Arms  Yes□        
No□ 
 
Legs  Yes□        
No□ 
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2. c) Does your child use sunscreen on their face?  
       
                             □ Always 
                             □ Often 
                             □ Sometimes 
                             □ Rarely 
                             □ Never 
 
2. d) Does your child use sunscreen on their body?  
       
                             □ Always 
                             □ Often 
                             □ Sometimes 
                             □ Rarely 
                             □ Never 
 
2. e) Does your child take a multivitamin  
 
          Yes □              No □ 
 
If taking a multivitamin…. 
 
2. f)  How many times per day? 
 
_____________________________ 
 
2. g) What is the brand name used?  
 
_____________________________  
 
 
Outdoor Exposure  
3. a) How much time on average is your child exposed to sunlight between 
the hours of 10 am and 4pm?  
                             □ None  
                             □ Less than 30 minutes  
                             □ 30 to 59 minutes  
                             □ 1 to 2 hours  
                             □ More than 2 hours 
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3.  b) During the following months how often does your child go outdoors for 
at least 15 minutes?  
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to 
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December 
to 
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March to 
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3. c)  In the past 12 months has your child had a suntan? 
  
          Yes □              No □ 
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Focus group participants versus non-participants  
a
 Chi Squared, 
 
 
 
 
 
 
 
 
 
 
 
Focus Group 
Participants 
Non-Focus Group 
Participants 
 
 
 
 
P Value 
n  % n  % 
Nationality 
Bahraini 4 80 13 86.7 
0.601b 
Non-Bahraini 1 20 2 13.3 
Child gender 
Male 3 60 7 46.7 
0.267a 
Female 2 40 8 53.3 
Race 
Arab 5 100 14 93.3 
1.000
b
 
Non-Arab 0 0 1 6.7 
Religion 
Muslim 5 100 14 93.3 
1.000
b
 
Non-Muslim 0 0 1 6.7 
Economic 
Status 
Low  0 0 1 8.3 
1.000
b
 Middle  5 100 11 91.7 
High 0 0 0 0 
Governorate 
Muharraq 1 25 1 25 
0.223a Capital 2 50 0 
 
Central 1 25 3 75 
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Focus Group for parents of children with diabetes and their families 
Some possible topics of interest that will be explored are as follows: 
Introductory topics/ ‘warm up’ 
 When was your child diagnosed with diabetes 
 What was your initial reaction/feeling?  
 How do you feel now towards your child's condition?  
 Evaluating their perceptions of the disease prior to and after admission 
 Did you know what diabetes was prior to your child's diagnosis? 
 Do you feel that you have a clearer understanding or the disease now or are some 
things still vague? 
 How do you feel he will cope with the disease in the future? 
 Evaluating whether the hospital stay was considered a good or bad experience and what 
could have been done to improve the stay. 
 Upon arrival at the hospital did you feel that the admission procedure went smoothly or 
was it hectic? 
 Who was the person that broke the news of your child's condition? 
  Where you placed in a private or public room? Where you comfortable? 
 What did you think of the nurses that were taking care of your child in the wards? 
 Overall do you feel that your hospital stay was a good or bad experience 
 What could have been done in your opinion to improve the stay? 
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 Evaluating any education received during the hospital admission period (i.e. its strengths 
& weaknesses,) 
 What did you think of the education you received from the diabetes nurse educator? 
Was it clear? Was there too much material or too little material covered?  
 Do you feel that the time spent on education was sufficient?  
 Where the nurses reassuring? Confident? Competent? 
 Did you feel that the dietician explained clearly the exchanges and dietary 
management? Did she spend sufficient time with you?   
 Did you feel that the consultant was clear in his explanation of the disease? Do you 
feel he spent sufficient time at the initial diagnosis and during his follow-up visits? 
 What suggestions do you have or comments for the physician/ the diabetes nurse 
educator/dietician? 
 What do you feel were the diabetes teams' strength and what were their weaknesses?  
 Evaluating the follow-up system at the pediatric diabetes clinic 
 
 What do you think of the follow up system available? The voice mail, fax and 24hour 
emergency line?  
 Do you feel that the follow appointment time given with the physicians is suitable?  
 Do the nurse educators give you sufficient time or do you feel hurried?  
 What do you think of the diabetes clinic itself? Do they have sufficient place and space? 
 Exploring recommendations for future support programs 
 In the future what support or educational programs would you like to have? 
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Focus Group on staff working with children with diabetes and their families 
Some possible topics of interest that will be explored are as follows: 
 Evaluating barriers to education process and behavioral changes 
 What do you feel are some of the barriers to educating parents and/or child? i.e. 
educational materials, other resources, finances, time etc.… 
 Is time spent on education an issue? i.e. too long too short  
 What do you consider is the ideal amount of time required to cover the material? 
 From your experience what are the greatest barriers to behavioral health related 
changes? i.e. accepting diagnosis, willingness to administer insulin, willing to check 
BG by HgT, willing to make changes to diet.    
 Evaluating the role of the health care workers in educating family post diagnosis.  
 What is your role in education at time of diagnosis? 
 What is your role in post-discharge follow-ups? 
 Exploring recommendations for future educational programs  
 What would be needed in your opinion to strengthen the educational program? (time, 
money, resources)  
 Would you benefit from more educational resources and if so what kind? 
 Do you feel you need more training or educational courses 
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Focus Group on staff working with children with diabetes and their families 
Some possible topics of interest that will be explored are as follows: 
Introductory topics/ ‘warm up’ 
 Number of years spent working with diabetes 
 Time spent currently working with diabetes 
 Evaluating the role of the health care workers in educating family post diagnosis.  
 Who is part of your diabetes team?  
 Who do you work closest to? 
 What is your role at time of diagnosis? Whose job is it to break the news to the 
family? 
 What is your role in post-discharge follow-ups? 
 What is the role of the nurses in your team 
 What is the role of the dietician?  
 Do you refer your patients to other consultants and why?  
Evaluating barriers to education process and behavioral changes 
 What do you feel are some of the barriers to educating parents and/or child? i.e. 
educational materials, other resources, finances, time etc.… 
 From your experience what are the greatest barriers to behavioral health related 
changes? i.e. accepting diagnosis, willingness to administer insulin, willing to check 
BG by HgT, willing to make changes to diet.  
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 Do you think that certain groups are more/ less receptive to education – if so who?  
(e.g. different age groups/ parents versus children / with or without good family 
support) 
 Exploring recommendations for future educational programs  
 What would be needed in your opinion to strengthen the educational program? (time, 
money, resources)  
 Would you benefit from more educational resources and if so what kind? Face to 
face, online?  
 Do you feel you need more training or educational courses? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
283 
 
Diabetes Quality of Life Youth Questionnaire (DQOLY) from Dawn Youth Study 
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Problem Areas in Diabetes Questionnaire (PAID) questionnaire from Dawn Youth Study 
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Proposed transition program for adolescent with T1DM 
Lesson Plan 1: 
 
Introducing yourself as a Transition Coordinator 
 
My name is ________ I am a pediatric diabetes nurse, I will be your transition coordinator. 
My role will be to facilitate your transfer to adult clinic in one year‘s time.  
Part of my job will be to: 
 Meeting with you and your parent(s) before or after your routine visit with your 
endocrinologist for a total of 4 visits. ( 3 in pediatric clinic and 1 in adult clinic) 
 Each meeting will include a lesson plan for a period of approximately 30 minutes  
 After the lesson plan I will be asking you to fill out 2 questionnaires.  
 I will also be calling in between visits to remind you of appointment schedule, help you with 
questions, solve problems or help with any resources needed. 
 
 
 
 
 
 
 
 
 
 
5-10 
mins  
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Managing diabetes for the long-term  
Activity #1 
 
 Use the ―my blood sugar‖ tool to guide this section.  
 Ask them to communicate what the latest readings for long term blood sugar show? What 
does it tell them about their sugar control? 
 
 
 Ask them to identify on a scale of 0-10 how concerned they are about their blood sugar 
 
 
Complications : 
 Discuss importance of maintain good HbA1c control  
 Discuss consequences of poor control in terms of damage to the large blood vessels heart 
attacks and stroke: having diabetes increases your risk of having a heart attack or stroke, 
kidney disease, blindness and even amputations.  
 Clarify that in adult care unlike in pediatrics, they may see patients with these conditions  
 
 
 
 
 
 
 
Activity # 2: 
 
 
 
 
 
 
10 
mins  
 15 
mins  
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Activating Activa  
I have a high 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I don‘t like c ecking my 
blood sugar  
  
Consequences: How do you feel? 
What did you/didn‘t you do   
Beliefs: What do you think or tell 
yourself  
Effect: How would you like to feel? What 
would you ideally do?  
Activating Agent 
Discussion: Is it helpful or unhelpful, will it help 
me reach my goals 
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Complete Brochure of Points of Focus 
Lesson One Focus Points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________ 
5 mins  
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Lesson Plan 2 
 
How to manage diabetes effectively  
 
Re-assure patient that you are here to guide and support them along the path so as to maximize 
their health potential.  
 
 
Review the following points making sure to engage patient and actively listen: 
 
 
Treatment of Hypo-glycaemia (hypo)  
                   
 Explain that while hypo-glycaemia occurs when your blood glucose levels drop (usually 
below 4.0mmol/L) Hypos can be caused by missing a meal, not eating enough 
carbohydrates for a given dose of insulin, unplanned. 
 Explain or ask patient to explain how to treat a hypo 
 Review use of glucagon injection  
 
 
 
Treatment of  Hyper-glycaemia: 
 
 Hyper-glycaemia occurs when the levels are too high (usually above 15mmol/L).    
 Review causes of hyperglycemia  
 Review injection site rotation  
 Explain or ask patient to explain how to treat a hypo 
 Review importance of checking blood sugar  
 
 
 
 
 
 
 
 
 
 
 
CBT-Therapy activity  
 
 
 
 15 
mins  
 10 
mins  
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I have a high blood sugar 
reading   
  
Beliefs: What do you think or tell yourself  
 
                     Discussion 
Activating Agent 
Consequences: How do you feel? What did 
you/didn‘t you do   
Consequences: How do you feel? What did 
you/didn‘t you do   
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Complete Brochure of Points of Focus 
Lesson Two Focus Points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
_ 
5 mins  
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Lesson 3:   
Coping with Diabetes Day-by-Day  
 
Explain how these daily factors t can affect blood sugar; engage patient and actively listen 
 Exercise: 
i. Exercise brings down blood glucose levels.  
ii. Explain how different kinds of exercise affect insulin and carbohydrate balance.  
iii. Explain how to avoid hypos whilst exercising(i.e. a snack prior to exercise or 
starting with higher levels than usual can help to avoid having a hypo 
 Diet:  
i. Importance of eating healthy low fat foods 
ii. Balancing carbohydrate with insulin  
 Hormones 
i. Puberty hormones can impact blood sugar causing hyperglycemia  
 Illness:  
i. It is important to have a sick plan in place to help manage your diabetes during 
times of illness.  
ii. Review sick days rules   
iii. Review when to contact diabetes educator and when to go to the 
hospital/emergency 
 
 
 
 
 
 
 
 
Activity # 2 CBT-Therapy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15 
mins  
 10 
mins  
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I want to eat whenever and 
whatever I want    
  
Consequences: How do you feel? What did 
you/didn‘t you do   
Beliefs: What do you think or tell yourself  
 
Discussion 
Effect: How would you like to feel? What 
would you ideally do?  
 
Activating Agent 
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Complete Brochure of Points of Focus 
Lesson Three Focus Points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
5 mins  
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Lesson 4: Family support, conflict and communication  
 
 Ask patient what he/she sees; actively listen 
 Use the children‘s circle tool to explain to patient how diabetes is different when you are 
a child. Focus on the child being within the family circle and the child‘s surroundings  
 Explain that transitioning into adult care means that you will gradually be moving out of 
the family circle (overlapping and sharing responsibility at one point) but your family and 
friends will still be there to support you. 
 Explain briefly the difference in communication between pediatric and adult care (i.e. 
pediatric care, the healthcare provider will communicate with you and your parents; but 
in adult care, they expect to be communicating with you.) 
 
Children‘s Circle Tool (DAWN-2) 
 
 
 
Activity # 2 CBT-Therapy 
 
 
10 
mins  
15 
mins  
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My parent(s) upset me 
when…    
  
Consequences: How do you feel? What did 
you/didn‘t you do   
Beliefs: What do you think or tell yourself  
 
   Discussion 
Effect: How would you like to feel? What 
would you ideally do?  
Activating Agent 
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Complete Brochure of Points of Focus  
 
Lesson Four: Focus Points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________ 
5 
mins  
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